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Abstract
Summary
Failure of the embryo to implant into the uterine lining results in infertility and is also 
the rate limiting step in IVF. The tethered, glycoprotein MUC1 is a protective cell 
surface receptor that has been associated with infertility. Evidence suggests MUC1 and 
other endometrial mucins regulate embryo implantation. Endometrial epithelia must be 
shielded from infection whilst permitting the recognition and implantation of the 
embryo. The protein backbone of MUC1 is thought to act as a scaffold for L-selectin 
ligands and may be integral to the initial tethering of the embryo during early 
implantation.
Objectives
The remit of this thesis was to model the expression of MUC1 and other mucins in the 
human endometrium using endometrial cell lines and to use atomic force microscopy to 
understand the role played by these proteins in shaping the non-specific and embryo 
specific adhesive characteristics of endometrial monolayers. If possible the proposed L- 
selectin implantation mechanism was to be identified and functionally characterised.
Methodology
This project successfully married the traditional molecular tools of quantitative PCR 
and immunocytochemistry with novel application of INCELL analyzer high content 
screening protein analysis, peak force quantitative nano-mechanical mapping atomic 
force microscopy and single molecule force spectroscopy atomic force microscopy to 
characterise the specific and non-specific surface adhesion on live endometrial 
monolayers.
Results
Firstly, immunocytochemistry and qRTPCR revealed that basal MUC1 expression was 
significantly higher in Hec-l-B relative to Hec-IA, Ishikawa and Hec50. Secondly, 
INCELL analysis qualified a distinct heterogeneous expression of MUC1 across the 
endometrial monolayer and delineated altered patterning following treatment with 
estradiol and progestins. Thirdly, we have shown a direct and proportional correlation 
between MUC1 expression and adhesion in live Hec-IA and Hec-IB cell monolayers. 
Fourthly, this work has confirmed and characterised binding of recombinant L-selectin 
to the endometrial epithelial cell surface. Fifthly, it is shown that L-selectin surface 
binding decreases following a reduction in MUC1 surface presentation.
Conclusions
The results implicate MUC1 as a key component of endometrial adhesion and an initial 
mediator of implantation with a functional patterned expression suggesting areas of 
altered receptivity exist across endometrial monolayers. Abnormal MUC1 expression 
has been shown in endometrial pathologies and unexplained infertility. The current 
investigation suggests MUC1 protein may assist embryo attachment by retarding it 
sufficiently through mechanical impedance to allow specific L-selectin binding further 
securing the embryo. A non-receptive endometrium may contribute towards the infertile 
phenotype despite repeated IVF treatments, thus novel examination of potential embryo 
adhesion molecules such as MUC1 may aid understanding of endometrial 
characteristics which prevent embryo implantation and contribute towards IVF failure.
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1.01 Infertility
The National Institute of Clinical Excellence (NICE) defines infertility as “A woman of 
reproductive age who has not conceived after 1 year of unprotected vaginal sexual 
intercourse” (NICE clinical guideline #156). Infertility is estimated to affect 14.3% of 
heterosexual couples in the UK, and prevalence has been revised upwards (from 9%) 
since the last NICE guidelines were issued in 2003. The causal factors behind infertility 
are numerous and include; uterine or endometrial factors (Strowitzki et al. 2006), 
gamete or embryo defects (S. Zhang et al. 2013), and pelvic conditions such as 
polycystic ovaries or endometriosis which can both dramatically impact fertility 
(Falconer 2013). These causes are summarised in Figure 1.
a unexplained infertility (no identified 
male or female cause)
a ovulatory disorders 
y tubal damage
a  factors in the male causing infertility 
a uterine or peritoneal disorders
Figure 1: The aetiology of infertility. Recently revised NICE guidelines (Feb 2013) 
show the breakdown of the causes of infertility in the UK, 25% of all cases have no 
defined cause.
If the cause is known then specifically targeted medical treatments can be used to 
restore fertility such as the application of ovarian hormones to reverse anovulatory 
disorders, minimal invasive surgery (MIS) for treatment of endometriosis and assisted 
reproductive technology (ART). ART encompasses a broad spectrum of assisted 
conception techniques that do not require vaginal intercourse, such as in vitro 
fertilization (IVF), embryo cryopreservation, and intra-uterine insemination (IUI). One 
quarter of infertility cases have no defined cause, meaning it is difficult for clinicians to 
prescribe an appropriate course of action. It has been suggested that a defect in the 
lining of the uterus could be a silent contributing factor behind a large proportion of
16
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unknown infertility cases (Graham et a!. 1990; Diedrich et al. 2007; Sundqvist et al. 
2012; Aplin et al. 1994; Carson et al. 2000).
1.02 The uterus and reproductive tract
The female reproductive tract is a multifunctional system evolved to support pregnancy 
(Figure 2). The ovaries produce the female reproductive cells (oocytes) and facilitate 
their transport through the fallopian tubes (oviduct) to the uterus for 
fertilisation/conception. Following conception the fertilised embryo travels to the uterus 
and implants into the uterine lining (endometrium), signalling the beginning of 
pregnancy. In the absence of fertilisation and/or implantation the uterine lining 
undergoes a cyclic shedding and regeneration termed the menstrual cycle. The ovaries 
are a key component of the female reproductive system and produce the requisite 
steroid hormones for the menstrual cycle control.
Body o f  uterus
Fallopian tubeFallopian tube
Ovarv Ovary \  Ovarian 
ligament
Ampulla
EndometriumMyometrium
C ervix
Figure 2: The structure of the female reproductive system. The female reproductive 
system principally consists of ovaries (small paired organs situated near the pelvis) and 
the uterus (a thick, pear shaped, muscular organ) interconnected by the fallopian tubes. 
Further down the cervix connects the uterus to the vagina, which allows passage of 
sperm during intercourse and also the release of menstrual fluid during menstruation.
1.021 The ovaries
The ovaries are small, round, paired organs that are covered by the mesovarium portion 
of the broad ovarian ligament and situated in the ovarian fossa, a shallow depression in
17
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the pelvic wall adjacent to the uterus body. The central medulla is the central portion of 
the ovarian body and is surrounded by a tough connective tissue known as tunica 
albunginea. The major functions of the ovaries are the production of female germ cells 
(oocytes) which are released from a dominant ovarian follicle in a process known as 
oogenesis (Sanchez & Smitz 2012) and the generation of bioactive molecules, primarily 
steroids such as the estrogens and progestins. Such compounds are critical for ovarian 
function, regulation of the hypothalamic pituitary ovarian (HPO) axis (Figure 3), 
development of secondary sex characteristics and importantly regulation of endometrial 
receptivity to enable a fertilised embryo to implant and gestate (Ozturk & Demir 2010).
Hypothalamus
G n R H
P itu ita r y
LI I
Ovaries
E n d o m e tr iu m
Figure 3: The hypothalmic-pituitary-ovarian axis. Gonadatrophin releasing hormone 
(GnRH) secreted from the hypothalamus acts on the pituitary gland causing it to secrete 
follicle stimulating hormone (FSH) and lutenizing hormone (LH). LH and FSH regulate 
the secretion of estrogen and progesterone from the ovaries, which in turn control 
endometrial receptivity and exert negative feedback control on the pituitary gland and 
hypothalamus.
1.022 The fallopian tubes
The fallopian tubes (oviducts) act as a conduit between the ovaries and the 
endometrium. The ampulla is the widest region of the oviduct and typically serves as 
the site of conception (the meeting of the sperm and the egg). Post-fertilisation, the 
oviduct facilitates the transfer the embryo to the site of implantation in a process known 
as gamete transfer.
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1.023 The uterine cavity
The uterus has a small central cavity that serves to host the developing embryo from 
implantation stage to successful parturition over a 9 month gestational period. The 
utems is located deep within the pelvic region suspended by cardinal, uterosacral and 
broad ligaments that allow for some movement. The uterus consists of three layered 
tissues, the outer peritoneum, the muscular myometrium and the inner mucosa, termed 
endometrium. The uterus is attached to the cervix, a hollow structure that adjoins the 
vagina and facilitates child-birth, sexual intercourse and passing of menstrual fluid.
1.024 The endometrium
The endometrium is a highly dynamic tissue lining the uterus that undergoes monthly 
cycles of growth, differentiation, shedding and regeneration between the years of 
menarche (age-12) and menopause (age 50+). Structurally it consists of a single-layered 
epithelium and its basal lamina, uterine glands, and a specialized, cell-rich connective 
tissue (stroma) containing a rich supply of blood vessels.
The endometrium functions to lubricate and thus prevent adhesion and abrasion 
between the opposing walls of the myometrium (sub-endometrial layer) and to provide 
a suitable surface for the fertilised embryo to implant into the uterine lining. The 
endometrial epithelium is the first point of contact between the maternal and embryonic 
tissues and thus must be receptive to the embryo. Like other epithelia, the endometrium 
possesses defence mechanisms to resist bacterial infection while allowing the 
recognition and adherence of an embryo. This adhesion/anti-adhesion balance is 
paramount and is addressed in detail later. This modulation of endometrial adhesion 
depends on the expression of cell surface proteins that are regulated by steroid 
hormones secreted by the ovaries (Maybin & Critchley 2012). The endometrial 
epithelium is the critical surface in establishing pregnancy and undergoes cellular and 
morphological changes in response to these steroid hormones that prepare the 
epithelium for implantation (Wang & Dey 2006). These morphological changes include 
the appearance of ciliated epithelial cells and flower-like projections called pinopods 
(Figure 4) that are thought to be indicative of suitable embryo implantation sites, 
referred to as nidation sites (Quinn & Casper 2009; Murphy 2006).
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A
Figure 4: The surface of the endometrium. (A) Electron micrographs show cultured 
endometrial biopsy from woman who had undergone combined estrogen/progesterone 
treatment, replicating “receptive” conditions. Smooth epithelial projections termed 
pinopods and ciliated cells are shown. (B) The embryo adheres to the uterine 
epithelium. The nidation site where conditions are favourable for trophoblast attachment 
is shown in red. The defining characteristics of this site are unknown. Images 
reproduced from (Nardo et al. 2002) and (Petersen et al. 2005).
1.03 The ovarian hormones
The hormones that control the development and maintenance of endometrial receptivity 
are progestins and estrogens which are secreted by the ovaries (Dey et al. 2004). These 
ovarian secretions are in turn regulated by gonadatrophin releasing hormone (GnRH) 
secreted from the hypothalamus and luteinizing hormone (LH) and follicle stimulating 
hormone (FSH) secreted from the anterior pituitary gland. This co-ordinated regulation 
is the basis for the HPO axis (Figure 3) (Yen 1977). The primary female reproductive 
hormones are estrogen and progesterone, and are critical regulators of sexual 
differentiation, maturation, foetal growth, foetal development and endometrial 
receptivity (Krolik & Milnerowicz 2012; Ozturk & Demir 2010).
The ovaries secrete progesterone and estrogen at varying concentrations throughout a 
monthly cycle known as the ovarian cycle (Figure 5). Estrogen is produced naturally in 
three closely related isoforms; estrone (Ei) estradiol (E2) and estriol (E3). E2 is the 
primary estrogen produced between menarche and menopause, while in post­
menopausal women estrone becomes dominant (Blair 2010). During the late follicular 
phase (days 9-14) of the ovarian cycle (ovarian cycle is shown in Figure 5), estrogen is 
the dominant hormone secreted. In the ovary, competitive follicular development begins 
due to an increase in FSH and a surge in LH secreted by the anterior pituitary gland 
occurs mid-cycle; 24-36 hours post-surge the oocyte is released from the dominant
T r o p h o b la s t  
B
N id a t io n  s it e
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follicle (Christensen et al. 2012). During the surge LH stimulates the dominant follicle 
to release high concentrations of E2 (Baerwald et al. 2012). The outcompeted follicles 
undergo atrophy in a process known as ovarian follicle atresia.
After ovulation occurs the oocyte is swept down the oviduct by ciliated cells ready for 
potential fertilisation in the ampulla. The residual primary follicle is now transformed 
through the action of LH and FSH into the corpus luteum, a post ovulatory body that 
secretes modest concentrations of E 2  and greatly increased progesterone ( P 4 ) .  The luteal 
phase is characterised by elevated P 4  which primes the endometrium ready to receive 
the fertilised embryo. This priming of the endometrium is driven through the actions of 
E 2  and P 4  mediated by their respective receptors that are expressed in endometrial 
stromal and epithelial tissues.
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Figure 5: The ovarian cycle. During the follicular stage the secretion of LH by the 
anterior pituitary gland stimulates the primary follicle to produce E2 , which in turn 
exerts its effects on the endometrium. After ovulation the corpus luteum secretes P 4  that 
primes the endometrium for implantation. Chart reproduced from serum concentrations 
stated in (Strieker et al. 2006), data compiled from 20 women not in receipt of 
contraception.
1.04 The ovarian hormone receptors
Estrogen and progesterone receptors (ER, PR) belong to the nuclear hormone receptor 
(NHR) super-family (Mangelsdorf et al. 1995) which comprises 48+ transcription 
regulators and factors that are dependent on hormone ligand activation (Germain et al.
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2006). In addition to ER and PR other examples of NHR include peroxisome 
proliferator-activated receptors (PPARs), thyroid receptors (TRs), androgen receptors 
(ARs) and retinoid acid receptors (RARs) (Lonard & O’Malley 2006; Lonard et al.
2007).
Estrogen action is mediated through 2 main receptor isoforms: ER alpha (ERa) and ER 
beta (ERp) encoded by 2 genes ERS1 and ESR2 (Amal et al. 2010; Nilsson 2002). 
These receptors localise to the plasma membrane of endometrial epithelial cells. Both 
estrogen receptors show overlapping expression in most tissues however distinct 
patterns of expression are found across gonadal tract, breast, testis, bone, skeletal 
muscle, liver, adipose tissue, central nervous system (CNS), vascular endothelium and 
bone marrow (Matthews & Gustafsson 2003). The ERa isoform is predominantly 
expressed in the endometrium of pre-menopausal women and has been shown to 
decrease post-menopause (Sakaguchi et al. 2003). Chapter 2 of this thesis describes two 
endometrial cell lines originating from women aged 39 (pre-menopause) and 72 (post 
menopause) and chapter 3 shows the relative expression levels of ERa and ERp in these 
models cell lines, demonstrating experimentally the disparity of ER expression.
P4  is the major progestin in animals and its effects are mediated through progesterone 
receptor (PR). P4  is produced by the corpus luteum, the adrenal glands and the placenta, 
and plays a critical role in the regulation of the endometrium. During the first half of the 
ovarian cycle E2  acts to expand the endometrial lining through stromal cell proliferation 
(Ozturk & Demir 2010). Post-ovulation P4 serum levels increase over 40 fold (0.74- 
40.32) during the luteal phase (Figure 6 ) and this induces cellular differentiation of 
epithelial and stromal cells while antagonising the proliferative effect of E 2  through ER 
repression (Klaassens et al. 2006). The role of P4  in inhibiting E2  driven proliferation is 
vital in maintaining endometrial homeostasis and preventing excessive E2  driven cell 
proliferation (Kim et al. 2013). This is the rationale behind the use of P4  and the 
synthetic progestin medroxy-progesterone acetate (MPA) to treat ER-positive advanced 
endometrial carcinomas (Kim et al. 2013; Thigpen et al. 1999).
The action of P4  is mediated through two isoform of PR that, unlike ER, are expressed 
from the same gene sequence but have different promoters (Kastner et al. 1990). The 
two isoforms PR-A and PR-B are structurally distinct and exert different genomic 
effects in response to ligand binding. This results in a system in which the expression of
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progesterone target genes can be controlled by the ratio of PR-A:PR-B in specific 
tissues, and this has been shown to vary through the uterine cycle (Mote et al. 1999), 
and in endometrial cancers (Kumar et al. 1998).
1.05 The uterine cycle
The release of E2  and P4  during the follicular and luteal phases of the ovarian cycle 
results in ligand bound activation (or repression) of ER and PR target genes in the 
endometrium. Cyclic changes to these hormones thus regulate a corresponding series of 
physiological changes (mediated through ER and PR signalling cascades) to the lining 
of the uterus over the monthly cycle that prepare for embryo implantation.
Following successful implantation the embryo invades the uterine epithelium and the 
syncytiotrophoblast cells which line the trophoblast begin producing human chorionic 
gonadotrophin (hCG) (Handschuh et al. 2007). HCG stimulates the corpus lutem to 
continue secreting progesterone and thus prevents menstruation (see Figure 6  for 
menstruation)(Strott et al. 1969). HCG (referred to as the “pregnancy hormone”) 
sustains pregnancy by promoting angiogenesis of the uterine lining (Bemdt et al. 2009), 
suppression of maternal leukocyte migration (Akoum et al. 2005) and response and 
growth of the uterus in line with the developing embryo (Reshef et al. 1990).
In the absence of implantation the endometrium proliferates and degenerates over a 28 
day cycle which is divided into three distinct stages; the menstrual, proliferative and the 
secretory phase (Figure 6 ). During the menstrual phase a decrease in serum levels of E 2  
and P4  cause the lining of the endometrium to be lost through menstruation with only 
the stratum basale (basal layer, 2-3 cells thick) being retained. This lost tissue is 
regenerated through the action of E2  during the proliferative phase where the stratum 
basale serves as a source for regeneration of the stratum functionale (functional layer of 
the epithelium that faces the lumen)(King & Critchley 2010). The growth and 
regeneration of the stromal and epithelial layers appears to be interconnected as 
epithelial cells proliferation rates are reduced in co-culture with stomal cells (Arnold et 
al. 2 0 0 1 ) suggesting that hormonal effects are exerted through paracrine signalling 
through the epithelial basement membrane. It is important to consider paracrine signals 
when devising cellular models of the endometrium as stromal signalling has been 
shown to influence endometrial epithelial cell proliferation and gene expression (Arnold 
et al. 2001). Finally, the secretory stage is marked by P4  induced morphological changes
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that prepare the epithelial layer for embryo implantation. This remodelling of the 
endometrium is termed decidualisation and involves a secretory transformation of the 
uterine glands, influx of maternal immune cells, thickening of the stromal layer and 
vascular remodelling of the stromal glands (Gellersen et al. 2007).
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Figure 6: The uterine cycle. During the menstrual phase the lining of the endometrium 
is lost. The estrogen driven proliferative phase is characterized by cell growth and a 
thickening of the endometrium. The secretory phase is marked by vascularization, 
uterine gland development and a reduction in smooth muscle contractibility. The line 
graph is reproduced from serum concentrations stated in (Strieker et al. 2006), data 
compiled from 20 women not in receipt of contraception.
During the late secretory phase (day 21) the endometrium briefly becomes receptive to 
the fertilised embryo. This receptive state relies on chemokines (e.g. CCL14 which 
induces trophoblast migration) (Hannan et al. 2006), cytokines that regulate the 
maternal immune cell response to the semi foreign embryo (e.g leukemia inhibitory 
factor and interleukin-6) (Cork et al. 2002) and adhesion molecules (e.g. MUC1 and L- 
selectin)(Carson et al. 2006) that establish a physical attachment to the endometrial 
epithelium (van Mourik et al. 2009). After such a period (day 24) the endometrium 
becomes refractory to the embryo leading to the idea of an “implantation window”.
This window of implantation (WOI) depends on the timely co-operation the three main 
systems that include cytokines, adhesion molecules, and immune cell suppression. 
Infertile pathologies can interfere with the this complex regulation required for
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implantation but can also affect reproductive outcome by preventing ovulation or 
gamete transfer to the site of implantation.
1.06 Infertile pathologies
1.061 Endometriosis
Endometriosis is a common gynaecological disorder defined by the spreading of 
endometrial glands and stroma and lesions beyond the endometrium to extra-uterine 
locations, such as the ovaries, fallopian tubes or rectovaginal space (Olive & Schwartz 
1993). Endometriosis affects around 6% of women who suffer from reduced fertility, 
pelvic pain and tubal dysfunction. The causative factors behind endometriosis are 
debated, it has been suggested that retrograde menstruation (reversal of menstrual flow) 
and failure of the immune system to remove resulting endometrial explants was first 
proposed (Sampson 1927) and is still the subject of debate (Redwine 2002; Bricou et al.
2008). Treatment can involve MIS to remove endometriotic tissue or hormonal 
therapies. As endometriosis is a proliferation of endometrial tissue specific targeting of 
ovarian E2  production has had some success. However, endometriotic tissues have been 
shown to express 17-p-hydroxysteroid dehydrogenase (Zeitoun et al. 1998) which 
catalyses the local production of E2  from Ei (estrone). Recently it has been shown that 
this enzyme localises to endometrial lesions (Huhtinen et al. 2012) and that levels of Ei 
and E2  in endometriotic tissue are unrelated to circulating levels (secreted from the 
ovary) (Huhtinen et al. 2012). Thus future approaches that target localised E2  are 
required.
1.062 Polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is a reproductive endocrine disorder defined by 
endocrine dysregulation (including elevated testosterone and early cycle LH), chronic 
anovulation and ovarian cysts that frequently results in infertility. PCOS is the most 
common endocrinopathy and affects 5-10% of reproductive age women (Krysiak et al.
2006). Treatment involves lifestyle changes such as weight loss and reduced alcohol 
intake before pharmacological intervention using metformin to restore menstrual 
cycling, reduce BMI and decrease testosterone (Velija-Asimi 2013). Ovulation may be 
restored by the introduction of clomiphene citrate (CC) (Panidis et al. 2013). CC is a 
synthetic estrogen that antagonises ER and thus reduces the negative feedback of E2  
acting on the pituitary gland resulting removing the repression of LH and FSH which
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can help produce high quality mature oocytes (see Figure 3 for the hypothalamic- 
pituitary-ovarian axis). Combined metformin-CC treatment increases ovulation and 
conception rates in a synergistic fashion (Ayaz et al. 2013)
1.063 Unexplained infertility
Women with unexplained infertility (UIF) are usually considered sub-fertile with no 
cause attributable using current diagnostic technology, but they may become pregnant 
after fertility treatments (Evers 2002). The normal treatments for UIF are (in order of 
application) timing therapy that coordinates the time of ovulation and coitus, controlled 
ovarian hyperstimulation (COH) (to induce ovulation), IUI, diagnostic MIS (to inspect 
the endometrium) and finally IVF (Tsuji et al. 2009). The combination of COH and IUI 
results in a meeting of oocyte and sperm in the ampulla and maximises the chance of 
successful fertilisation (Tsuji et al. 2009), however this does not always result in clinical 
pregnancy (a pregnancy confirmed by high levels of hCG and ultrasound imaging).
1.064 Limiting factors for receptivity
The hormonal regulation of the ovarian and uterine cycles through the HPO axis has 
been extensively studied and application of this knowledge has resulted in clinical 
outcomes for reproductive pathologies, such as the use of CC to artificially raise FSH 
and induce ovulation in women with anovulatory polycystic ovaries or UIF (Casper
2007). While the induced ovulation success of CC is high, typically 60-90% the overall 
pregnancy rate following treatment is still low (Neveu et al. 2007) suggesting an as yet 
unknown rate limiting step in achieving fertility. Furthermore, a recent study 
investigated the rate of clinical pregnancy in UIF women following COH and IUI and 
found this to be 466 out of 2929 individuals (15.6%) (Wolff et al. 2013). Despite 
successful ovulation and the artificial introduction of sperm clinical pregnancy is still 
infrequent which has led to the notion that an endometrial factor may be responsible for 
UIF (Wolff et al. 2013). This notion is supported by the low success rate of IVF which 
is between 20.7% (natural cycle) (Pelinck et al. 2007) and 30.0% (COH) per treatment 
and by the relatively high occurrence of miscarriage in both natural and assisted 
contraception.
Advances in reproductive medicine mean ovulation and fertilisation can be induced and 
embryos can be screened for defects, however pregnancy is still not established
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suggesting a failure of fertilised embryo to implant to the uterine epithelium due to a 
lack of endometrial receptivity. Endometrial factors such as thickness (Hawkins et al. 
2013), and expression of adhesion proteins (Liu et al. 2013) contribute to this receptive 
phenotype. The decoration of the endometrial epithelium with adhesion proteins during 
the WOI and the relevance of the patterned expression on the endometrial surface is not 
fully understood but it has been suggested that this facilitates embryo implantation and 
thus contributes to the receptive phenotype (Sharma and Kumar 2012; Rashid et al. 
2011; Dominguez et al. 2010)
1.07 Endometrial receptivity
Endometrial receptivity refers to the physiological state in which the endometrium 
epithelium is able to facilitate embryo attachment, adhesion and subsequent penetration 
into the underlying stroma. The human embryo implants 7-10 days after the LH peak 
(Bergh et al. 1992), 9 days after ovulation. This implantation cascade is a linear process 
that requires a viable embryo at the correct developmental stage, a receptive 
endometrium and a subtle dialogue or crosstalk between the embryo and the 
endometrial surfaces (Rashid et al. 2011; Valles & Dominguez 2006; Carson et al. 
2000). Adhesion across the endometrial monolayer is of paramount importance during 
the initial stage of the implantation cascade and crucial for establishment of clinical 
pregnancy.
Human implantation can be separated 3 main phases (Bentin-Ley & Lopata 2000; 
Schlafke & Enders 1967). The first phase is termed apposition. during which the 
trophoblast moves into close proximity of the uterine epithelium allowing initial 
tethering to the uterine epithelium. The second stage is known as adhesion in which the 
embryo firmly anchors to the epithelial basal lamina and at this point cannot be 
removed by uterine flushing. Finally, the embryo trophoectoderm forms a penetration 
cone that infiltrates through the epithelial layer and underlying basal lamina displacing 
cells of the stromal compartment (Bentin-Ley et al. 2000), a process known as invasion 
(Figure 7). The initial apposition stage and subsequent cell adhesion between the 
trophoectoderm and endometrial epithelium depends on a complex expression of 
adhesion molecules at their respective apical cell surfaces (Pafilis et al. 2007). This 
occurs despite the generally non-adherent nature of the apical epithelial cell surface, and 
as such embryo implantation is characterised as cell biological paradox.
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Figure 7: The three phases of human implantation. Embryo implantation occurs in three 
phases; apposition, adhesion and invasion. The endometrial physiology changes 
throughout the menstrual cycle and is receptive to the embryo in the late secretory 
phase. The trophoblast approaches the uterus wall and initial tethering secures the 
trophoectoderm to the apical epithelium to allow stable adhesion and invasion of the 
stromal layer following the localised degeneration of the epithelium.
There is debate in the literature as to whether human implantation fails primarily due to 
poor embryo quality or molecular aspects resulting in poor uterine receptivity (Koot et 
al. 2012). Implantation failure due to embryo genetic and metabolic abnormalities has 
been be proposed (Pellicer et al. 1999; Quenby et al. 2002), but it is strongly suggested 
that an unreceptive epithelium may contribute (Cameo et al. 2004).
1.08 Endometrial adhesion proteins and uterine receptivity
Intracellular recognition and attachment of the embryo involves classes of proteins 
localised to the apical endometrial membrane, including but not limited to; mucins 
(Home et al. 2001), cadherins (Riethmacher et al. 1995), immunoglobulins (Deffere et 
al. 2005; Chae et al. 2010), integrins (Lessey 1998; Lessey et al. 1992) and selectins 
(Genbacev et al. 2003). Interestingly, examples from each of these classes of protein 
have been shown to influence endometrial receptivity (Home et al. 2001; Riethmacher 
et al. 1995; Deffere et al. 2005; Lessey 1998; Genbacev et al. 2003). It is likely that the 
expression and post-translational modification of these proteins is able to alter 
membrane adhesion function (Pinho et al. 2011). Moreover, it is N-linked glycosylation 
of key transmembrane proteins such as the mucins that is believed to aid initial embryo 
recognition (Margarit et al. 2009). The function of each class of proteins during the 
WOI is outlined below and illustrated in Figure 11.
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1.081 Cadherins
Cadherins are glyco-proteins that specialise in cell-cell adhesion. The family is 
subdivided into E-, P-, and N- cadherins on the basis of tissue localisation and 
immunological activity. E-cadherin localises to adherent junctions on the lateral side of 
epithelial cells and has established roles in cell-cell adhesion (Gumbiner 1996), and 
maintenance of cell polarity (Nelson et al. 2013). The E-cadherin interaction is 
homophilic and dependent on Ca2+. In the reproductive setting, E-cadherin has roles in 
embryogenesis where it is involved in gastrulation, neuralation and organogenesis 
(Barth et al. 1997). E-cadherin dysfunction due to mutations in the E-cadherin gene can 
result in defective embryo development and subsequent implantation failure in mice 
(Riethmacher et al. 1995). In the human endometrium there is conflicting evidence 
surrounding E-cadherin regulation. E-cadherin mRNA is up-regulated during the 
window of implantation (Fujimoto et al. 1996), but several studies have shown E- 
cadherin protein expression remains stable during the menstrual cycle (Beliard et al. 
1997; Poncelet et al. 2002; Dawood et al. 1998). However, more recently the cellular 
distribution of E-cadherin has been shown to change from lateral to apically polarised 
during the window of implantation (Buck et al. 2012). Cellular Ca2+ is a critical 
regulator of E-cadherin, increasing concentrations of Ca2+ stimulate E-cadherin 
disassembly at lateral adherent junctions (Li et al. 2002) providing a rationale for this 
change in cellular distribution. Moreover, calcitonin (a regulator of serum Ca2+) has 
been shown to be up-regulated in the mid-secretory phase under P4  stimulation (Kumar 
et al. 1998). Thus during the WOI progesterone may regulate E-cadherin via calcitonin 
release. It is possible that expression of E-cadherin in the apposition phase of 
implantation could play a role in embryo adhesion because it is expressed on the 
trophoblast (Coutifaris et al. 1991), the endometrium (Shirane et al. 2012) and is a 
homophilic binding protein (Chappuis-Flament 2001). It is also possible that E-cadherin 
depolarisation during the invasion stage of implantation allows for trophoblast 
penetration through the luminal epithelium by weakening epithelial cell junctions. E- 
cadherin up-regulation has been observed at implantation sites (Jha et al. 2006) which 
suggests the protein has a role to play.
1.082 Immunoglobulins
Intercellular adhesion molecule 1 (ICAM-1) belongs to the immunoglobulin class of 
proteins and is expressed on the surface of fibroblasts, leukocytes, endothelial and 
epithelial cells. ICAM-1 mediates cell-cell adhesion through its interaction with
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integrins (Oberyszyn et al. 1998), which are widely expressed on the membranes of 
many cell types. ICAM-1 is known to be involved in leukocyte trans-epithelial 
migration (Hubbard & Rothlein 2000) through and interaction with endothelial p2 
integrin which results in the stable attachment of the leukocyte to the epithelium. 
Leukocyte migration has other molecular parallels with embryo implantation such as the 
use of L-selectin and its ligands to initiate adhesion of leukocyte and trophoblast 
(Dominguez et al. 2005), thus ICAM1 potentially has shared role in these processes. 
ICAM-1 is expressed on endometrial stromal and epithelial cells where it is localised to 
the apical surface. Interestingly, expression in the apical epithelial layer (where it is 
placed to interact with the trophoblast) is higher than in the stroma but both cell types 
have strong expression suggesting an inherent role for ICAM-1 in endometrial 
physiology (Defrere et al. 2005) and possible recognition of the embryo through 
integrins, which have been shown to be expressed on the trophoblast (Shu et al. 2013).
1.083 Integrins
Integrins are transmembrane heterodimeric proteins consisting of a  and (3 subunits 
linked by non-convalent bonds. In total 18 a  and 8  p subunits have been identified in 
humans, which can combine to form 24 distinct integrin molecules. A diverse variety of 
integrins have been described within the endometrium (Lessey et al. 1994; Coughlan et 
al. 2013) and most endometrial integrins display constant expression throughout the 
menstrual cycle, however some have been shown to increase in the secretory phase, and 
could serve as markers of receptivity (Lessey et al. 2000). The integrins a lp l ,  a4pl and 
aVp3 are all expressed during the WOI, but of this group only the p3 subunit shows 
increased mRNA expression after day 19, and is undetectable beforehand. 
Immunohistochemistry (IHC) has revealed the presence of aVp3 in luminal epithelium 
in the endometrium together with one of its ligands osteopontin (OPN), during the WOI 
(Apparao et al. 2001). The localisation to the apical epithelial surface, and the tightly 
regulated window of expression suggest aVp3 is a potential receptor involved in 
mediating embryo adhesion. The expression of integrins is not limited to the uterine 
epithelium, the trophoectoderm has been shown to express integrins at the time of 
implantation (Wang & Armant 2002). One possibility is that integrins on the uterine 
epithelium and trophoblast bind to common ligands present in extra cellular matrix 
(ECM) of the trophoblast and epithelium respectively, thus resulting in the sandwich 
model of trophoblast adhesion. Examples of aVp3 ligands are epithelium secreted OPN
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and trophoblast secreted oncofetal flbronectin (OFN). Integrin (33 has been shown to be 
required for embryo adhesion as siRNA treatment of 03 in Ishikawa cells reduced 
attachment of rat trophoblasts (Kaneko et al. 2011). These experiments revealed 03 
expression on the trophoblast and on the apical uterine epithelium; trophoblast local 
expression was up-regulated by close endometrial proximity (Kaneko et al. 2011).
The aV03 and OPN adhesion mechanism is very likely to be intricately involved in the 
later stages of embryo adhesion as knocking down aV03 expression reduces trophoblast 
attachment. The distribution of integrin 03 in trophoblast cells polarises to the apical 
surface following attachment (Kaneko et al. 2011) suggesting that limited attachment 
occurs before activation of the integrin adhesion mechanism and it has been suggested 
that “juxtacrine” signalling is required for integrin activation (Armant 2005). Moreover, 
aV03 and OPN are relatively small proteins at 90KDa and 70KDa respectively and are 
dwarfed by other components of the endometrial epithelium and as such unlikely to be 
the first (and most critical) point of contact for the approaching embryo.
1.084 Selecting
The selectin family consists of a group of three closely related cell adhesion molecules 
(CAMS), P-selectin (140kDa), L-selectin (74-100 kDa) and E-selectin (120kDa). Each 
selectin has been well conserved during mammalian evolution as human, mouse, rat, 
and bovine share a high degree of amino acid sequence homology (Jebali et al. 2011). 
The selectin family share a unique, characteristic and highly conserved N-terminal 
calcium dependent lectin domain (Lasky 1995), a regulatory epidermal growth factor 
(EGF)-like domain which is 47% conserved, and 2-9 short consensus repeats (SCR) 
domains that are 35% conserved (Figure 8 ) (Kansas 1996; Tedder 1995; Ley 2003). 
However, the transmembrane (Barthel et al. 2008) and cytoplasmic domains are not 
conserved at all between groups. The similarity in the lectin and EGF domains suggests 
overlapping affinity for ligands such as tetrasaccharide carbohydrate moieties like sialyl 
lewis x (sLex) and sialyl lewis a (sLea) (Rosen 2004; McEver 2002). Mucins are often 
decorated with these carbohydrate groups allowing them to present ligands to selectins.
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Figure 8: The structure of P, E and L-selectin. All selectins contain a calcium dependent 
lectin domain~120aa, an EGF-like domain-36aa, a short consensus repeat region (which 
differs between selectins)-63aa, a transmembrane ~2 3 aa and cytoplasmic region 17-35aa. 
The lectin domain is associated with carbohydrate binding and can interact with a 
diverse range of ligands.
Prior to hatching from the zona pellucida [glycoprotein coat], embryo L-selectin 
expression was found to be weak and diffuse or absent, whereas after hatching strong 
staining was observed over the entire embryo surface and with particular association to 
the trophectoderm (Genbacev et al. 2003). Increased expression the sLex L-selectin 
ligand (specifically) has been shown on the surface of pinopods, which are markers of 
fertility (Nejatbakhsh et al. 2012), and up-regulation in vitro of these ligands increases 
trophoblast attachment (Liu et al. 2011). Moreover, decreased expression of these 
ligands has been shown in infertile pathologies PCOS and endometriosis compared to 
fertile controls, and absence of these ligands associated with recurrent implantation 
failure (RIF) (Foulk et al. 2007) leading to the suggestion that they are required for 
successful implantation and may be markers of fertility (Foulk et al. 2007).
1.08S L-selectin and sialyl lewis x ligands
The interaction between selectins and their ligands has long been established in the 
process of leuckocyte rolling (Alon et al. 1996; Alon & Feigelson 2002; Rosen 2004). 
Both the capture and rolling of leuckocytes is mediated by endothelial selectins that are 
able to form transient, low affinity contacts with selectin ligands on leuckocytes. This
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slows the leuckocyte allowing it to sense signals on the inflamed endothelium and 
facilitates integrin activation leading to consequent leuckocyte arrest (Bianchi et al. 
2013). Limited parallels have been drawn with the initial stages of embryo attachment 
to the uterine epithelium (Dominguez et al. 2005), where L-selectin may interact with 
ligands known to be expressed on the endometrial surface during the WOI (Lai et al. 
2006; Lai et al. 2005) to secure the initial attachment of the embryo (Figure 9). Binding 
of L-selectin to its glycoprotein ligands occurs by the N-terminal lectin domain that 
recognizes the tetrasaccharide sLex, its isomer sLea and other related oligosaccharides 
(Foxall et al. 1992).
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Figure 9: Localisation of L-selectin and its ligands. Immunostaining has shown that L- 
selectin is strongly expressed on the blastocyst prior to hatching (Genbacev et al. 2003) 
and that L-selectin ligand is expressed on the uterine epitheium. Images reproduced 
from (Genbacev et al. 2003; Margarit et al. 2010)
Beads coated with 6-sulfo sLex, the recognition determinant moiety for L-selectin, were 
introduced to placental tissue explants under flow conditions to assess the interaction 
with L-selectin (Genbacev et al. 2003). The beads bound to cytotrophoblast cells and to 
the syncytiotrophoblast surface, the cells that express L-selectin in situ and in vitro. Pre-
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incubating cytotrophoblast cells with blocking antibody to L-selectin [DREG-56 mAb] 
abolished most of the binding to 6 -sulfo sLex conjugated beads. This suggests that L- 
selectin on the trophoblast and sLex carbohydrate ligand motifs on the uterine 
epithelium could be potential mediators of embryo adhesion (Genbacev et al. 2003; 
Minas et al. 2005; Kim et al. 1999). A number of physiological ligands including 
mucins, have the ability to host sLex type tetrasaccharides and it has been shown with 
purified mucins and selectin affinity chromatography that sialic acid dependent mucin 
affinity occurs for all three selectins (Kim et al. 1999).
1.086 Mucins
Mucins are large (250KDa-2.5MDa), extensively glycosylated proteins present on the 
apical surface of endometrial epithelial cells (Hey et al. 1995; Lagow et al. 1999). Many 
mucins have been identified and have been sub-classified into secreted or gel forming 
(MUC2, MUC3, MUC5AC, MUC5B and MUC6 ) and membrane tethered or cell 
surface (MUC1, MUC3, MUC4, MUC12, MUC13, MUC16 and MUC17). The secreted 
mucins form a gel layer termed the adhesive mucus layer (AML) that provides the 
respiratory, gastrointestinal and reproductive epithelia with a degree of protection 
against bacterial and (in the case of the intestine) enzymatic insults (Lamont 1992; Gum 
1995). The secretory surfaces of the liver, pancreas and gall bladder are also protected 
by this gel layer and the membrane tethered mucins consolidate this gel like defence. 
Strict classification of the membrane tethered forms is clouded by the occurrence of 
splice variants that generate secreted forms (Choudhury et al. 2001; Zaretsky et al. 
1990) and the spontaneous shedding and continual regeneration of some mucins at the 
cell surface (Thathiah et al. 2003; Thathiah & Carson 2004).
Mucins are characterised by a highly variable tandem repeat (VNTR) domain (also 
known as the mucin domain). The VNTR region contains sites for addition of sialic acid 
residues that imbue mucins with a net negative charge and has been shown to be a 
determining factor in the ability of mucins to protect epithelia from microbes such as 
plasmodium (Kato et al. 2013), bacteria (Martin-Sosa et al. 2002; Derrien et al. 2010) 
and rotovirus (Yolken et al. 1992). The VNTR domain may play a significant role in 
embryo recognition and this concept is explored in chapter 5 of this thesis. The tethered 
mucins known to be expressed in the endometrium are MUC1, MUC4 and MUC16
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(Figure 10) (Brayman et al. 2004) and these are the subject of the mucin component of 
this thesis.
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Figure 10: The structure of endometrial mucins. All three mucins share small 
cytoplasmic and transmembrane domains and a large extracellular domain containing 
the VNTR that is subjected to extensive glycosylation. Due to the large number of 
proline residues and O-linked glycans in this region, the extracellular domain is 
proposed to have a very rigid structure extending out from the membrane (sizes 
indicated here). The VNTR region dominates the extracellular domain while the SEA 
(sea urchin, enterokinase, agrin) domain is a target for cleavage. The relatively small 
cytoplasmic tail is subject to phosphorylation and can act as a transcription factor. All 
mucins have a VNTR repeating sequence which differs in primary amino acid sequence 
and repeat number. The amino acid sequence of MUC1,4 and 16 VNTRs is shown.
The tethered mucins contain a small cytoplasmic domain, a transmembrane region and a 
large extracellular domain that contains the VNTR region (Figure 10). A sea urchin, 
enterokinase, agrin (SEA) domain is a site for mucin cleavage (Wreschner et al. 2002) 
and is thought to facilitate shedding of mucins from the epithelium using proteolysis 
enzymes such as tumor necrosis factor-a converting enzyme/AD AM 17 (Thathiah et al. 
2003) and membrane-type matrix metalloprotease (Thathiah & Carson 2004). It has 
been suggested that the large size of the mucins and glycosylation state of the VNTR 
region provides steric-hindrance by masking other adhesion proteins such as E-cadherin 
and integrins from recognising the approaching embryo thus modulating their activity
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(Hilkens et al. 1992). The branched and rigid structural properties of mucins are likely 
to dictate the biomechanical (adhesive) properties of endometrial monolayers, a 
characteristic explored in chapter 4.
This thesis focuses on investigating whether MUC1 is the major determinant of embryo 
epitope recognition, while not overlooking the potential overlapping functions of MUC4 
and MUC16. MUC1 is abundantly expressed at the apical surface of both luminal and 
glandular epithelia of the uterus in various species (Hoffman et al. 1998; Hey et al. 
1994; Hild-petito et al. 1996; Surveyor et al. 1995; Julian et al. 2005). Down-regulation 
of MUC1 during the WOI or at nidation sites is a requisite for uterine receptivity in a 
wide variety of large animal models (Hild-petito et al. 1996; Surveyor et al. 1995; Julian 
et al. 2005; DeSouza et al. 1998; Bowen et al. 1996). In humans MUC1 is retained 
during the window of implantation (Hey et al. 1994; DeLoia et al. 1998; Hey et al. 
1995), which distinguishes humans from other species. This suggests that although 
differentially regulated, MUC1 is related to fertility in humans. The glycosylation status 
of MUC1 has been linked to endometrial receptivity (Hey et al. 1995; Margarit et al. 
2010), and it is known to host carbohydrate ligands recognised by L-selectin. The 
adhesive interaction between MUC1 and L-selectin expressed on the embryo is 
therefore one of the core threads of investigation throughout this thesis.
1.09 MUC1 hosts sialyl lewis x ligands
The sLex moiety and its positional isomer sLea have been associated with endometrial 
MUC1 protein in the EEC cell lines Hec-l-A and Hec-l-B (Hey & Aplin 1996). Further 
experiments showed that Hec-l-A expressed both sLex and sLea while Hec-l-B 
expressed only sLea. Moreover, immunoprecipitation has demonstrated that sLea is 
associated with MUC1 in Hec-l-B cells, and both sLex and sLea are associated with 
MUC1 in Hec-l-A cells (Hey & Aplin 1996), suggesting that MUC1 may be a potential 
mediator in embryo adhesion.
MUC1 glycosylation and generation of sLex and sLea depends initially on terminal N- 
Acetylglucosamine (GlcNAc) carbohydrate residues attached to the VNTR region in the 
core extracellular domain of the molecule. The VNTR consists of a tandem repeating 
20-amino acid sequence -Pro-Pro-Ala-His-Gly-Val-Thr-Ser-Ala-Pro-Asp-Thr-Arg-Pro- 
Ala-Pro-Gly-Ser-Thr-Ala (Hattrup & Gendler 2008; Tarp & Clausen 2008). Formation
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of GlcNAc can occur at five potential O-glycosylation sites in the repeat (Figure 13). 
GalNAc formation through a-O-glycosidic linkage to Ser/Thr residues in the VNTR 
region is dependent on the glycosyltransferase enzyme, GlcNAc6ST-2
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Figure 11: Mechanisms of human implantation. The endometrial epithelium is 
decorated with a range of adhesion molecules that mediate embryo implantation. E- 
cadherin homophilic junctions are present in the epithelial and stromal layers, but can 
redistribute to the apical epithelial surface during the WOI. ICAM-1 is expressed on the 
stromal and the epithelial layers and may recognize integrins on the approaching 
tropoblast. Integrin av(33 is expressed on the epithelium and trophoectoderm and 
recognizes secreted OPN, a linker molecule that is up-regulated during the WOI. MUC1 
is large protein that supports carbohydrate ligands for L-selectin that is expressed on the 
trophoblast.
After attachment of the initial GlcNAc residue other glycotransferase enzymes catalyse 
the formation of the functional sialyl lewis epitopes. In the case of sLex, (34-Gal- 
transferase, a3-sialyltransferase and a3-Fuc-transferase sequentially attach 04- 
Galactose, a3-sialic acid and a3-Fucose to GlcNAc. SLea chains are synthesized by 03- 
Gal-transferase, a3-sialyltransferase and a4-Fuc-transferase (Brockhausen 2006) 
(Figure 12).
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Figure 12: Generation of sLex and sLea antigen assembly begins with terminal N- 
acetylglucosamine (GlcNAc) residues found on endometrial glycoproteins. The sLex 
structure is synthesised by the addition of a p4-Galactose to GlcNAc by p4- 
Galtransferase (P4-GalT), followed by the addition of a3-sialic acid to Galactose by a3- 
sialyltransferase (ST3Gal) and of a3-Fucose to GlcNAc by a3-Fuctransferase (a3- 
FucT). SLea antigen is assembled by p3-Gal-transferase (p3-GalT), ST3Gal and a4-Fuc- 
transferase (a4-FucT). (diagram reproduced from 'Brockhausen 2006').
1.10 Sialyl lewis ligands and endometrial receptivity
SLex and sLea are both recognised by all three selectins (Galustian et al. 2002), however 
L-selectin is thought to have the highest affinity for the sLex isoform (Silva et al. 2011), 
and it is sLex not sLea that has been proposed to mediate adhesion during implantation 
(Liu et al. 2011). The anti-Human Cutaneous Lymphocyte Antigen (CLA) monoclonal 
antibody (HECA-452) recognises sLex and requires both the presence of a3 sialylation 
and a3 fucosylation for epitope recognition (Toppila et al. 1999). MECA-79 is an anti- 
sLex mAb that requires the presence of 6-sulfo sLex, a sulfation dependent determinant 
on L-selectin ligands that overlaps with the ligands’ recognition epitope (Pablos et al. 
2005).
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Figure 13: Each VNTR motif is able to host five glycans. The VNTR domain of MUC1 
is a 20aa sequence that is repeated 20-125 times. Each repeat is able to host 5 glycans 
via serine and threonine residues in the protein core. The construction of sialyl lewis 
antigen begins with the attachment of GlcNAc to the VNTR core via an a-O-glycosidic 
linkage and requires (34-galtransferase, a3-sialyltransferase and a3-fuctransferase for 
addition of p4-galatose, a3-sialic acid and a3-fucose thus completing the sLex epitope.
It has been shown that sLex is elevated when the endometrium becomes receptive during 
the WOI (Genbacev et al. 2003), and that elevated sLex has been associated with 
improved implantation (Wang et al. 2008). Moreover, suppression of the 
fucosyltransferase a3-FucT, which catalyzes the final stage synthesis of sLe , both 
reduces sLex and decreases implantation in an in vitro model (Liu et al. 2008).
The expression of the sulfo-transferase enzyme, GlcNAc6ST-2 (N-acetylglucosamine- 
6-O-sulfotransferase), a has been shown to be a requisite for the generation of 6-sulfo 
sLex in the non-endometrial tissues (Hiraoka et al. 1999), and knocking down 
GlcNAc6ST-2 gene expression in mice models reduced sLex highlighting the 
importance of GlcNAc6ST-2 in sLex generation (Hemmerich & Rosen 2000; 
Tangemann et al. 1999). It has also been shown siRNA treatment of GlcNAc6ST-2 
readily reduced sLea generation (Okayama et al. 2011) highlighting the important role 
of this enzyme.
Studies in our group have used endometrial biopsy material and have reported a 
reduction in GlcNAc6ST-2 expression, correlating with reduced MECA-79 expression
39
Chapter 1 Thesis Introduction
in infertile patients (Margarit et al. 2010). The GlcNAc6ST-2 enzyme catalyses the very 
first step in the generation of both sLex and sLea, and as such is a crucial factor in the 
establishment of these moieties (Figure 12).
1.11 Endometrial pathologies and L-selectin ligands
Previous publications from our group have reported significant decreases in 6 -sulfo sLex 
(as recognised by MECA-79 mAb) in patients presenting with infertile pathologies such 
as UIF, PCOS and endometriosis compared to the fertile controls (Margarit et al. 2010). 
MUC1 may carry sLex L-selectin ligands throughout the secretory phase of the 
menstrual cycle, which gives MUC1 the potential to interact with L-selectin expressed 
by the trophoblast at the time of implantation (Carson et al. 2006). As MUC1 structure 
affects the extent of glycosylation (there are 5 potential sites per VNTR repeat) (Figure 
13) this may link MUC1 length with the ability of the molecule to present L-selectin 
ligands to the trophoblast. Home and colleagues reported that MUC1 isoforms with 
shorter VNTR regions correlated with an unexplained infertile phenotype, while the 
longer VNTR isoforms appeared more frequently in fertile women (Home et al. 2001). 
The presentation of sLex L-selectin ligand at the endometrial surface is a potential 
marker for fertility and is likely dependent on a multitude of factors such as expression 
of scaffold proteins (of which MUC1 is a prime candidate), the expression of structural 
isoforms of such proteins and expression of a host of glycotransferase enzymes such as 
GlcNAc.
1.12 Current approaches to modeling implantation in vitro
Despite continued and intense biochemical investigations into potential receptivity 
markers such as the human gene expression endometrial receptivity database (HGEx- 
ERdb) (Bhagwat et al. 2013) the process of human implantation is not fully understood. 
Functional models of implantation offer an alternative to biochemical screening but are 
subject to their own limitations. It is not possible to study the mechanism of human 
implantation in vivo and even ex vivo models present many difficulties (Hannan et al.
2010). Very few laboratories have access to human embryos which must be specifically 
donated for the purpose of research and consent obtained. It is somewhat easier to 
obtain biopsy material through endometrial pipelle extraction, and whilst primary 
endometrial stromal cells are relatively easy to prepare from endometrial biopsy 
epithelial cells are very difficult to isolate and it is not possible to maintain these cells 
indefinitely in culture.
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Animal models are routinely used for the study of early implantation events and rodents 
are still the most commonly used (Ye et al. 2012; Grzmil et al. 2013), but larger 
primates such as baboons (Fazleabas et al. 1999) and monkeys (Enders & Lopata 1999) 
are also subjects of study. However, animal models all have limitations as substitutes 
for human implantation. Primates (in particular the baboon) and guinea pigs are most 
similar to humans, however primates are costly, impractical and produce few offspring 
(Lee & DeMayo 2004; Enders et al. 1983; Enders et al. 1989; Enders & Lopata 1999; 
Tarantal & Hendrickx 1988) and guinea pig blastocysts implant with the zona pellucida 
intact (a glycoprotein coat from which human embryos “hatch”) (Enders 2000; Enders 
& Schlafke 1969). Mice, rats, and rabbits are the easiest to sustain and most well 
defined, but do not exhibit interstitial implantation (the complete embedding of the 
blastocyst within the endometrium of the uterine wall) (Dey et al. 2004; Dey 2006; 
Hoffman et al. 1998) and have short uterine cycle lengths; 4-5 days in rodents compared 
to 28 in humans (Caligioni 2009). Pigs, sheep, and cows have prolonged implantation 
events but also do not exhibit interstitial implantation (Gray et al. 2002; Gray et al. 
2001; Wooding 1984; Wooding 1992). Moreover, MUC1 is down-regulated during the 
WOI of most animals (Surveyor et al. 1995; Julian et al. 2005; DeSouza et al. 1998) 
compared to humans where it is retained (DeLoia et al. 1998) and crucially the role of 
L-selectin and sLex ligands in animals is still undetermined.
Therefore, use of appropriate cell lines, particularly for functional studies of 
implantation offers an alternative model. Use of cell lines derived from endometrial 
cancers such as Hec-1, Ishikawa, EEC-1, and RL95 and trophoblast choriocarcinomas 
(trophoblastic, placental cancer) such as JAR, JEG-3 and BeWo is established 
(Teklenburg & Macklon 2009; Hannan et al. 2010). These cell lines are often used for 
attachment models that involve a co-culture of endometrial epithelial cells and 
trophoblast spheroids. Typically, the epithelial cells are grown in monolayer 
configuration which is used to mimic the endometrial epithelium, where they are 
subjected to various hormonal or biochemical stimulation and then spheroids are 
introduced. This co-culture is subjected to physical agitation (rocker machine) and 
attachment (or detachment) rates are used as a measure of endometrial receptivity 
(Figure 14). Spheroids are generated by the accumulation of trophoblastic cells by 
rocking in culture until the reach the size of the pre-implantation embryo (-105 pm) at 
which point they are selected for co-culture (Ho et al. 2012).
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This model of implantation has been widely used (Hohn et al. 2000; John et al. 1993; 
Kosaka et al. 2003; Li et al. 2002; Rahnama et al. 2009; Thie & Denker 2002; Tinel et 
al. 2000; Kaneko et al. 2013; So et al. 2012). However, experiments such as these are 
time consuming and result in low sample numbers because spheroids are selected 
microscopically and their attachment is quantified by manual counting. More recently 
Ho and colleagues refined this system by introducing a sieve between 70- 100pm 
allowing more rapid collection of trophoblast spheroids. They also fluorescently stained 
spheroids so attachment rates could be calculated using a fluorescent signal from a plate 
reader (Ho et al. 2012).
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Figure 14: Methodology of automated adhesion assays. Endometrial epithelial cells are 
grown in flasks, trypsinized, and seeded onto 96-well plates to form monolayers. 
Trophoblast spheroids are generated by rocking trophoblast cell lines until the resulting 
aggregated spheroids are between 70- 100pm, they are then stained and selected for co­
culture. Spheroids are allowed to incubate on top of endometrial monolayers and then 
subjected to washing. Remaining spheroids are used as a measure of attachment (Ho et 
al. 2012).
The application of the above methodology has generated functional data on endometrial 
receptivity and embryo implantation. It has been demonstrated in vitro that sex steroids 
E2 and MPA facilitate trophoblast attachment and invasion by inducing decidualisation
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in a epithelial-stromal 3D co-culture system (Wang et al. 2013). Furthermore, the 
importance of stromal cells and PR-B presence on epithelial cell receptivity has been 
shown by co-culturing stromal cells from endometrial biopsy with the endometrial 
epithelial cell line RL95. A correlation between spheroid attachment rate and PR-B 
protein was observed, that depended on the stromal layer (Evron et al. 2011). The effect 
COH on trophoblast attachment in infertile women under-going IVF has been 
investigated, while COH is used successfully to induce ovulation in IVF these 
experiments show the negative effect of high serum E2  on endometrial epithelial cells is 
to reduce spheroid attachment (Chai et al. 2011). The effects of environmental toxicants 
such as the herbicide 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD, “Agent Orange”) on 
implantation and infertility has been examined using monolayers of RL95 and Ishikawa 
cells (Tsang et al. 2012).
The effect of menstrual cycle regulated adhesion proteins on spheroid attachment has 
been investigated. Increased spheroid attachment has been seen reported following 
induction of integrin aV(33 in Ishikawa cells (Xiong et al. 2012) and the difucosylated 
oligosaccharide Lewis y contained within integrin aVp3 has been shown to be required 
for endometrial receptivity on RL95-2 cells (Zhang et al. 2011). These experiments can 
also eliminate potential receptivity markers, for example experiments using the 
endometrial cell line Hec-l-A showed trophoblast adhesion is not affected by 
endometrial leptin receptor gene silencing (Cervero et al. 2007).
While there is room for further refinement such as the automated acquisition and 
counting of fluorescent spheroids using high content screening, and dual colour stains to 
aid counting epithelial and trophoblast co-cultures (Holmberg et al. 2012) some of the 
limitations of this strategy are insurmountable. The data generated from such 
experiments reveals only the number of bound spheroids, and no information is gained 
on the strength or number of molecular interactions underpinning the trophoblast 
adhesion. Furthermore, it is unclear how representative artificial trophoblast spheroids 
are as very little data involving human embryos is forthcoming; whether the rocking 
action employed to dislodge said spheroids is in any way akin to the forces experienced 
by the embryo in the human endometrium is also unknown.
A developing strategy is to use co-cultures under-flow conditions to quantify the micro­
biomechanics of implantation. This involves some variation of a sealed flow system
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containing confluent monolayers of endometrial cells. In these experiments 
trophoblastic cells are introduced into the system under flow and attachment rates are 
counted. This model has been used to implicate L-selectin binding to sLex in the initial 
stages of implantation (Yucha et al. 2013), but most shear stress studies of trophoblast 
adhesion to date centre on the action of early human pregnancy placental trophoblasts as 
they migrate along uterine spiral arteries (SAs) during placental development (James et 
al. 2012; James et al. 2011; Liu et al. 2010; Cao et al. 2008). This approach is 
advantageous compared to the spheroid adhesion assays because the shear stress 
experienced by the adhering cells can be calculated as a co-efficient of flow rate. The 
limitations of this system are the monolayers of endometrial epithelial cells are exposed 
to un-natural forces (the pressure in the uterus has been estimated 5-25 mmHg based on 
secretory phase uterine contractions) (Eytan et al. 1999) and flow rate must be high 
enough to dislodge trophoblast cells while not removing the adherent monolayer (as 
shown in Figure 15C). Moreover, these experiments are technically demanding, 
requiring understanding of fluid flow dynamics to calculate the flow rate and therefore 
the force required for detachment.
While these studies have added knowledge to the complex process of implantation, their 
focus was not to specifically investigate the L-selectin binding process; there is no data 
showing in specific targeted quantification of the L-selectin-sLex forces involved in 
embryo attachment. When we consider the scale of the forces occurring across the 
maternal-embryo interface are likely to be in the pico-newton scale (Zhang, Bogorin, et 
al. 2004) then trophoblast attachment assays appear crude and the requirement for a 
more sensitive technology becomes apparent. The atomic force microscope allows us to 
investigate and quantify the nano-mechanical forces occurring across endometrial 
monolayers and relate these to implantation.
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Figure 15: Flowing trophoblast cells over endometrial monolayers. (A) Schematic 
representation of a lamina flow system used to measure the force of detachment. 
Trophoblast cells in media are introduced to a laminar flow slide and allowed to adhere. 
A shear stress is applied and the detachment rates of trophoblastic cells are measured. 
(B) An example of one such slide in combination with optical microscopy. (C) The 
effect of lOml/hour flow rate over 30mins on endometrial monolayers showing shear 
stress also affects the monolayer of epithelial cells (images from author’s data).
1.13 Atomic force microscopy
Classical microscopy techniques such as scanning electron microscopy (SEM) and 
transmission electron microscopy (TEM) can be used to detect the position, distribution 
and the dynamics of biomolecules and to visualise and characterise cellular morphology 
at the sub-nanometer scale (Riva et al. 2010) thanks largely to improvements in 
chemical fixation (Wierzbicki et al. 2013). Atomic force microscopy (AFM) is a 
mechanical profiling technique complementary to SEM and TEM that generates 3D
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maps of surfaces at cellular, molecular or atomic resolution (Giessibl 2005). AFM 
typically involves an interaction between a sharp tip (radius ~10nm) made from silicon or 
silicon nitride and a surface. The tip is located on the end of a micro-fabricated 
cantilever around 200pm in length which is scanned across the sample. The forces that 
act between the tip and the surface are measureable with sub pico-newton sensitivity 
allowing calculation of the nano-mechanical surface properties such as topography 
(height), adhesion, deformation, energy dissipation and stiffness by observing the 
cantilever deflections resulting from tip-sample interaction (Song & Bhushan 2008).
Figure 16 shows a schematic diagram of an AFM tip-cantilever assembly interacting 
with an endometrial epithelial cell. The relative movement of the tip across the sample 
results from a cylindrical piezoelectric actuator which positions the AFM tip in the x,y 
and z direction and can act as the holder of either the cantilever or the sample depending 
on the system design. The deflection of the cantilever is measured using the optical 
lever method. A laser beam is projected onto the upper surface of the cantilever close to 
the tip (laser spot). The reflected beam is reflected by a mirror (not shown here) into a 
four-segment photo-diode. The distance from the cantilever to the photodiode is 
hundreds of times the length of the cantilever, therefore extremely small deflections in 
cantilever position are multiplied many times, making AFM a very sensitive technique.
L aser  sp o t
C ell su r face
Figure 16: Schematic representation of AFM apparatus. (A) laser beam is reflected off 
the reflective back of a micro-fabricated cantilever to a photodiode. (B) The tip apex is 
brought into contact with the cell surface and any cantilever deflections are recorded by
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the change in position of the laser spot multiplied using an optical lever and recorded on 
a photodetector.
1.131 Attractive and repulsive regimes
AFM is a described as a contact probe technique; however this “contact” is the interplay 
between forces on the tip and the surface substrate. Experiments using intermittent 
contact AFM (see below) have revealed the existence of two force regimes that the tip 
encounters on approach (Figure 17). The attractive regime is dominated by van der 
Walls (VDWs) (Wang et al. 2004), casimir (a quantum force between two polarizable 
atoms) (Lin & Zhao 2005) and electrostatic (Zhang et al. 2007) long range, non-linear, 
forces of attraction that pull the cantilever towards the cell (Giessibl 1997; Gotsmann et 
al. 1999; Holscher & Schwarz 2007). This may result in a “jump to contact” 
phenomenon as the tip snaps towards the sample surface on approach (Figure 17). As 
the inter-atomic distance decreases the net force becomes more repulsive, and once the 
atoms of the tip and surface are in contact the net force is completely repulsive. The 
repulsive interaction regime is dominated by a net repulsive force caused by this atomic 
contact. This repulsion is made up of inter-atomic forces that affect the cantilever by 
deflecting it or dampening its oscillation depending on the AFM mode used (Garcia & 
San Paulo 1999), and are largely responsible for the topographical measurements 
generated. The term atomic force microscopy is derived from the inter-atomic forces 
experienced within the repulsive regime used for topographical measurements (Binnig 
1986). In order to study biological surfaces, the AFM may be operated in several modes 
that monitor these forces through deflection of the cantilever (Moreno-Herrero et al. 
2004; Zhang et al. 2012).
Tip is in hard contact
with the surface
repulsive regime
Tip is far from the 
surface
no deflection
Tip is pulled towards 
♦  the surface
attractive regime
Z position
Figure 17: As the tip approaches the surface it encounters two non-linear force regimes. 
The attractive regime pulls the tip towards the surface; at a certain point the net force 
becomes repulsive owing to the short range strong forces in the repulsive regime.
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1.132 Contact mode
In contact mode the tip is lowered toward the surface by piezoelectric actuator 
constricting in the Z direction, as it enters the repulsive regime the force on the tip 
increases causing the cantilever to deflect until a pre-determined level of cantilever 
deflection is reached, known as the set point. When the set point is reached a feedback 
loop maintains the voltage at the piezo and ensures that the tip is held at this force. The 
piezo now constricts in the x  and y  direction causing the tip to be line-scanned across the 
surface and the tip is deflected as it encounters surface corrugation. The actual 
deflection is compared to the desired deflection (the set point) and the piezo exerts force 
on the cantilever to maintain the tip sample distance and therefore constant height above 
the surface. The force (measured in volts or newtons) required by the piezo to maintain 
constant tip-surface separation is used to calculate surface topography, which can be 
viewed as a 3D map by imaging software.
Although it has very high resolution (~ O.lnm), contact mode can damage biological 
samples because it generates frictional (lateral) forces that tear soft surfaces such as cell 
membranes (Muller & Dufrene 2011). There have been some attempts to mediate these 
effects such as the electrostatic dampening of the lateral force between the tip and the 
sample by altering the pH and electrolyte concentrations of imaging buffers (Muller et 
al. 1999) and use of low set point forces (<lnN) (Neuman & Nagy 2008). Low force 
contact mode has been used image glutaraldehyde fixed alveolar epithelial cell layers 
and has complementary image resolution to SEM and CM (Hecht et al. 2011). 
However, the most effective way is to reduce the lateral forces and therefore sample 
degradation is by using an intermittent-contact AFM mode.
1.133 Intermittent contact mode
Where live (or fixed) cell membranes are to be investigated then intermittent- 
contact/tapping/altemating current (Zhong et al. 1993; Morita 2002) emerges as the 
preferred mode. Intermittent-contact (IC) mode is a high-amplitude (100-200nm) (Gross 
et al. 2009) mode in which the cantilever is oscillated at high frequency, close to its 
natural resonance frequency. At this resonance frequency even a small driving force 
imparted by the piezo actuator will produce large amplitude oscillations of the 
cantilever and the vibrating system as a whole stores more energy. The propensity for
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an oscillating system to retain energy is referred to as the Q-factor of the system 
(Bhiladvala & Wang 2004) and is defined as the ratio of the energy stored in an 
oscillatory system to the energy lost from the system during one oscillation cycle. When 
imaging cells in aqueous conditions the Q-factor is reduced 10-20 fold (Frederix et al.
2009) so sufficiently stiff cantilevers (having a spring constant, k of 10-1 OONm'1) must 
be used to ensure the forces of adhesion and friction associated with cells in aqueous 
conditions do not overcome the force required to oscillate the cantilever (Putman et al. 
1994). As the oscillating tip scans across the sample, changes in surface topography 
modulate this oscillation. Areas of increasing elevation act to reduce oscillating 
amplitude, while depressions cause it to increase. Rather than relying on a deflection set 
point as in contact mode, IC mode (and non-contact mode) monitors the change in the 
resonance amplitude (or frequency) of the cantilever. The resulting change in amplitude 
is compared with the amplitude set point and the piezo voltage is adjusted to maintain a 
constant amplitude and therefore tip-sample separation. While the short range repulsive 
forces are widely assumed to be responsible for dampening the oscillation, the VDWs 
forces of attraction also contribute to this effect (Garcia & San Paulo 2000). Moreover, 
the feedback loop is unable to determine whether reduction in oscillating amplitude is 
the result of attractive, repulsive or a combination of both forces (Garcia & San Paulo 
2000).
As the cantilever is oscillating at high frequency the surface contact time is reduced and 
thus lateral forces between the tip and the surface are greatly reduced; IC mode is 
excellent for soft biological samples, such as cell membranes which are frequently 
damaged by contact mode (Howard et al. 1996). The data provided by IC mode includes 
topography (generated by the amplitude feedback signal) and phase (Tamayo & Garca 
1997). Phase imaging measures the phase lag of the cantilever oscillation relative to the 
piezo drive amplitude (Babcock & Prater 1995). Deviations in surface properties induce 
shifts in the phase of the two waves, which are mapped to produce phase images and 
can reveal fine cellular structures in high contrast which are not visible in topographical 
imaging (Babcock & Prater 1995). Phase imaging is able to identify boundaries between 
regions with altered surface properties that are not related to height, such as surface 
viscous damping, adhesion and membrane stiffness (Liu et al. 2009). IC mode has been 
used to successfully image moving DNA molecules (Argaman et al. 1997), cell
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membranes in liquid (Kamruzzahan et al. 2004) and dynamic morphological changes to 
membrane structure over time using live cells (Li et al. 2013).
■ M
7  v
Piezo drive Cantilever oscillation
Figure 18: Intermittent contact mode AFM. (A) The cantilever is oscillated at high 
frequency across the sample. Surface forces affect oscillation amplitude and are 
recorded by the laser deflection. (B) Surface properties not related to height (such as 
stiffness, which compresses the shift) induce a phase shift between the piezo drive 
frequency and the cantilever oscillation frequency. This can be used to generate high 
contrast images of the cell surface ultrastructure.
IC mode has been established as an imaging tool comparable with SEM (Hecht et al.
2011), however the resonant oscillation of the tip that is integral to IC mode masks the 
force curves making extraction of nano-mechanical information impractical (Stark et al. 
2002; Legleiter et al. 2006).
1.134 Force distance mode
Force distance curve based AFM (FD-AFM) is a nano-indentation technique that 
measures the force on the tip against the z-position to ascertain properties about the 
material (Muller et al. 2009). In imaging mode the AFM generates high resolution 
topographical data based on tip sample interactions. In contrast, FD-AFM can be used 
to measure the surface nano-mechanical properties (Alsteens et al. 2012) of living (and 
non-living) systems at high sensitivity (Hugel & Seitz 2001; Kirmizis & Logothetidis
2010). As the tip is brought towards the surface it interacts with the sample, and forces 
acting on the tip cause the cantilever to deflect facilitating detection of interaction 
forces. When maximum indentation is reached the force set point (a user controlled 
parameter) triggers a feedback loop that instructs the piezo to withdraw the probe to the 
starting position thus controlling indentation. The tip moves in the lateral direction and 
the process is repeated (Figure 19A), resulting in a grid of sample points across the
Phospholipid
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surface that is termed a ‘force map’. The force on the tip against vertical distance from 
the sample is displayed using a graphical output termed a force distance curve (Figure 
19B). FD curve AFM can reveal physical surface properties of biological surfaces such 
as stiffness, adhesion, indentation (deformation), energy dissipation (Heinz & Hoh 
1999). These properties are calculated by fitting mathematical models of contact 
mechanics to the FD curves using open source, proprietary or home written software 
environments. In contrast to IC mode, FD AFM requires the use of soft cantilevers (k = 
O.Ol-O.SNm"1) to detect minute forces on biological membranes which can be as low as 
50 piconewtons (Muller et al. 2009).
A
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Figure 19: Force Distance AFM. (A) The AFM probe is indented into a biological
surface and withdrawn; the interaction with surface forces is recorded by the deflection
on a cantilever. (B) The data is outputted in a graph of force against distance; models of
contact mechanics applied to these ‘force curves’ permits calculation of mechanical
properties such as adhesion, stiffness, deformation and energy dissipation.
1.135 Single molecule force spectroscopy
A significant development in FD-AFM has been the separation of specific interactions 
from non-specific interactions on biological surfaces. Biological membranes are no 
longer considered to be homogeneous fluids, instead they are composed of mobile lipid 
rafts associated with varied and dynamic expression of surface glycoproteins, receptors 
and glycolipids (Simons & Vaz 2004). For identification and characterisation of specific 
interactions across these heterogeneous surfaces a single functionalization molecule 
may be attached via a flexible linker to the AFM tip (Zimmermann et al. 2010), a 
derivation termed single molecule force spectroscopy. Nano-indentation is performed as 
in FD AFM however, when the tip is withdrawn from the sample any specific bonds 
between the functionalization molecule and the surface stretch and then rupture (Figure 
20A). The rupture event can be characterised by the rupture force and the distance the
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rupture occurs from the surface (Figure 20B). The force required for bond rupture (the 
bond strength) is dependent on bond loading rate (Evans & Ritchie 1997) and thus is a 
dynamic force (Evans & Calderwood 2007). The dynamic rupturing of molecular bonds 
can be described as a transition between bound and unbound energy states, and external 
force applied to the bond increases the chance of a transition to the unbound state, a 
probability which increases with bond loading rate (Duffene et al. 2013). The retraction 
FD curves are analysed using specialist software such as Open Fovea (Roduit et al.
2012), Hooke (Sandal et al. 2009), PUNIAS and JPK DP (JPK Instruments AG 2012) to 
detect step changes in force that represent separation of molecular bonds.
Figure 20: Single Molecule Force Spectroscopy AFM. (A) The tip is functionalized 
with a biomolecule and indented into the cell membrane, the bond is loaded as the tip 
withdraws from the surface resulting in bond stretching and then bond rupture. (B) 
Force curves are analysed for bond ruptures on the retraction part of the force curve. 
Such ruptures appear as “steps” on the retraction curve (dashed red line).
Early characterisation of bio-intermolecular bonds began with large bio-molecules 
immobilised on atomically flat substrates such as dextran polysaccharides on gold (Rief 
et al. 1997) and LexA protein on mica (Kiihner et al. 2004). The intermolecular 
homophilic bond strength of adhesion proteins such as E-cadherin has been investigated 
(Baumgartner et al. 2000; Perret et al. 2004) but these studies utilised recombinant 
protein fragments attached to a mica substrate. More recent developments in 
functionalised force mapping have investigated the bond strength of rituximab (an anti- 
CD20 monoclonal antibody targeted drug) to receptors on lymphoma cells (Li et al.
2013), the affinity of anti-cancer peptides to HeLa cell membranes (Shan et al. 2012), 
location (Ahmad et al. 2011) and binding affinities (Li et al. 2013) of Fc gamma 
receptors on macrophage cells providing information about the mechanism behind
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macrophage binding to target cells coated in antibody. These experiments were all 
conducted using intact fixed cells. Using intact cells rather than immobilised substrates 
ensures the natural orientation of cell receptors within the membrane and any post- 
translational modifications (such as glycosylation) of the proteins are preserved. This is 
especially important in the endometrium when we consider that these modifications are 
critical to function (for example the addition of sLex tetrasaccharides to MUC1). 
Furthermore, using intact cells retains the functionality of the cytoskeletion so that 
transmembrane receptors (such as mucins, integrins) can still interact with the 
cytoskeleton through their cytoplasmic domains.
However, fixing the cells with protein cross-linking agents such as glutaraldehyde and 
paraformaldehyde may reduce the functionality of transmembrane receptors due to 
crosslinking inducing conformational changes in functional N-terminal domains 
(Migneault et al. 2004). Moreover, cell signalling pathways of live cells can regulate 
receptor action and therefore bond characteristics, this has been demonstrated 
experimentally; ICAM-1 bonds with p2 integrin on live neutrophils displayed longer 
lifetimes and increased bond strength compared to ICAM-1 bonds with a2p2 integrin 
coated glass beads (Kinoshita et al. 2010).
1.136 High resolution force distance mode
Conventional FD-AFM is slow, requiring around 30 minutes to record high resolution 
(<10nm), multiparameter force maps (Duffene et al. 2013) which is a limitation of 
traditional force mapping in live cell systems. Recent advances in AFM technology 
(Berquand 2011; JPK instruments 2012) have enabled the capturing of arrays of FD 
curves with much improved speed (7-10minutes for 512x512 pixel images) while still 
recording viable force curves. These advances in instrumentation allow extraction of 
quantitative information from high resolution images at speeds comparable to IC mode 
(Duffene et al. 2013). The high resolution FD mode ‘Peak Force Tapping’ (PFT) was 
used for the experiments in this thesis. When in PFT mode the piezo oscillates the base 
of the cantilever in a similar fashion to IC mode, however the probe moves in a 
sigmoidal sweep compared to linear as in traditional FD-AFM. The z-piezo is 
modulated far below the cantilever resonance frequency (150kHz in this case), typically 
l-2kHz (Berquand 2011) and the tip scans across the image and performs a rapid force 
curve at each pixel. The sinusoidal waveform causes the tip velocity to approach zero as
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the tip approaches the surface which allows quantification of very small forces (<10nN) 
(Pittenger et al. 2013). Peak force mode is similar to IC mode in that fact that the tip 
only contacts the sample for a small proportion of the time, however unlike IC mode 
where the amplitude set point is used to modulate the amplitude signal PFT measures 
the peak force experienced by the tip (typically during the repulsive regime) and feeds 
back this parameter in order to maintain a constant peak force. The peak force is defined 
as the force difference between the contact point and point of maximum indentation on 
the approach to the sample. Figure 21 shows the periodic interaction with the probe and 
the surface. The dashed line shows the z position of the tip as one period interaction is 
completed. As the modulation frequency is between 1 -2kHz in the current form, elapsed 
time from point A to E is 0.5-Is'3. This results in a periodic interaction many orders of 
magnitude faster than the traditional quantitative AFM mode; force spectroscopy where 
modulation frequency is l-5Hz resulting in an interaction typically lasting 0.5-ls '1.
Piezo Z position
Peak F. Peak F
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Time D Time
Figure 21: Peak Force Tapping AFM. Diagram shows two indentations of the tip during 
PFT. The dotted line represents the position of the tip through each oscillation, the red 
and blue lines show the force acting on the tip as a function of time. The peak force 
occurs when the tip contacts the surface and is used to feedback to the piezo. 
Conventional force curves analysis is used to obtain the desired nano-mechanical 
properties of surfaces. Points A-E are areas of maximal or minimal force that 
correspond with tip position.
In order to quantify the surface properties, calibration of cantilever normal elastic 
constant (kn) (also known as spring constant) is conducted prior to experimentation. 
Although probes have a nominal kn from manufacture this can vary up to 200% from 
actual k„ (Hazel & Tsukruk 1999) so experimental determination of this value is 
conducted using the accepted thermal tune method (Sader et al. 2012).
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Deflection sensitivity (Dsens) is a crucial parameter that is also calibrated prior to 
imaging. A PFT force curve is a measure of tip position against the output voltage o f a 
position sensitive photodiode detector. The displacement of the cantilever is measured 
using the optical lever, however when the laser is aligned, the relative positions of the 
cantilever and the laser spot can affect the displacement calibration, and therefore the 
output voltage. Usually the cantilever is indented into a non-deforming surface, 
therefore the deflection of the cantilever is directly equivalent to the piezo position 
(Tranchida et al. 2007). Once these calibrations have been completed PFT mode allows 
extraction of quantifiable data for topography, peak-force error (phase signal), adhesion, 
stiffness (using DMT model), deformation and dissipation per pixel of the AFM image. 
This derivation is termed Peak Force Quantitative Nanomechanical Mapping (PFQNM), 
which is faster than force spectroscopy and provides more information than IC mode 
(Berquand 2011).
PFQNM has been widely used on hard surfaces (Duner et al. 2012; Trtik et al. 2012; 
Chafidz et al. 2012; Panaitescu et al. 2012; Kaplova et al. 2012) but publications 
showing quantitative maps of eukaryotes (Pletikapic et al. 2012) microbal and yeast 
systems are emerging (Alsteens et al. 2012). One notable live cell study characterised 
the in vitro hardening of keratinocyte cells in response to the herbicide glyphosate (Heu 
et al. 2012). To my knowledge PFQNM has never been used to characterise endometrial 
cells before. FD-AFM and PFQNM are complementary modes, as PFQNM performs a 
high frequency sinusoidal sweep making calculation of the tip velocity is difficult and 
thus is not applicable for cases where the loading rate (tip velocity) dependence of the 
measurement is important, such as bond rupture events. For this application traditional 
FD mode is still preferred.
1.137 AFM to study endometrial adhesion
Despite the advancements in technology platforms such as live cell AFM, there is a lack 
of uptake of these technologies in the field of reproductive biology. Previous 
publications from our group correlated changes in endometrial cell height and surface 
roughness to a hormonal environment replicating that of the WOI (Francis et al. 2009) 
suggesting that the AFM can detect nano-scale changes to endometrial cell surfacess. In 
vivo the endometrium exists as a flat layer with varying degrees of adhesion across the 
apical surface; the development of PFQNM combined with advanced molecular biology 
techniques provided an opportunity to characterise this adhesion and investigate the role
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played by key proteins. The endometrium is a key interface in human fertility, it is the 
site of embryo attachment, yet the vagaries of the molecular interactions which occur 
between embryonic and maternal cells following fertilisation, and the unique process of 
endometrial receptivity and implantation represent an obvious target for single molecule 
force spectroscopy.
1.14 Aims and objectives
This thesis constitutes a systemic study of the role played by MUC1 and L-selectin in 
trophoblast-endometrial interactions during the apposition phase of implantation. The 
main aim of this thesis is to investigate the proposed L-selectin/sLex adhesion 
mechanism involved in embryo attachment and the role of MUC1 in L-selectin 
adhesion. My secondary aim was to assess the patterning of endometrial adhesion 
mediators and their functional significance utilising the novel application of two 
advanced quantitative tools, the INCELL Analyzer and AFM. In chapter 3 my objective 
was to build an in vitro model of mucin expression during the WOI which is 
characterised by high and low expression at the EEC surface and secondly develop the 
use of INCELL technology as a high content, quantitative mapping tool capable of 
delineating the complex staining pattern of adhesion proteins and providing novel 
insights into the effect of steroid hormones on EEC lines. In chapter 4 my objective was 
to explore the use of PFQNM on EEC lines as a tool comparable to force distance AFM 
which is capable of characterising the nano-mechanical and topographical properties of 
cells which express varying levels of mucins using an in vitro model allowing direct 
correlation of the quantitative QNM data with advanced molecular biology (siRNA) to 
fully delineate the role of MUC1 at the EEC surface. The final aim of this thesis was to 
develop SMFS strategies to interrogate MUC1 as a scaffold for L-selectin ligands and 
assess its suitability for further understanding this adhesion system and its role in 
endometrium receptivity and embryo implantation
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2.01 Endometrial epithelial cancer cell lines (EEC)
Hec-l-A cells were first derived from explants of a moderately differentiated 
endometrial adenocarcinoma of a 71 year old woman over 40 years ago (Kuramoto et 
al. 1972). They are the most widely used cell line in implantation research (Hannan et 
al. 2010) and are considered poorly adhesive to trophoblast cells. Hec-l-B cells were 
acquired from a sub-population of Hec-l-A cultures that sustained a stationary growth 
period from 135-190 days (Kuramoto 1972). The original cell line Hec-l-A and sub­
strain Hec-l-B exhibit morphological and karyotypic differences. Hec-l-B cells have a 
raised morphology (Kuramoto et al. 1972) and are predominantly tetraploid, whilst Hec- 
l-A are flatter and predominantly diploid (Satyaswaroop et al. 1978). Additionally, the 
cell lines differ on the expression of nuclear receptors and adhesion proteins and thus 
must be characterised individually prior to use in research experiments.
Ishikawa cells were derived from a well differentiated endometrial adenocarcinoma of a 
39 year old woman (Nishida et al.1985) and are the best characterised of the all 
endometrial cell lines. Ishikawa cells have small vacuoles that produce mucus, irregular 
nuclei and a doubling time of up to 36hrs (Albitar et al. 2007). They display mixed 
characteristics of glandular and luminal epithelium and express functional steroid 
receptors for progesterone and estrogen (Croxtall et al. 1990; Boehme et al. 2009). 
Ishikawa is considered a good model for receptive human endometria and has been 
shown to facilitate adhesion of embryo derived cells (Heneweer et al. 2005).
Hec50 cells were isolated from a metastatic lesion in the peritoneal cavity in a patient 
with advanced disease. Hec50 forms sheets of undifferentiated cells and does not 
develop glands or produce secretions, compared to Ishikawa cells they have many more 
chromosomal rearrangements (29 versus 7) and the doubling time is much more rapid 
(Albitar et al. 2007). Hec50 cells have been shown to be negative for PR (Davies et al. 
2004) and while some studies shown Hec50 cells to be positive for ER they lack an 
estrogen response. This may be due to structural or functional alterations in the ER 
protein resulting in a loss of its capability to undergo the estrogen-directed 
conformational changes required for biological activity (Kassan et al. 1989).
2.011 EEC cell lines in culture
Commercially available Hec-l-A, Hec-l-B, Ishikawa and Hec50 EEC cell lines were 
obtained from the American Type Culture Collection (ATCC). All cell culture work 
was undertaken utilising appropriate aseptic techniques in ventilated tissue culture
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hoods. Cell lines were maintained in commercially available DMEM/F-12 + 
Glutamax™ full media (GIBCO) supplemented with 10% foetal bovine serum (FBS), 
sodium bicarbonate ImM, sodium pyruvate lmM and 1% antibiotic-antimycotic 
solution in plastic culture vessels (25cm2, 75cm2, 125cm2) at 37.0 °C and 5% CO2  
incubator (Nuaire). Cells were supplemented with free, full serum media every 2 days 
and passaged when confluent. Only cells passaged 2 or more times were used for 
experiments.
2.012 Passage of EEC cell lines in culture
Cells were passaged when confluent. Media was removed and cells were washed with 
phospho-buffered saline (PBS) (-Mg2+,-Ca24) (GIBCO) to remove residual medium. 
PBS and residual media was then aspirated and cells were incubated in PBS at 37.0 °C 
and 5% CO2  for 5 minutes. Following further aspiration the cells were incubated in 1ml 
Trypsin-EDTA (0.25%) at 37.0 °C and 5% CO2  for 5 minutes (or until the cells 
appeared rounded and detached). Trypsin cleaves E-cadherin and other adhesion 
proteins freeing the cells from plastic surface of the culture flask. 10ml of media was 
added to neutralise the trypsin and the resulting cell suspension was split into two 
centrifuge tubes and centrifuged at 1500rpm for 5 minutes. The pellet was re-suspended 
in 10ml of DMEM/F-12 + Glutamax™ media (GIBCO) and the cell suspension was 
added to a fresh culture vessel for incubation.
Cell growth dynamics were characterised using a high content screening (HCS) system 
to rapidly count large numbers of cells and assess their level of confluence at any given 
stage. EEC cells were grown in a T125 cell culture flasks (Greiner bio-one #660175) 
until confluence (lOxlO6 cells), trypsinised as above and serially diluted to the 
following concentrations (units are cells/ml); 2xl04, 5xl04, lx l0 5, 2xl05, 3xl05 and 
5x10s. 1ml of each dilution was added to one well of a 6 well plate (Greiner bio-one 
#657160), the cells allowed to adhere and then another 1ml of DMEM/F-12 + 
Glutamax™ media was added to each well. This was repeated with four 6-well plates 
for each cell line, resulting in a total of 16 plates. All plates were incubated at 37.0°C 
and 5% CO2 . Every 24hrs four plates were removed (one from each cell line), media 
aspirated from all wells and the cells rinsed with PBS. Nuclei were stained with 
NucBlue™ (Life technologies # R37605) 4',6-diamidino-2-phenylindole (DAPI) 
preparation (2 drops/ ml PBS for 25 minutes at 25°C). The INCELL analyzer 2000 (GE 
Healthcare) was used to image 15 randomly selected fields (random selection is a
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When not in use all hormone stocks were maintained at -20°C in glass vials. Fresh 
stocks were made up periodically to counter the effects of ethanol evaporation when in 
use, ensuring consistent cell exposure to correct concentrations.
Hormones in combination - Preparations of hormones were combined in an extended 
treatment regime that lasted for 72hrs. Media was aspirated and cells were incubated in 
serum stripped media containing lOnM E2  at 37.0°C and 5% CO2  for 24hrs. This 
treatment was then removed and the cells were washed once with hormone free serum 
media before being incubated in varying combinations of hormones for 48hrs 
summarised inTable 2.
Treatment 1 2 3 4 5
Shorthand Control E-»P E-»P+E E-»MPA E-»MPA+E
First 24hrs Ethanol E2  (lOnM) E2  (lOnM) E2  (lOnM) E2  (lOnM)
Last 48hrs Ethanol P4 (lOOnM) P4 (lOOnM) E2 (lOnM) MPA (lOOnM) MPA (lOOnM) E2 (lOnM)
Table 2: Combined hormone stimulations. In order to mimic the combination of E2  and 
P4  exposure of the luminal epithelial cells during the secretory phase of the menstrual 
cycle, multiple combination treatments were employed in this study to test for their 
effect on mucin expression dining an in vitro model of the WOI.
2.03 RNA interference
Specific gene silencing was conducted with MUC1 and MUC16 siRNA (Santa Cruz 
Biotechnology [sc-37266 and sc-44971 respectively]). For each siRNA used a control 
siRNA-A (Santa Cruz Biotechnology [sc-37007]) that is not complementary to any 
known human transcript was used. Lyophilised siRNAs were reconstituted in 330pl 
ddH20 to a stock concentration of lOpM and aliquoted into lOpl vials before being 
stored at -20°C as per manufacturer’s guidelines.
Gene silencing was optimised by testing multiple concentrations of MUC1 siRNA on 
Hec-l-A and Hec-l-B cell monolayers and assessing gene knockdown by using 
qRTPCR. The cells were sub-cultured and prepared as outlined above. 5xl04 cells in 
suspension were aspirated onto the appropriate culture vessel for the endpoint assay 
(Figure 22) and allowed to attach for 5 minutes. Antibiotic free media was added and 
cells incubated in a controlled atmosphere of 5% CO2  at 37°C for a minimum of 24hrs. 
When the cells reached the 40% confluence, the culture medium was aspirated and 
replaced with pre-incubated in reduced serum OPTI-C medium (Invitrogen #31985- 
062) containing 25, 50 or 75nM siRNA and 0.0375% RNAi MAX (Invitrogen 
#13778030) ensuring full coverage of the monolayer. 1.5ml of antibiotic free medium
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software feature) in the DAPI channel at low magnification (lOx objective) across each 
well. These 15 images (per well) were post processed (see section 2.062 HCS Image 
analysis for INCELL image processing) and nuclei were counted, the average number 
of nuclei per field was divided by the number of nuclei in a field of confluent monolayer 
of that cell line (typically around 2000) generating a percentage for cell confluence. 
Table 1 shows the confluence calculation of Hec-l-A cells at various seeding densities 
at the 24hr end point. Nuclei were counted after 24, 48, 72 and 96hrs for each cell line 
tested.
Bid point 24hn
No. Seeded 20000 50000 100000 200000 300000 500000
Well (field) Nuc. Count Well (field) Nuc. Count Well (field) Nuc. Count Well (field) Nuc. Count WeU (field) Nuc. Count Well (field) Nuc. Count
A -1 (fid 1) 31 A - 2 (fid 1) 68 A - 3 (fid 1) 48 B - 1 (fid 1) 326 B -2(fld  1) 259 B - 3 (fid 1) 327
A - 1 (fid 2) 119 A -2 (fld 2 ) 76 A - 3 (fid 2) 142 B • 1 (fid 2) 116 B -2(fld  2) 200 B - 3 (fid 2) 310
A - 1 (fid 3) 40 A - 2 (fid 3) 83 A - 3 (fid 3) 102 B - 1 (fid 3) 247 B - 2 (fid 3) 580 B -3  (fld 3) 620
A -1 (fid 4) 49 A - 2 (fid 4) 47 A - 3 (fid 4) 74 B - 1 (fid 4) 209 B - 2 (fid 4) 549 B - 3 (fid 4) 354
A -1 (fid 5) 22 A - 2 (fid 5) 75 A - 3 (fid 5) 89 B - 1 (fid 5) 296 B - 2 (fid 5) 248 B -3  (fid 5) 341
A - 1 (fid 6) 89 A - 2 (fid 6) 91 A - 3 (fid 6) 229 B - 1 (fid 6) 216 B - 2 (fid 6) 225 B -3  (fid 6) 381
A -1  (fid 7) 16 A - 2 (fid 7) 73 A - 3 (fid 7) 144 B - 1 (fid 7) 183 B - 2 (fid 7) 255 B -3  (fld 7) 1023
A - 1 (fid 8) 42 A - 2 (fid 8) 142 A -3  (fid 8) 240 B - 1 (fid 8) 189 B -2(fld  8) 586 B -3  (fid 8) 716
A - 1 (fid 9) 57 A - 2 (fid 9) 84 A - 3 (fid 9) 82 B - 1 (fid 9) 258 B - 2 (fid 9) 510 B -3  (fld 9) 393
A - 1 (fid 10) 50 A - 2 (fid 10) 111 A -3  (fid 10) 188 B - 1 (fid 10) 176 B -2(fld  10) 215 B -3  (fld 10) 426
A - 1 (fid 11) 68 A - 2(fid 11) 91 A -3  (fid 11) 158 B - 1 (fid 11) 548 B - 2 (fid 11) 681 B -3  (fld 11) 773
A - 1 (fid 12) 106 A - 2 (fid 12) 133 A -3  (fid 12) 161 B - 1 (fid 12) 197 B -2(fld  12) 183 B -3  (fld 12) 353
A - 1 (fid 13) IS A • 2 (fid 13) 125 A - 3 (fid 13) 226 B - 1 (fid 13) 182 B -2(fld  13) 606 B -3  (fld 13) 1426
A - 1 (fid 14) 41 A - 2 (fid 14) 63 A - 3 (fid 14) 85 B - 1 (fid 14) 327 B -2(fld  14) 503 B -3  (fld 14) 589
A - 1 (fid 15) 41 A >2(fld 15) 44 A -3  (fid 15) 81 B - 1 (fid IS) 315 B - 2 (fid 15) 239 B -3  (fld 15) 338
Average 52 87 137 252 389 558
Confluence % 2.6 4.4 6.8 12.6 19.5 27.9
Table 1: Calculating Hec-l-A growth characteristics. Each column contains the number 
of nuclei counted in each field, of which there are 15 per well. Each well had a different 
initial seeding density ranging from 20000 cells to 500000 cells.
This simple experiment counted large numbers of cells, randomly sampled across the 
well ensuring that the growth rate of any one of the four cell lines in culture could be 
predicted accurately.
2.02 Hormone treatments
All cell treatments were conducted in appropriate culture vessels for their downstream 
assay (Figure 22). Cells were seeded at the correct density to ensure 80-100% 
confluence at the end of the culture period and grown in the presence of FBS 
supplemented serum for a minimum of 24hrs. 24hrs prior to treatment, the culture 
media was replaced with stripped serum to ensure the removal of all large molecular 
weight proteins and steroids from the cell medium.
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Stripped serum media was made up with hormone stripped FBS. Dextran coated 
charcoal treatment of FBS was carried out in order to remove any naturally occurring 
steroid hormones from the serum. This was achieved by adding 1 .Og of dextran coated 
activated charcoal (SIGMA-ALDRICH [C-6241] 5g) to 500ml of FBS (GIBCO 
[10437028] 500ml). The solution was incubated at 56°C for 2hrs, filter sterilized and 
stored in 50ml Falcon tubes at -20°C prior to use. Hec-l-A and Hec-l-B cell 
monolayers were removed with 0.25% trypsin-EDTA (Life Technologies [25200-072]) 
and re-suspended in fresh culture media (detailed above). 1.0ml of cell suspension 
(containing 5xl04 cells) was aspirated onto appropriate dishes (Figure 22) and allowed 
to attach for 5 minutes. 2.0mls appropriate media was added and cells incubated in a 
controlled atmosphere of 5% CO2  at 37°C for 24hrs. Stock solution consisting of 2pl of 
P4, E2  or MPA in ethanol was combined with 2ml of hormone stripped serum media. 
Culture medium was aspirated and cells covered with this preparation and incubated in 
a controlled atmosphere of 5% CO2  at 37°C for 48hrs.
Progesterone (P4) - 0.314g of progesterone (SIGMA-ALDRICH; P-0130 [>99%]) was 
added to 10ml absolute ethanol (Fisher-Scientific) to a concentration of ImM. This 
stock was diluted 1/10 resulting in a IOOjiM working stock and when required, 2pl of 
the working stock was added to 2ml hormone stripped serum media resulting in a final 
treatment concentration of 1 OOnM.
Estradiol (E2)  - 0.272g of estradiol (SIGMA-ALDRICH; E-8875 [>98%]) was added to 
10ml absolute ethanol (Fisher-Scientific) to a concentration of ImM. This stock was 
diluted 1/100 resulting in a lOpM working stock and when required 2pl of this working 
stock was added to 2ml hormone stripped serum media resulting in a final treatment 
concentration of lOnM.
Methoxyprogesterone acetate (MPA) - 0.386g of MPA (SIGMA-ALDRICH; P-0130 
[>99%]) was added to lOmL absolute ethanol (Fisher-Scientific) to a concentration of 
ImM. This stock was diluted 1/10 resulting in a lOOpM working stock and when 
needed 2 pi working stock was added to 2ml hormone stripped serum media resulting in 
a final treatment concentration of lOOnM.
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was added and cells incubated in 5% CO2 at 37°C for 48hrs. All subsequent silencing of 
MUC1 and MUC16 gene expression was conducted with 50nM siRNA and 0.0375% 
Lipofectamine RNAi MAX (as per manufacturer’s guidelines) for 48hrs.
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Figure 22: Cell culture vessels used for qRTPCR, INCELL analyzer based HCS, and 
AFM. Depending on the final endpoint assay the culture vessels for the cells and all 
appropriate treatments varied. All are outlined here.
2.04 Quantitative Real Time Polymerase Chain Reaction (QRTPCR)
RNA extraction -Total RNA was isolated from confluent monolayers using the RNeasy
mini kit and DNAsel kit (Qiagen [74106 and 79254]), following the manufacturer’s 
instructions. Total RNA captured on the column was eluted into 90pl of RNAse free 
water (Qiagen #129112).
Reverse Transcription -The concentration of total RNA extracted was determined using 
a Nano-drop ND-1000 spectrophotometer and all samples were adjusted to a 
concentration of lOOpg/ml using RNAse free H2 O (Qiagen #129112). Total RNA was 
reverse transcribed to produce cDNA using the high capacity cDNA kit (Applied 
Biosystems [4387406]). The reaction master mix consisted of 2.0pl lOx RT buffer, 
0.8pl 25x dNTP mix, 2.0pl lOx random decamer primers, 1 pi of reverse transcriptase 
enzyme 1.0 pi of RNAse inhibitor, and 1.2 pi of dF^O. The kit was supplemented with
2.0 pi of oligo-dT primers (Ambion [AM5730G]) to ensure a preference for mRNA in 
the reverse transcription reaction. lOpl RNA (lOOpg/ml) was combined with lOpl 
reaction master mix resulting in a 20pL final volume and placed in a T-100
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thermocycler (Biorad [186-1096]). The reaction mix was incubated at 25°C for lOmins, 
37°C for 120mins, 85°C for lOmins and 4°C for lOmins.
QRTPCR - cDNA was amplified using gene specific primer pairs (Table 4) to obtain a 
PCR product between 75-263bp for each of the genes under study. RP-L19 was used as 
a housekeeping gene, and genomic DNA and RNA were used as positive and negative 
controls respectively. Amplification reactions of volume of lOpL were prepared by 
adding 5 pL of SsoFast™ EvaGreen® Supermix containing the Pyrococcus furiosus 
(Pfu) DNA polymerase (Bio-Rad #1725200), 1.25pL of each primer (4pM 
concentration) and 2.5pi of cDNA (1/10 dilution). QRTPCR amplifications were 
conducted in triplicate in 96-well optical reaction plates and run on the CfX-96 PCR 
detection system (Biorad). Plates were heated first to 95°C for 5min to activate the DNA 
polymerase enzyme and run for 40 cycles of Is at 95°C, 5s at the optimal annealing 
temperature for each primer pair and 5s at 72°C to allow extension. To obtain the 
melting curves for each sample a final step of 40 cycles was performed for 5s at 53°C, 
increasing the set point temperature by 0.5°C per cycle up to a maximum temperature of 
95°C. No amplicons were obtained using RNA directly in the QRTPCR reaction.
Relative quantification of gene expression data was determined from quantification 
cycle (Cq) values for each sample using the standard curve method (Karlen et al. 2007). 
Each plate included a standard curve of known concentration, serial dilutions of cDNA 
1/5, 1/10, 1/100 and 1/1000 (Table 3) that were converted into common logarithm (log 
base 10) values and plotted against the respective Cq. A trend line was fitted to the 
resulting calibration curve (Figure 23) and the equation of the line (y=mx+c) used to 
calculate the log dilution from samples of unknown cDNA starting quantity.
y  =  m x + c
equation of the line, where (m) represents the gradient and (c); represents the point at 
which the line intercepts the y axis, (y) represents the Cq and (x) the common logarithm 
of the starting quantity can then be re-arranged to find (x). The common logarithm 
values were converted to nominal values by taking the result and making it the power of 
the base [10Ares"“].
The co-efficient of determination (R ) was then calculated in Excel to determine how 
closely the points from different cDNA dilutions adhere to the standard curve, and this
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value used as a determination of PCR efficiency. An R2 value >0.99 provides good 
confidence in correlating two values and shows the reaction was very efficient. All 
standard curves had an R2 value of >0.98 (Summarised in Figure 23).
All expression levels were normalised with values obtained for the internal reference 
gene RP-L19. Once normalised, expression was calculated as a relative value of 
transcript levels between treated and control or individual cell line samples for each 
gene. Normalised starting quantity (SQ) values from triplicate wells were combined to 
give an average SQ per repeat. Significance was tested using a two-tailed Student’s T- 
test conducted on average values from three independent repeats. Treated samples were 
compared against the untreated controls where P values <0.05, <0.01 and <0.001 were 
considered statistically significant and denoted with a: *, ** and *** respectively.
Well ID Dilution Log dilution Quantification Cycle (Cq) Avg.Cq Logdiuhion Starting quantity Relative factor
Standard
1/5 02 -0.699 18.14
Standard
1/10 0.1 -1 18.67
Standard
1/10 0.1 -1 18.73
Standard
1/10 0.1 -1 18.65
Standard
1/100 0.01 -2 21.91
Standard
1/1000 0.001 -3 25.37
Heel A 18.91
Heel A 18.81
Heel A 18.77
18.68 0.97 9.27
18.83 1.01 10.31
Table 3: Data analysis of raw quantification cycle data. Standard curves ranging 
between 1/5 and 1/1000 dilutions of cDNA were converted into natural logarithms. The 
Log dilutions are then plotted against the Cq values. The equation of the line for this plot 
is re-arranged to yield log dilutions of unknown triplicate samples (Hec-l-A shown 
here). Log dilutions are converted back to starting quantities by making the log the 
power of the base 10.
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Figure 23: qRTPCR standard curve analysis. The standard curve is plotted using the log 
standard dilutions of 1/5, 3(1/10), 1/100 and 1/1000 against their respective Cq. Log 
quantities of unknowns may be fitted to this standard curve using the equation of the 
line. The R2 value shows the efficiency of the reaction.
Primers for use in qRTPCR were designed using the National Centre for Biotechnology 
Information (NCBI) “PRIMER BLAST” against the nucleotide sequences of: ribosomal 
protein LI 9 (RPL19), mucin 1 (MUC1), mucin 4 (MUC4), mucin 16 (MUC16), 
progesterone receptor (PR), estrogen receptor a (ESR1), estrogen receptor p (ESR2) and 
N-acetylglucosamine-6-O-sulfotransferase (GlcNAc6ST). The forwards and reverse 
primer sequences, the temperature required for template annealing (calculated using 
Biorad CFX software), and amplicon length are shown in Table 4.
G en e
N C BI a c s e n s io n
Prim er d irectio n O lig o -n u c le o t id e  s e q u e n c e
A n n e a lin g  
tem p . ( Q
A m p lico n  
le n g th  (b p )
R PL -19 NM 000981.3 F 5'-CCTGrACGGrCCATTC-3'
5'-AATCCTCATTCTCCTCATCC-3'
54.3 144
R
M u cin -1 NM 002456.5 F 5'-TGGrGCTGGrcrGrCnTCTG-3’
5’-CrCGCTCATAGGATGGTAGGrA-3'
54.2 233
R
M u c in -4 AF522055.1 F 5'-CTCTGCCTCCTTCCGCATGT-3' 
5-TCCCTCr A GTGTCGCr GTTCTr-3'
56.2 145
R
M u c in -1 6 AF361486 F 5'-TT CGCCTGCCA GT CCT A A A G-3' 
5'-GrGCTGGCCATTTGCATTGA-3’
55.0 283
R
PR M15716 F 5'-CTGCA CTCGGCCTCA A CGGG-3' 
5'-TGrGGGCrCrGGCrGGCrTC-3'
53.5 119
R
ER a N M _ 0 0 0 1 2 5 F 5'-CCTCATCCrcrCCCACATCAG-3'
5'-GGCGTCCAGCATCTCCAG-3'
53.5 240
R
Erp DQ838583 F 5'-TGCTGAA CGCCGTGA CCGA TG-3' 
5'-ATGGATTGCTGCTGGGAGGAGA-3'
54.2 167
R
G L c N A cS T AB014680 F 5'-A TCCGTGA GA GCCTA CA GGT-3' 
5'-CA TTGCGTGCA GA T A CCA CG-3'
59.5 382
R
Table 4: Primer sequences. The nucleotide sequence of each gene was acquired using a 
NCBI nucleotide search. Ascension numbers are shown. Primers were designed using
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the “Pick Primers” function and annealing temperatures and amplicon lengths are 
shown.
2.05 Immunocytochemistry (ICC)
Confluent monolayers for each cell line were trypsinised and re-suspended in fresh 
DMEM-F12 media. Cells were adjusted to a seeding concentration of 8xl04 cells/ml 
and seeded onto slides within quadriperm vessels (Nunc), allowed to attach for 5 mins 
before flooding with 5ml of media and left to grow for a minimum of 24hrs or until they 
were 80-100% confluent.
Each slide was labelled with mouse VU4H5 anti-MUCl antibody (Santa Cruz 
Biotechnology) at a 1:50 dilution. A positive control section of colon adenocarcinoma 
was used. Primary antibody incubation was for 36 minutes at 37°C. Positive 
immunostaining was detected through interaction of avidin-biotin peroxidise (ABP) 
complex with biotin conjugated secondary antibody using a ventana I view DAB 
detection kit (Ventana Biotek Solutions [760-500]). The slides were subsequently 
counter stained with haemotoxylin, dehydrated and mounted to be examined under light 
microscopy. An immunocytochemical scoring system was used in which the same 
observers examined a designated representative area for each of the
immunocytochemical slides prepared. The observers were blinded to the origin of the 
slides and cell type before scoring. The endometrial epithelial cells were assessed for 
stain intensity throughout the cell. The intensity of the staining was assessed as follows: 
(0) -  absent, (1) -  less than 25%, (2) - 25-50%, (3) - 50-75% and (4)-75-100% of the 
cell surface stained.
Two observers scored 20 cells independently from each slide area (triplicate slides for 
each treatment and cell line sample) and scores were collated into a single data set 
giving 120 cells for each steroid receptor in each cell line. Significance was tested using 
the Kruskal-Wallis one-way analysis of variance for non-parametric data. This test 
detected whether at least one of the samples was significantly different from the group. 
Where a significant difference between groups was detected then Mann-Whitney U test 
was used to analyse specific sample pairs for significant differences. All cell lines were 
compared using Kruskal-Wallis and then Hec-l-B was compared to Hec-l-A, Ishikawa 
and Hec50 using Mann-Whitney. P values <0.05, <0.01 and <0.001 were considered 
statistically significant and denoted with a: *, ** and *** respectively.
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2.06 High Content Screening (HCS) of MUC1 and sLex using INCELL technology
The cells were cultured as previously described. Cell monolayers were fixed with
paraformaldehyde (4% w/v for lOmin at 4°C), and permeablised with Triton X-100 
(0.01% v/v for 5min at 25°C). Cells were incubated in blocking buffer (5% goat serum 
+ 1% BSA in PBS) for lhr at 25°C. Next, cells were incubated in either mouse VU4H5 
anti-MUCl antibody (Santa Cruz Biotechnology #sc-7313) at a final concentration 
2ug/ml or CTAGE1 Antibody-FITC (MECA-79) (Santa Cruz Biotechnology #sc- 
53514) for lhr at 25°C. For fluorescent detection, the VU4H5 antibody required the 
addition of anti-mouse Texas-Red conjugated secondary antibody (Molecular Probes 
#T-6390) at a final concentration 2ug/ml in PBS for lhr at 25°C. For MECA-79, Texas- 
red conjugated secondary antibody was omitted because the primary antibody was 
conjugated to a FITC reporter element. The cell nuclei in both preparations were 
counter stained with NucBlue™ (Life technologies # R37605) 4',6-diamidino-2- 
phenylindole (DAPI) preparation (2 drops/ ml PBS for 25 minutes at 25°C). 5x 5min 
washes in PBS followed each incubation step and the cells were imaged in excess PBS.
2.061 HCS Image acquisition
HCS of MUC1 and sLex using immuno-fluorescence was undertaken using the INCELL 
Analyzer 2000 (GE healthcare). Image data was recorded in two emission spectra 
channels; DAPI nuclear staining (Channel 1 X 470nm for 0.0150s) and Texas Red 
MUC1 staining (Channel 2: X 620nm for 5.000s) or FITC MECA-79 staining (Channel 
2: X 521nm for 5.000s). The nuclear stain was a requirement to separate individual cells 
in subsequent analysis. Thirty low magnification images (10 x objective) were obtained 
for control and treated. These images contained a total of -15000 cells (30 images of 
approx. 500 cells).
The INCELL analyzer acquisition software allows for a random distribution of fields 
across the well surface and regions of the centre or edge of the well may be excluded 
from field selection. The regions close to the well boundary were excluded from field 
selection as they were not representative of other areas of the well. The exposure time 
for each channel was kept constant across all experiments, therefore changes in 
fluorescence were directly attributable to protein expression levels. The output file is 
termed XDCE, which is a folder containing compiled images from all channels and all 
fields of view screened.
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2.062 HCS Image analysis
XDCE files were analysed by using INCELL investigator software suite (GE Healthcare 
Analysis) to quantify MUCl/sLex immune-fluorescence. Briefly, an object 
segmentation feature masked the nuclei by segmenting on the basis of intensity in the 
DAPI channel. The high contrast in fluorescence output between the nuclear material 
and background facilitated efficient separation of nuclei against background. The 
masked bitmap was eroded in order to separate clumped nuclei prevalent in the 
monolayer. The initial segmentation was then repeated as above and nuclei in close 
proximity were separated as individual objects using the eroded mask from the previous 
step. A 10pm collar drawn around the nuclear mask isolated the cytoplasmic region of 
each cell (see Figure 24, Figure 25 -Nuclei identification). Fluorescence output in 
absolute grey levels was recorded pixel by pixel across the cell area mask and each cell 
was assigned a value for MUC1 expression based upon area the average pixel 
fluorescence. The software allows for calculation of total cellular fluorescence but this 
meant cell size would be a conflicting factor and thus was not desirable.
Depending on the output parameters specified, average fluorescence output per cell, that 
is across the pixels over the cell body or a mean output for the cell population was 
generated. This mean output for the population is denoted “average well intensity” and 
displayed in the form of a bar graph normalised against negative control. This 
normalisation process involved subtracting the average well intensity from a no 
antibody negative control from the experimental value to account for any background 
staining meaning the remaining signal was due to specific bound primary antibody. This 
was repeated with three independent repeats and the well values were tested for 
significance using a two-tailed Student’s T-test conducted on average values from three 
independent repeats. Treated samples were compared against the untreated controls 
where P values <0.05, <0.01 and <0.001 were considered statistically significant and 
denoted with a: *, ** and *** respectively.
In some instances (e.g. Figure 42, Chapter 3) the spread of the data is best illustrated 
with a histogram. This time the individual fluorescence output values per cell were 
sorted on the basis of intensity to look for subtle changes in the distribution of protein 
expression, cells comprising these histogram data sets are compiled from three repeats 
and total cells sorted.
69
Chapter 2 Materials and Methods
Figure 24: Analysing image data using HCS. Image shows analysis of EEC cells stained 
for MUC1 (green). Nuclei were counter stained (blue) in order to separate clumped 
cells. Red outlines denote estimated cell boundaries. Values for MCI expression are 
average fluorescence per pixel inside marked area. This analysis helped identification of 
high expressing cells (1,2,3) compared to lower expressers (4,5,6).
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Figure 25: Overview of HCS. Endometrial monolayers are grown to 40-60% confluence 
(shown here) and treated with ovarian hormones or siRNA. Cells are then fixed and 
media removed. From here the analysis is conducted in two channels. First cells are 
stained with DAPI to identify the nuclear region while a single (MECA-79) or dual 
(MUC1) antibody stain is used for identification of expressed proteins. The INCELL 
analyzer 2000 captures two superimposed images, one in the DAPI emission 
wavelength and one in the Texas-red (MUC1) or FITC (MECA-79) emission spectrum.
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These images are post-processed separately, nuclei are used to identify individual cells 
and the resulting mask is expanded to encompass the cytoplasmic region. At the final 
stage the images are fused and fluorescence signal within the cytoplasmic region is 
assessed in the protein channel. This results in a fluorescence value per cell, relating to 
the expression of protein in that cell.
2.07 Atomic force microscopy
During my project I undertook an industrial placement at Bruker nano in Mannheim, 
Germany. The imaging and QNM data presented in this thesis was acquired using a 
Bioscope catalyst II AFM (BRUKER Nano) equipped with a Nanoscope V controller 
and coupled to a DMI6000 (Leica, Mannheim, Germany). Upon my return to Swansea, 
I trained to use a Nanowizard II AFM (JPK, Berlin, Germany) mounted on a Zeiss 
LSM510 confocal microscope. All SMFS data presented was conducted on this 
instrument.
2.071 Sample preparation for AFM imaging
Fixed cell imaging in liquid - Cell lines were cultured as outlined in the appropriate 
section above (2.012 Passage of EEC cell lines in culture) in 50mm diameter glass 
dishes (WillCo Wells #GWSt5040) until 80-100% confluent. After 48hrs or the after the 
desired treatment regime was complete, the culture media was removed and the cells 
washed in 3mls PBS for 5mins, before being fixed with 4% paraformaldehyde at 4°C 
for lOmins. Cells were then rinsed in PBS to remove excess fixative and taken to the 
AFM for fixed cell imaging in fresh PBS at room temperature (RT).
Live cell imaging - cell lines were cultured as outlined in the appropriate section above 
(2.012 Passage of EEC cell lines in culture) in 50mm diameter glass dishes (WillCo 
Wells #GWSt5040) for use on the Bruker Bioscope Catalyst II AFM or 35mm diameter 
glass dishes (Fluorodish #FD35) for use on the JPK Nanowizard II AFM. After 48hrs or 
the culmination of the desired treatment regime, the culture media was replaced with 
2ml of pre-warmed DMEM/F-12 phenol red free media (GIBCO # 21041-025) prior to 
live cell imaging. Application of fresh phenol red free media removed any accumulated 
floating cell debris from the sample which could interfere with the AFM probe and the 
lack of phenol red enabled easy alignment of the laser spot on the upper reflective 
surface of the cantilever. Cells were imaged over a maximum time of 90 minutes and 
maintained at 37°C using the stage heater system to ensure cells remained adherent and 
viable.
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For all imaging in liquid, tapping mode was employed utilising the flexibility of the 
ScanAsyst Fluid cantilevers which had a nominal spring constant of 0.7N/m and a tip 
apex radius of 20-60nm. These probes have an intentionally dull tip ideal for force 
measurements and imaging extremely delicate cell surfacess in fluid. Care was taken to 
avoid the generation of imaging artefacts throughout.
2.072 Surface roughness
Mean surface roughness (Ra) is defined as the arithmetic mean of the deviations in 
height from the line mean value. Analysis of surface roughness used 10 randomly 
selected 3 pm2 square areas of each monolayer image in the height channel of peak force 
QNM. Three areas of monolayer were analysed for roughness from Hec-l-A and Hec-1- 
B cells to determine the effect of mucin protein expression on surface roughness (Figure 
26). Significant difference between the two data sets was assessed using the Kruskal- 
Wallis one-way analysis of variance for non-parametric data. P values <0.05, <0.01 and 
<0.001 were considered statistically significant and denoted with a: *, ** and *** 
respectively.
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Figure 26: Analysis of surface roughness within the Nanoscope analysis software. 
Surface roughness was measure by selecting 30 3 pm2 areas across the monolayer for 
Hec-l-A and Hec-l-B.
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2.073 Peak Force Quantitative Nano-mechanical Mapping (PFQNM)
2.0731 PFQNM Image acquisition
All PFQNM measurements were performed in aqueous solution; either on fixed cells in 
PBS or at near physiological conditions in media by using a Bioscope catalyst II AFM 
(BRUKER Nano) equipped with a Nanoscope V controller and coupled to a DMI6000 
(Leica, Mannheim, Germany). Nano-meter scale images of surface topography and 
other surface properties were recorded in peak force tapping (PFT) mode using 
ScanAsyst fluid probes (Bruker Nano). Prior to experimentation the spring constant was 
calibrated using thermal tune sweep (300hz to 500hz) and found to be within 0.1 and
0.3 N/m. The cantilever deflection sensitivity was calculated using the in built 
Nanoscope software, by ramping into a non-compliant surface (glass) and fitting a trend 
line to the indentation curve, allowing the direct quantification of nano-mechanical 
surface properties using Peak Force QNM.
ScanAsyst fluid probes featured a triangular cantilever (k = 0.35-1.5N/m, resonance 
frequency lOOKhz, LxWxH 70x10x0.6pm) coated with 45+/-5nm Ti/Au reflective layer 
and a sharp tip of height 2-6.5pm and nominal radius 20nm. Scanning parameters were 
maintained around 0.1 Hz and 128 samples/line, corresponding to 16384 force curves 
per area. The scan area typically encompassed 50-150pm2 regions of monolayer 
depending on topographical limitations and the peak-force amplitude was 300nm. 
Typically a frequency of oscillation of 1kHz was used and the z-range set to the 
maximum 27.1pm. The indentation force was kept as low as possible to preserve the 
live cell membrane and did not exceed 3nN. Each time the tip contacted the surface a 
force curve was recorded from which several parameters like topography, adhesion, 
dissipation and deformation were monitored and calculated using the in built nanoscope 
analysis software.
Nanoscope v8.2 software (Bruker Analysis software) allows capture of a single very 
high resolution (5000 samples/line) scan line. Termed High Speed Data Capture 
(HSDC) this feature allows 5000+ force curves to be recorded independent of the 
PFQNM image. These force curves can be exported for subsequent post processing 
using advanced models of elastic interaction in third party software. For every PFQNM 
image a corresponding HSDC file was captured.
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2.0732 PFQNM image analysis
Nano-mechanical data presented in chapter 4 was generated using the Bioscope catalyst 
II AFM operating in peak force QNM imaging and high speed data capture (HSDC) 
modes. The fixed cell images were post-processed for adhesion, deformation, 
dissipation and height using the “ bearing analysis’’ function of Nanoscope analysis 
vl.42r02 (Bruker Analysis Software). The returned value is an average of 262144 force 
curves. Three images were processed from one biological repeat thus returning a total of 
786432 force curves.
The live cell images were processed for adhesion and deformation again using “bearing 
analysis”. The returned value is an average of 16384 force curves, however this time 
three images were processed from each of three biological repeats thus contributing to a 
total of 147456 force curves for each condition.
Grouping Number of 
biological repeats
Nianber of 
areai per repeat
Range of ican 
sizes (pm)
Image resolution 
(samples/line)
Image 
aspect ratio
Nunbcr o f force 
ctrves per image
Total number of force 
cirves per grow
Hec-l-A  [FIXED] 1 3 30-70 512 262144 786432
Hec-l-B [FIXED] 1 3 30-50 512 262144 786432
Hec-l-A 3 3 65-100 128 16384 147465
Hec-l-B 3 3 50-100 128 16384 147465
Hec-l-A  MUC1 siRNA 3 3 100-150 128 16384 147465
H ec-l-B MUC1 siRNA 3 3 50-73 128 16384 147465
Table 5: The experimental design of fixed and live cell PFQNM studies. The 
preliminary fixed cell data set was obtained from 3 areas of the fixed cell monolayer 
from Hec-l-A and Hec-l-B cells. High resolution quantitative maps resulted in a large 
number of force curves per data set. The subsequent live cell investigation used lower 
resolution images but an increased number of independent repeats ensuring the 
biological robustness of the approach.
During the timeframe of this study the current AFM software (Nanoscope v8.2) by 
default calculated elastic modulus using DMT (Deijaguin et al. 1975) which assumes 
that adhesion forces occur outside the contact area and takes no account for adhesion 
between the tip and surface. In addition, DMT also requires the sample thickness to be 
many times thicker than the indentation depth. This model is suitable for high-density 
polymers or other such non-compliant samples but it is not particularly suitable for 
biological samples as the indentation depth into cells can be hundreds of nanometers. 
Therefore, force curve analysis for elastic modulus was conducted outside o f the 
provided Nanoscope analysis vl.42r02 software using the Sneddon model (Sneddon 
1965; Belikov et al. 2009), which takes the deformation induced by the indenter into 
account, considering the AFM tip as an infinite cone, and is well adapted to biological 
samples (Berquand et al. 2013; Kuznetsova et al. 2007; Lombardo et al. 2012).
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As Sneddon was not native to the Bioscope Catalyst II Nanoscope software, for each 
image, a single HSDC file containing 5000 force curves was recorded for each image. 
The raw force curves were exported for analysis in custom software environment, 
Rainbow (Belikov et al. 2009), which gives the user the possibility to apply several 
different models, including Sneddon, to extract Young’s modulus.
Figure 27: The indentation of a conical shape into a flat surface. Contact stiffness, S is 
related to the projected contact area A, and the elastic constants of the material, E and v, 
Poisson’s ratio.
The projected contact area, A can be calculated by:
2.074 Single Molecule Force Spectroscopy (SMFS)
Cell monolayers were prepared and treated as desired, as described in section 2.012 
Passage of EEC cell lines in culture.
2.0741 Functionalising the AFM  probe
AFM probes were first cleaned by rinsing in deionised water and then immersed in 
HAPTES (SIGMA ALDRICH) buffer (0.1% v/v, pH 7.0) for 7mins at 25°C. The 
silanized probes were rinsed 5x in deionised H2 O then immersed in glutaraldehyde 
(0.5% w/v pH 7.0) for 7 mins at 25°C. The probes were again rinsed with water before 
being immersed in mouse VU4H5 anti-MUCl antibody (Santa Cruz Biotechnology #sc- 
7313) at a concentration of 200pg /ml, for 7mins at 25°C. This antibody recognises the 
extracellular VNTR domain of MUC1 and is identical to that used for both ICC and 
HCS analysis. After this final incubation the AFM probes were rinsed 5x in Tris HC1 
(5% w/v pH 7.0). Probes were then immediately immersed in Tris HC1 and were not 
allowed to dry out before taking measurements. This procedure was repeated with 
GAPDH antibody and recombinant human L-selectin protein fragments.
r
A = tan 6 (s1 — s 0) 2 
Where 6 is the angle of the cone and s1 is the surface and s° is the indentation depth.
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Recombinant L-selectin human L-selectin comprises a 294 amino acid fragment (39- 
332) out of a total length of 385 amino acids and corresponds to the mature L-Selectin 
extracellular (Tedder et al. 1990; Lasky et al. 1989). The recombinant protein is 
expressed in E. coli with an amino-terminal hexahistidine tag with metal affinity so 
allowing chromatography to isolate and concentrate L-selectin.
Functionalisation protein Source Applied Concentration Target Buffer
GAPDH antibody M ouse 200 pg/lml
Full length 
GAPDH
PBS
MUC1 antibody M ouse 200 pg/lml MUC1 VNTR PBS
Eselectin E  coli 100 pg/0.5ml LS ligands
1:1 Glycerol 
:PBS
Table 6: The Functionalisation tools used to probe endometrial cell surfacess. DNP-10 
probes were functionalised with a range of binding proteins. All proteins were supplied 
at an effective concentration of 200pg/ml.
Figure 28: Functionalisation of DNP-10 probes. (A) A probe is washed with ddFfzO 
prior to functionalization, the water stream is run parallel to cantilevers C and D to 
ensure cantilevers are not damaged or bent. Carbon fibre tipped tweezers ensure a good 
grip on the probe during this process (B) A DNP-10 chip can be seen immersed in L- 
selectin allowing the formation of an imine bond to link the protein to the tip, all 
cantilevers are seen inundated in protein solution. (C) A probe is removed from 
parafilm substrate at the end of the final incubation, it was then washed with and used 
immediately.
Tips were functionalised fresh before every experiment and were never allowed to dry 
out. The silanization reagent APTES is hydrolytically unstable and has a half-life of 8.4 
hrs in water pH 7 at 24°C. This compound hydrolyses generating ethanol and transient 
silanetriol derivatives, which will crosslink and prevent the silanization reaction
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occurring on the AFM tip. The half-life may be extended to 56hrs by storing at 10°C but 
to ensure reproducibility APTES was made up fresh from concentrate and adjusted to 
pH 7 before every functionalization.
2.0742 Force mapping with the functionalised probe
The JPK Nano wizard II AFM was operated in force spectroscopy mode using silicon 
nitride DNP-10 probes (Bruker nano). Cell monolayers were probed near physiological 
conditions for single molecule force interactions by using cantilever D, a triangular 
cantilever (k = 0.06-0.12N/m, resonance frequency 18Khz, LxWxH 205x25x0.6pm) 
back coated with a 45+/-5nm Ti/Au reflective layer and a sharp tip of height 2.5-8pm 
and radius 20nm functionalised with mouse VU4H5 anti-MUCl antibody (Santa Cruz 
Biotechnology #sc-7313). These cantilevers are very soft (nominal k 0.06N/m) and 
facilitate the detection of surface binding events. The functionalised probe was indented 
into 2pm2 area of the cell periphery allowed to rest for 100ms"1 to facilitate molecular 
binding and then withdrawn. The approach and retraction velocity of the tip was 3 pm/s"
l. Resolution was 16 samples/line and indentation force was between 2-3nN. Ramp size 
was maintained at 5.0pm in order to ensure that molecular binding occurred on the 
approach to the sample and the tip was withdrawn clear of the sample when retracted 
maximally. The number of event maps varied and for each cell line; there were 3 areas 
probed with GAPDH, 5 areas probed with anti-MUCl and 9 areas probed with L- 
selectin. The negative control GAPDH consisted of one repeat, while anti-MUCl and 
L-selectin maps consisted of 3 independent repeats, all data is shown. At least 256 force 
curves were obtained for each map.
The data presented in chapter 5 (-) consists of maps showing the location of steps on the 
retraction force curve, a percentage o f positive curves (a curve with >1 step is 
considered positive) and histograms showing the spread of step sizes, which 
corresponds to the force required for tip/sample separation. The maps illustrate the 
spatial location and density of step occurrence, but additionally the colour of the pixel 
provides the number of steps on that single retraction curve resulting in a very 
informative visual illustration of binding. The percentage value revealed the frequency 
of surface binding, the percentage of positive curves was averaged across the number of 
maps and a Student’s 2 tailed T.test was performed to assess whether the differences in 
positive curve number between the two cell lines on control vs siRNA were significant. 
P values <0.05, <0.01 and <0.001 were considered statistically significant and denoted
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with a: *, ** and *** respectively. The step size histogram was a spread of all the 
measured step sizes to allow visualisation of the most common step size and therefore 
rupture force.
2.0743 Force curve processing and step fitting
JPK data processing software was used to fit steps to the retraction curves in order to 
detect specific surface interactions. Curves were analysed by force volume file, 
resulting in batches of 256 curves. Identical processing conditions were applied to all 
force volume files using a saved batch processing algorithm. Force curves were viewed 
in JPK data processing batch analysis (Figure 29A). Analysis was semi-automated as 
curves were checked manually before being accepted. Vertical deflection (baseline) 
correction was applied so the baseline was at OnN, then a contact point correction was 
applied and adjusted the contact point to Onm (Figure 29B). Next the curves were 
smoothed and steps were fitted to the curve using in built features of the software 
(Figure 29C). The step fitting algorithm provided data on the size of the step (pN) and 
the distance it occurred from the contact point.
The step fitting algorithm (JPK Software Analysis) represents the step signal as the sum 
of a slowly varying background signal (F_bg), a set of steps (i.e. a piecewise constant 
fimction)(F_step) and the background noise (Fnoise). [The green curve displayed in 
the software represents F_bg + F step]
To obtain F step, we start with F step = 0.
The software sweeps a reference step over the z range and look for the best overlap with 
F_noise. This gives one step, and accordingly F step is updated. Applying the same 
procedure, the next step is identified, until the step height is smaller than the statistical 
noise level.
The two parameters to control the algorithm are “smoothing”  which defines how 
smooth the ‘slowly varying background signal’ is and ‘significance’ which sets the 
threshold below which steps are considered to be noise (and are thus discarded). A 
significance value of 0.001 means that the only step heights accepted have a probability 
of less than 1/1000 of being due to noise fluctuations (based on an estimate for the RMS 
of F noise)
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Figure 29: Force curve analysis and step fitting. JPK data processing software counted 
the number of steps in the force curve. Vertical lines running top to bottom are 
identified steps. Green line is the smoothed force retraction curve.
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3.1 Introduction
If the endometrium is not receptive to the embryo, implantation does not occur. In 
humans, natural conception per cycle is poor (-30%), and 75% of failed pregnancies are 
considered to be due to implantation failure (Carson et al. 2000). The idea of a well- 
defined window of implantation is long established (Edwards 1988; Yoshinaga 1988) 
but after 25 years of intense biochemical analysis and implantation modelling in 
animals the molecular mediators of implantation remain elusive (Aplin 2006; Koot et al. 
2012). Recurrent implantation failure (RIF) also remains the major limiting factor in 
assisted reproduction (Norwitz et al. 2001).
The phenotype of endometrium epithelium changes drastically from the proliferative to 
mid-secretory stages of the menstrual cycle, and only during a short period does the 
endometrium express the molecular requisites for successful implantation. The WOI is a 
limited period when blastocyst competency is superimposed on the receptive state of the 
uterus. Endometrial receptivity is achieved through the acquisition of adhesion ligands 
together with the loss of inhibitory components that act as a barrier to the approaching 
embryo (Aplin 2000). This receptive period occurs between days 21-24 of the menstrual 
cycle when the endometrium is primed for embryo attachment. The endometrium must 
acquire the morphological and molecular state for attachment and this development is 
driven by the ovarian hormones progesterone and estradiol, human chorionic 
gonadotrophin (hCG) from the trophoblast, growth factors and cytokines (Dey et al. 
2004).
To date in vivo studies of implantation have used animal models. However, the 
regulation and expression of adhesive proteins during the WOI (such as MUC1) is not 
analogous between humans and commonly used animal models like rodents and rabbits 
(Dharmaraj et al. 2009). Larger primates such as the olive baboon (Papio anubis 
anubis) which is an excellent model for human implantation (Fazleabas et al. 1999), do 
express these proteins during the WOI (Hild-petito et al. 1996) and the size of these 
animals enables the use of endometrial biopsy, embryo flushing or transfer and 
hysteroscopy in a non-invasive way.
It is not possible to study this process of human implantation in vivo and even ex vivo 
models present difficulties. Very few laboratories have access to human embryos which 
must be specifically donated for the purpose of research and consent obtained. It is
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somewhat easier to obtain biopsy material through endometrial pipelle biopsy, however 
whilst primary endometrial stromal cells are relatively easy to prepare from endometrial 
biopsy, epithelial cells are very difficult to isolate. Therefore, use of appropriate cell 
lines, particularly for functional studies of implantation is imperative. Use of cell lines 
derived from endometrial cancers such as Hec-1, Ishikawa, EEC-1, and RL95 and 
trophoblast (embryo) choriocarcinomas such as JAR, JEG-3 and BeWo is established 
(Teklenburg & Macklon 2009; Hannan et al. 2010).
This chapter required a model with which to manipulate expression of potential 
apposition stage adhesion proteins in vitro for functional studies using the AFM in 
chapters 4 and 5. To address such a requirement, the expression and regulation of 
selected potential tethering mucin proteins was examined using qRTPCR and high 
content analysis techniques across a range of EEC cell lines; Hec-l-A, Hec-l-B, 
Ishikawa and Hec50. Endometrial cell lines have been shown to vary in expression of 
(potential) adhesion molecules and have been used as models for receptive (Heneweer 
et al. 2005; Wang et al. 2012) and non-receptive (Thie et al. 1998) implantation 
surfaces. Thus, selection of an appropriate cell line that expresses suitable implantation 
markers was critical. Additionally, it has been shown that certain cell lines such as 
Ishikawa can display varying expression patterns of adhesion molecules and nuclear 
receptors in culture (Nishida 2002). This further highlighted the need to effectively and 
thoroughly characterise the cell lines available for this project before proceeding with a 
functional implantation model.
The endometrial epithelium must express molecules that allow the recognition and 
implantation of a blastocyst. It has been observed in endometrial cell lines (Meseguer et 
al. 2001) and in primary tissue (Home et al. 2002) that the distribution of these 
molecules is not uniform across the endometrial monolayer, but little attempt has been 
made to explain these observations and the functional impact on the receptivity of this 
surface. Current data from in vitro models of implantation suggest the initial tethering 
of the embryo to a mucin on the apical glycocalyx via a carbohydrate mediated selectin 
interaction (Margarit et al. 2009; Genbacev et al. 2003; Carson et al. 2006), after which 
the uterine phenotype is modified by a medium- or short- range embryonic signal 
(Meseguer et al. 2001; Hey et al. 1994) allowing stable adhesion and then full 
trophoblast invasion to follow.
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Mucins are a family of secreted and transmembrane >200KDa glycoproteins found on 
all epithelial cells, hematopoetic cells, activated T-cells and are secreted into gland 
lumens (Aplin et al. 1994). MUC1, MUC4 and MUC16 are present on the surface of 
human endometrial epithelial cells (Brayman et al. 2004) and typically extend away 
from the cell surface to a range of 300-2000nm, far beyond the range of other surface 
receptors which rarely extend greater than 50nm into the lumen (Bramwell et al. 1986). 
Mucins typically display a high degree of glycosylation, 50-90% by mass (Gendler 
2001). A hallmark of the mucin family is a nucleotide tandem repeat domain that 
translates into a VNTR region encompassing a high proportion of serine and threonine 
residues (Moniaux et al. 2001). Functional carbohydrate epitopes are attached via an O- 
glycosidic-linkage formed through N-acetylgalactosamine (GalNAc) residues to serine 
or threonine on the VNTR protein core (Thathiah & Carson 2002). This domain is 
theorised to act as the scaffold for ligands that recognise the embryo and allow it to 
adhere and implant successfully (Margarit et al. 2009; Wang et al. 2008), a hypothesis 
that is tested thoroughly in chapter 5.
MUC1 is a major component of the endometrial epithelial glycocalyx expressed in both 
proliferative and secretory phases of many mammals (Hild-petito et al. 1996; Surveyor 
et al. 1995; Julian et al. 2005; DeSouza et al. 1998; Bowen et al. 1997) including 
humans (DeLoia et al. 1998; Aplin et al. 1994; Hey et al. 1994). MUC1 has a molecular 
weight of 200kD making it relatively small in comparison to other mucins such as 
MUC4 (930kD) and MUC16 (2000kD). However, the molecular mass of MUC1 can 
double due to VNTR length variations and altered glycosylation which have both been 
associated with infertility in humans (Home et al. 2001; Margarit et al. 2009). MUC1 is 
believed to play host to ligands with embryo affinity and it is up-regulated during the 
window of implantation through the action of progesterone (Bergh PA 1992). MUC1 
has been shown recently to be statistically significantly decrease in women with 
recurrent pregnancy loss (RPL) (Xu et al. 2012) whereas RPL patients had no altered 
integrin expression (Coughlan et al. 2013).
MUC4 is a 930KDa protein expressed in endometrial epithelium and theorised to 
extend 2000nm into the lumen (Koscinski et al. 2006). Like MUC1, MUC4 has a 
VNTR domain rich in serine and threonine residues comprising 145-395 repeats 
(Degand et al. 1998) and is theoretically capable of embryo affinity. In the pig 
endometrial MUC4 expression is up-regulated during the window of implantation
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(Ferrell et al. 2003) while in the rat it is down-regulated (Idris & Carraway 2000) 
suggesting an anti-adhesive role. However unlike MUC1, MUC4 is not subject to 
hormonal regulation, and variations in the VNTR number do not correlate with 
implantation failure in humans (Koscinski et al. 2006).
MUC16 (2000kD) is the largest of the endometrial mucins. Although MUC16 has a 
larger glycosylated ectodomain than MUC1, and therefore could present embryo 
binding ligands, expression is reduced during the window of implantation in humans 
(Gipson et al. 2008). Adhesion assays using the human endometrial cell line EEC-1 
which is positive for MUC1 and MUC16 showed that when MUC16 is targeted with 
siRNA embryo attachment increased (Gipson et al. 2008) suggesting the protein 
contributes to the non-receptive component of the endometrial surface.
Utereodomes (pinopods) are endometrial projections associated with implantation 
(Murphy 2006) and have been observed to correlate with the presence or absence of 
adhesion molecules such as MUC1 (Xu et al. 2012) and MUC16 (Gipson et al. 2008). 
Quenby et al used immunohistochemistry and H-score with frozen sections of primary 
biopsies for integrins (a lp l, a4pl, aVp3), OPN and MUC1, and paraffin embedded 
sections for OPN and MUC1 to correlate distribution patterns of adhesion molecules 
with recurrent pregnancy loss (Quenby et al. 2007). Integrin patterning was highly 
variable and additional MUC1 reactivity was noted intra-cellularly and in gland 
secretions (Quenby et al. 2007). Patterning of adhesion molecules may create receptive 
areas of the endometrial surface but current approaches to investigate these observations 
such as ICC and confocal microscopy are limited by resolution or small sample sizes 
respectively.
The epithelial monolayer is an ideal model system with which to characterise the 
expression of mucin proteins at the epithelial interface. This thesis sets out to 
investigate endometrial adhesion molecules and their ligands as there is a need to 
understand their regulation and distribution across the endometrium. My hypothesis is 
that EEC cell lines are good models for adhesion protein presentation and that 
expression and patterning of such molecules is subject to ovarian hormone regulation. 
Endometrial cell lines have been shown to be representative of luminal and glandular 
epithelium and express a range of proteins that has allowed their use in adhesion 
experiments. The aim of this chapter is to explore and develop a model for regulation of
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mucins and particularly MUC1 as a representative adhesion protein using EEC cell 
lines.
3.2 Results
In order to investigate the role of MUC1 at the surface of the endometrium, four EEC 
cell lines were characterized for their growth rate, expression of key functional adhesion 
protein candidates and steroid hormone receptor profiles. The Hec-l-A, Hec-l-B, 
Ishikawa and Hec50 cell lines were assessed for mRNA and expression of mucin 
proteins that could potentially act as the first point of contact for the embryo as it 
approaches the uterine epithelium. The cell lines were characterised for estrogen and 
progesterone receptors and regulation of endometrial mucins was explored using E2 , P4  
and MPA. The patterned expression of the endometrial mucin MUC1 was quantified 
using HCS and finally the effect of specific gene knockdown using mucin siRNA was 
explored as a method of regulating mucin presentation at the epithelial surface.
3.21 Growth rate of EEC cell lines in culture
The objective of this chapter was to develop an EEC cell line model for study of mucin 
glycoproteins that may be required for implantation. This model utilised several 
treatments requiring incubation for 24, 48 and 72hrs after which the monolayer was 
studied using ICC and HCS (this chapter) and atomic force microscopy (AFM) 
(chapters 4 and 5). The growth rates of all four cell lines were recorded over 96hrs so 
seeding density could be adjusted thus ensuring all cell lines reached the same state of 
confluence at the treatment end point. Maintaining the endometrial cells in monolayer 
conditions during HCS and AFM most resembled the continuing epithelial layer 
presented to the approaching trophoblast (in vivo morphology), allowed investigation of 
monolayer molecular patterning, and addressed the possibility of altered adhesion 
molecule expression resulting from variations in monolayer confluence.
Cells were seeded at varying concentrations (2xl0 4  - 5xl0 5 cells/ml) and cultured under 
normal conditions (37°C 5% CO2 ). At set time intervals (24-96 hrs) media was aspirated 
and cells were fixed using paraformaldehyde. Cells from each concentration were 
stained with 4',6-diamidino-2-phenylindole (DAPI) and counted using HCS. Absolute 
numbers of cells per 500pm2 field were divided by the number of cells in a 100% 
confluent monolayer of Hec-l-A cells thus producing a percentage of confluence for 
each cell line under different growth periods (Figure 30). This created a reference 
system for later experiments whereby a desired final concentration could be calculated
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from the initial seeding concentration and required incubation time. This 
characterisation of varying grow rates was useful when working with four EEC cell 
lines simultaneously.
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Figure 30: The growth characteristics of EEC cell lines in culture. Hec-l-A (A), Hec-1- 
B (B), Ishikawa (C), and Heraklio (D) were trypsinised and re-suspended in media. Cell 
suspensions underwent serial dilution to form seeding concentrations of 2xl04, 5xl04, 
1x10s, 2xl05, 3xl05, 5xl0 5 cells/ml represented by growth curves 1-6 respectively. Cell 
suspensions were seeded on 6  well plates and cultured for 24, 48, 72 and 96 hrs. Cells 
were fixed and stained with DAPI. The INCELL analyzer 2000 was used to image 10 
500pm2 fields and cells assessed for confluence using data generated by INCELL 
developer post acquisition analysis software platform.
3.22 Expression of steroid hormone receptor mRNA in EEC cell lines
The menstrual cycle is regulated through the actions of the ovarian steroid hormones E2
and P4  mediated through their respective nuclear receptors, the estrogen receptor (ER) 
and the progesterone receptor (PR). ER exists in two isoforms ERa and ERp which are 
encoded by two different genes, ESR1 and ESR2. In contrast, the PR isoforms, PR-A 
and PR-B, are coded by the same gene (PGR) using different promoters. In order to test 
the hypothesis that ovarian hormones modulate mucin expression it was important 
investigate steroid receptor expression in the model cell lines to confirm that the 
receptors were present to modulate the effects of the hormones.
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Figure 31: The expression of steroid hormone receptor mRNA in EEC cell lines. Bar 
graphs (A-C) show mRNA levels of Progesterone receptor (PR) Estrogen receptor alpha 
(ERa) and Estrogen Receptor beta (ER0) in four EEC cell lines Hec-l-A, Hec-l-B, 
Ishikawa and Hec50 as assayed by real time quantitative PCR. (D) shows relative 
expression of all three steroid hormone receptors in the 4 cell lines. Data shown are 
average from three independent experiments. Values given are mean mRNA starting 
quantity normalised to RPL-19 ± STDEV from triplicates. Data was analysed using a 
two-tailed Student’s T-test *p<0.05, **p<0.01, ***p<0.001.
Figure 31A shows the expression of PR mRNA in Hec-l-A, Hec-l-B, Ishikawa and 
Hec50. PR mRNA was expressed in all the cell lines, Ishikawa was the highest 
expresser (4.11), 1.56 fold higher than the second highest expresser, Hec50 (2.65) 
(p<0.001) and 3.57 fold and 4.11 fold greater than Hec-l-A and Hec-l-B respectively
(p<0.001).
Figure 3IB shows ERa mRNA was expressed in Ishikawa and Hec50, as with PR 
Ishikawa expressed the highest levels of ERa in all the cell lines tested (3.65) displaying 
4.90 fold higher levels than Hec50 (0.74) (p<0.001). In contrast Hec-l-A and Hec-l-B 
could be considered negative for ERa transcript with values of 0.014 and 0.003 
respectively which were 246 fold and 1019 fold less than Ishikawa (p<0.001). 0.48).
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Figure 31C shows ERp mRNA expression in all the cell lines tested. The highest levels 
of expression were observed in Hec50 (0.34) which expressed 1.74 fold, 3.27 fold and 
2.31 fold more ERp transcript than Hec-l-A (0.19), Hec-l-B (0.10) and Ishikawa (0.15) 
respectively (p<0 .0 0 1 ).
These results demonstrate the positive expression of ERp and PR in all the model cell 
lines. Ishikawa, often described as a useful model cell line because of a positive 
hormone receptor status (Nishida 2002) is shown here to express high levels of PR and 
ERa relative to the other cell lines tested.
3.23 Expression of mucin mRNA in EEC cell lines
The female reproductive tract has been characterised for the expression of mucins. 
Gipson et al used northern blot and IHC to show that the tethered mucins MUC1, 
MUC4 and MUC16, were expressed on endometrial epithelia (Gipson et al. 1997). A 
screen for the basal level of MUC1, 4 and 16 at the RNA level in each of the candidate 
cell lines was conducted in the first instance.
MUC1 transcript was expressed in the model cell lines. Hec-l-B (1.34) expressed 13.1 
fold greater basal MUC1 mRNA compared to Hec-l-A (0.10) (p<0.01) which was the 
second highest expresser (Figure 32). Ishikawa (0.044) and Hec50 (0.046) both 
expressed lower levels of MUC1 transcript. The highest and lowest expressers of 
MUC1 mRNA were Hec-l-B and Ishikawa.
MUC4 transcript was present in Hec-l-A and Ishikawa (Figure 32B). Hec-l-A (0.11) 
expressed the highest level of MUC4 mRNA, 4.58 fold greater than Ishikawa (0.023) 
(p<0.01). Hec-l-B (0.000) and Hec50 (0.000) did not express MUC4 transcript.
MUC16 mRNA was present in Hec-l-A (0.09), Ishikawa (0.44) and Hec50 (0.03). 
Ishikawa expressed 4.68 fold greater MUC16 transcript than Hec-l-A (p<0.001) and 
was the highest of all the cell lines tested. Hec50 expressed very low MUC16 transcript. 
Hec-l-B (0.000) was negative for MUC16 mRNA.
The Hec-l-B cell line expressed high levels of MUC1 mRNA but was negative for 
MUC4 and MUC16 transcript, thus highlighting itself as a useful tool with which to 
interrogate MUC1 function independently of related mucin proteins.
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Figure 32: The expression of MUC1, MUC4 and MUC16 mRNA in EEC cell lines. Bar 
charts (A-C) show messenger transcript levels of MUC1, MUC4 and MUC16 in four 
EEC cell lines Hec-l-A (blue), Hec-l-B (red), Ishikawa (green) and Hec50 (orange) as 
assayed by real time quantitative PCR. Bar chart (D) shows combined expression of 
three epithelial mucins. Data shown are average from three independent experiments. 
Values given are mean mRNA starting quantity normalised to RPL-19 ± STDEV from 
triplicates. Data was analysed using a two-tailed Student’s T-test *p<0.05, **p<0.01, 
***p< 0  ooi vs control.
3.24 Hormonal regulation of mucin mRNA in EEC cell lines
P4 induces physiological changes to the endometrium during the secretory phase and 
prepares the uterine for implantation. P4 has been shown to increase MUC1 expression 
in EEC cell lines (Dharmaraj et al. 2010; Wang et al. 2010) but contrasting studies 
showed no MUC1 mRNA or protein response to P 4  (Tamm-Rosenstein et al. 2013). 
Hec-l-A, Hec-l-B, Ishikawa and Hec50 express varying levels of PR and ER mRNA, 
and in this section, the activity of the ligand signaling through these receptors and their 
effect on the expression of MUC1, 4 and 16 is monitored. Cell lines were treated with
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P4 at different concentrations in order to determine the concentration at which the 
receptor can be activated and induce transcription of mucin target genes.
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Figure 33: The effect of varying concentrations of progesterone on MUC1 mRNA 
expression in EEC cell lines Bar graphs show the effect of varying P4 concentrations on 
MUC1 transcript levels in Hec-l-A (A), Hec-l-B (B), Ishikawa (C) and Hec50 (D) by 
real-time QRTPCR. Hec-l-A, Hec-l-B, Ishikawa and Hec50 cells were treated with 
O.lnM, InM, lOnM, lOOnM and lpM progesterone for 48hrs. Data shown are average 
from three independent experiments. Values given are mean mRNA starting quantity 
normalised to RPL-19 ± STDEV from triplicates. Data was analysed using a two-tailed 
Student’s T-test *p<0.05 vs. control.
In Hec-l-A lOOnM P 4  induced MUC1 transcript-3.0 fold after 48hrs (p<0.05) but no 
significant effect was seen with concentrations of O.lnM, InM, lOnM or lpM (Figure 
33). MUC1 mRNA was also induced in Hec-l-B by lOOnM P4 , but only a subtle 1.49 
fold increase was observed after 48hrs (p<0.05), as with Hec-l-A no significant 
differences in MUC1 transcript were observed with other P4 concentrations. In contrast, 
treatment of Ishikawa cells with lOnM P 4  actually repressed MUC1 gene expression 3.2 
fold (p<0.05), while lpM P 4  induced MUC1 transcript 1.66 fold compared to control
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(p<0.05). Hec50 cells were generally unresponsive to P4 , however InM P4  induced 
MUC1 mRNA 6 . 6  fold after 48hrs (p<0.05). A large range o f concentrations were 
investigated but no conventional positive or negative dose dependent response was seen 
in any of the tested cell lines.
3.241 The effect o f progesterone and estradiol in isolation on mucin mRNA
The preliminary data in Figure 33 revealed that some cell lines appeared to be
responsive to P4  at lOOnM concentration, however, the effect was subtle and/or highly
variable. Treatment with P4  appeared to up-regulate and down-regulate MUC1 mRNA
in H ec-l-A  and Ishikawa respectively.
At this stage mucin regulation with ovarian hormones showed some promise and 
warranted further investigation. lOOnM P4  appeared to induce MUC1 expression in 
H ec-l-A  and Hec-l-B cells. The model cell lines were treated with lOOnM P4  or lOnM 
E2  and gene expression o f MUC1, MUC4 and MUC16 was quantified using qRTPCR.
MUC1 mRNA was expressed in all selected model cell lines (Figure 34A), and 
confirms previous experiments (Figure 4) showing H ec-l-B  to be a relatively high 
expresser. In Hec-l-A  cells treatment with P4  and E2  appeared to induce minor changes 
in MUC1 mRNA but they were not significant. In Hec-l-B  cells the effect o f P4  and E2 
stimulation was a minor decrease in MUC1 transcript after 48hrs while Ishikawa cells 
showed no changes with the respective treatments. Hec50 cells showed no significant 
MUC1 response to E2  or P4  after 48hrs. Stimulation with ovarian hormones produced no 
change to MUC1 expression in any o f the cell lines tested.
H ec-l-A  expressed MUC4 transcript and stimulation with P 4  or E2  for 48hrs resulted in 
a slight induction of MUC4 mRNA but this was not significant. Ishikawa was also 
shown to express MUC4 but stimulation with P4  or E2  showed no change relative to 
control. Hec-l-B and Hec50 cells were negative for MUC4 gene expression across all 
treatments (Figure 34B). Again, no significant changes were seen following any 
treatment.
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Figure 34: The effect of P4 and E2 on MUC1, MUC4 and MUC16 mRNA expression in 
EEC cell lines. P 4  and E2 do not regulate endometrial mucin mRNA in EEC cell lines. 
Bar graphs show the effect of P 4  and E2 on MUC1 (A), MUC4 (B) and MUC16 (C) 
transcript levels in Hec-l-A (blue), Hec-l-B (red), Ishikawa (green) and Hec50 (orange) 
by real-time QRTPCR. Hec-l-A, Hec-l-B, Ishikawa and Hec50 cells were treated with 
lOOnM P 4  or lOnM E2 for 48hrs. Data shown are average from three independent 
experiments. Values given are mean mRNA starting quantity normalised to RPL-19 ± 
STDEV from triplicates. Data was analysed using a two-tailed Student’s T-test 
*p=<0.05, **p=<0.01 vs. control.
Figure 34C shows the MUC16 gene expression levels following treatment with P 4  and 
E 2  for 48hrs. Hec-l-A cell showed no change in MUC16 mRNA when treated with P 4  
and E 2  respectively. MUC16 transcript in Ishikawa cells was not induced by P 4  and E 2 .  
There was low level expression of MUC16 mRNA in Hec50 cells and this remained 
stable after stimulation with P 4  and E 2 .  Hec-l-B was negative for MUC16 gene 
expression and stimulation with P 4  and E 2  did not affect this. As with MUC1 and MUC4 
no significant changes in MUC16 gene expression were observed.
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MUC1, MUC4 and MUC16 all showed very little response to P4  and E2 stimulation. 
Any induction or repression of mucin transcript is masked at the mRNA level by 
variation between repeats. Quantification of the subtle changes in MUC1 protein 
expression observed here required a more elaborate approach and is re-visited later in 
this chapter.
3.2.4.2 The effect o f progesterone and estradiol in combination on MUC1 mRNA 
Whilst there was no consistent MUC1 mRNA response to P4  or E2  after 48hrs in any of
the model cell lines, H ec-l-A  and Ishikawa cells were shown to express similar levels
of MUC1 mRNA under basal conditions and expressed both PR and ERp making them
the most suitable cell lines for a more elaborate treatment regime including lOnM E2
pre-treatment for 24hrs and then a lOOnM P4  +/- E2 incubation for 48hrs. This treatment
regime represented hormonal conditions in vivo during the WOI as E2 priming
replicates the hormonal conditions during the proliferative and estrogen dominated
phase of the menstrual cycle before the progesterone driven transition to the secretory
phase endometrium.
Secondly, the progesterone metabolite methoxy-progesterone acetate (MPA) was 
introduced. This compound is a progesterone receptor agonist and has 2 fold higher 
affinity for binding compared to P4  (Schindler et al. 2008), and provided the opportunity 
to investigate the effect o f alternative (and more potent) progestin treatment on PR 
downstream targets.
Figure 35 shows the effect for P4  and MPA on E2 primed endometrial monolayers. In 
Hec-l-A  cells. MUC1 transcript was induced 1.09 fold by E2 ->P4 , 1.14 fold by E2- 
>P4+E2 , almost no change after E2 ->MPA treatment (1.02 fold increase) and a subtle 
1.13 fold decrease due to E2 -> MPA+E2 . Ishikawa cells showed very small inductions 
o f 1.05, 1.01, 1.16 and 1.18 fold following E2->P4 , E2->P4+E2 , E2->MPA and E2-> 
MPA+E2 respectively.
However, no statistically significant induction of MUC1 transcript in H ec-l-A  or 
Ishikawa cells treated with P4  or MPA after priming the tissue with E2  was observed 
(Figure 35A+B) suggesting that MUC1 expression is not regulated by ovarian hormones 
in the selected model cell lines.
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Figure 35: The effect of progestins and E2 in combination on MUC1 mRNA expression 
in EEC cell lines. Combination treatments of P4 /MPA and E2 do not regulate MUC1 
transcript in EEC cell lines. Bar graphs show the effect of P4 , E2 and MPA with E2 pre- 
treatment on MUC1 transcript levels in Hec-l-A (A) (blue), and Ishikawa (B) (green) 
by qRTPCR. Hec-l-A and Ishikawa cells were primed with lOnM E2 for 24hrs then 
treated with lOOnM P4 or lOOnM MPA for 48hrs (with and without E2). Data shown are 
average from three independent experiments. Values given are mean mRNA starting 
quantity normalised to RPL-19 ± STDEV from triplicates. Data was analysed using a 
two-tailed Student’s T-test *p=<0.05, **p=<0.01 vs. control.
An aim of this chapter was to develop a model of mucin regulation. Treatment with 
varying concentrations of P4 , E2 and MPA produced very little alteration in the 
expression of MUC1 at the mRNA level. Whilst there may be a hormone effect, it does 
not result in the significant changes in mucin expression, and as such was deemed and 
unsuitable model for investigating nano-mechanical properties of endometrial 
monolayers. The scope for MUC1 induction may be limited because the cell lines are 
already expressing high levels of MUC1 under basal conditions, thus an alternative 
approach was adopted to regulate MUC1 using an siRNA knockdown based approach.
3.25 RNA interference of mucin mRNA in EEC cell lines
Hec-l-A and Hec-l-B cells, both relatively high expressers of MUC1, made suitable 
candidates for gene knockdown and were treated with short interfering (si)RNAs of 
complementary sequence to MUC1 and MUC16 transcripts. SiRNAs are involved in 
RNA interference (RNAi), a process by which mRNA is targeted for post-translational 
degradation effectively silencing gene expression (see section 2.03 RNA interference). 
Two commercially available siRNA kits transfected into cells with lipofectamine RNAi 
Max were used to silence MUC1 and MUC16 expression. The effect typically lasts 5-7 
days and as such is deemed a transient effect. A scrambled siRNA control, that has a
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sequence not complementary to any known human gene transcript, was also used 
together with lipofectmine transfection reagent to evaluate any non-specific effects
The Hec-l-A and Hec-l-B cell lines were treated with 25nM, 50nM and 75nM siRNA 
for 48hrs (Figure 36). Expression of MUC1 transcript was reduced 7.38 fold, 25.45, 
fold and 21.37 fold respectively in Hec-l-A (p=<0.05) and 26.47 fold, 29.04 fold, and 
36.74 fold in Hec-l-B (p=<0.001). The data showed no significant difference in 
expression between either of the two untreated controls and the scrambled siRNA 
transfection in either cell line, where the levels of MUC1 in Hec-l-A (low) and Hec-l-B 
(very high) were noted. The data showed that treatment with 50nM siRNA for 48hrs 
resulted in a knockdown efficiency of over 96% in both cell lines and that increasing the 
concentration of siRNA beyond 50nM did not increase the effectiveness of the 
treatment, therefore this concentration was selected for use in further experiments.
1.6
1.4
1.2
1  0 . 8
■§ 0.6
|  0 .4
E
z
0.2
H e c - l-A  con tro l 
H e c - l-B  con tro l 
s iR N A  treated
I *
\h
0 -\ t— r  r  I i / , r '-  r—' r  i r '  r _• ^  q C3 C C * C
U O O U O U
0 o N 1U C 1 s iR N A  0 o M U C 1 s iR N A
H e c - l-A  H e c - l-B
Figure 36: The effect of varying concentrations of MUC1 siRNA treatment on MUC1 
mRNA expression in Hec-l-A and Hec-l-B EE cell lines. Bar graphs show the effect of 
varying concentrations of MUC 1 siRNA (purple) on MUC1 transcript levels in Hec-l-A 
(blue) and Hec-l-B (red) at 48hrs. Hec-1 cells were treated with scrambled 50nM 
siRNA and 25nM, 50nM and 75nM MUC1 specific siRNA for 48hrs. Data shown are 
average from three independent experiments. Values given are mean mRNA starting 
quantity normalised to RPL-19 ± STDEV from triplicates. Data was analysed using a
96
Chapter 3 An in vitro model o f endometrial mucin expression
two-tailed Student’s T-test *p=<005, **p=<0.01, ***p=<0.001 vs. scrambled siRNA 
control.
Having optimised the treatment of siRNA to 50nM and 0.00375% lipofectamine for 
48hrs, transient transfection was expanded to include MUC 16 siRNA and performed on 
all four EEC cell lines (Figure 37).
Figure 37A shows the effect of specific gene silencing on the expression of MUC1 
transcript after 48hrs. MUC1 mRNA was reduced 15.8 fold in Hecl-A (p<0.05), 12.17 
fold in Hec-l-B (p<0.01), 11.0 fold in Ishikawa and 5.3 fold in Hec50 (p<0.05). 
Treatment resulted in similar knockdown of MUC1 transcript in Ishikawa cells as the 
other model cell lines however due to the variability in Ishikawa samples this was not 
determined to be significant.
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Figure 37: The effect of MUCl and MUC16 specific siRNA on MUCl and MUC16 
mRNA expression in EEC cell lines. MUCl and MUC 16 gene expression is negatively 
affected by MUCl and MUC 16 siRNA. Bar graphs show the effect of (A) MUCl 
siRNA (purple) and (B) MUC 16 siRNA (purple) on MUCl and MUC 16 transcript 
levels in Hec-l-A (blue), Hec-l-B (red), Ishikawa (green) and Hec50 (orange) by 
qRTPCR. Endometrial epithelial cells were treated with scrambled 50nM siRNA and 
50nM MUCl specific siRNA and MUC 16 specific siRNA for 48hrs. Data shown are 
average from three independent experiments. Values given are mean mRNA starting 
quantity normalised to RPL-19 ± STDEV from triplicates. Data was analysed using a 
two-tailed Student’s T-test *p=<0.05, **p=<0.01 vs. scrambled siRNA control.
Figure 37B shows the effect of specific MUC 16 gene silencing on the expression of 
M UCl6 mRNA after 48hrs. MUC16 transcript was reduced 1.22 fold in Hec-l-A, 1.8 
fold in Ishikawa (p<0.01) and 2.9 fold in Hec50. However, out of all cell lines tested
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only Ishikawa cells displayed significant knockdown of MUC 16. The Hec-l-B cell line 
did not express MUCl6.
Specific gene targeting resulted in efficient knockdown of mucins by siRNA, and 
therefore its effectiveness for interrogating the specific nano-mechanical properties of 
mucins. It seemed possible that a cell could adapt to loss of a particular mucin and 
compensate by increasing expression of other mucins making it difficult to determine 
whether changes to surface properties were the result of the specific targeting of M UCl. 
The turnover time for MUCl (with GlcNAc modification) on epithelial surfaces is 
approximately 14hrs (Razawi et al. 2013) and the time taken for newly synthsised 
mucin proteins to reach the cell surface around liar (Hanisch et al. 2012; Kinlough et al. 
2011) therefore any alterations in MUC4 or MUC 16 expression would occur in the 48hr 
timeframe of this experiment. Mucin interplay was assessed by measuring any changes 
in MUC4 or MUC 16 gene expression following MUCl gene silencing, and any changes 
in MUCl or MUC4 transcript levels following MUC 16 gene silencing.
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Figure 38: The effect of MUCl specific siRNA on MUC4 and MUC16 mRNA 
expression in EEC cell lines. MUC4 and M UCl6 gene expression is not affected by 
MUCl knockdown. Bar graphs show the effect of MUCl siRNA (purple) on MUC4 
and MUC 16 transcript levels in Hec-l-A (blue), Hec-l-B (red), Ishikawa (green) and 
Hec50 (orange) by qRTPCR. Endometrial epithelial cells were treated with scrambled 
50nM siRNA and 50nM MUCl specific siRNA for 48hrs. Data shown are average from 
three independent experiments. Values given are mean mRNA starting quantity 
normalised to RPL-19 ± STDEV from triplicates. Data was analysed using a two-tailed 
Student’s T-test *p=<0.05, **p=<0.01 vs. scrambled siRNA control.
Figure 38A shows the effect of MUCl specific gene silencing on MUC4 gene 
expression after 48hrs. MUC4 transcript levels were not significantly changed by
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MUCl siRNA in Hec-l-A, Ishikawa and Hec50. Hec-l-B showed no measureable 
levels of MUC4 mRNA and this was not changed by MUCl siRNA treatment.
Figure 38B shows the effect of MUCl specific gene silencing on the MUC 16 mRNA 
levels in the cell lines after 48hrs. MUC 16 mRNA was not induced or repressed by 
MUCl gene knockdown in Hec-l-A, Ishikawa and Hec50. Hec-l-B again showed no 
measureable MUC 16 transcript, and this was not affected by MUCl knockdown.
Taken together the data shown in Figure 37 and Figure 38 demonstrates that MUCl 
gene silencing using siRNA transfection in Hec-l-A, Hec-l-B and Ishikawa is very 
effective at down regulating MUCl the mRNA level and that there were no 
measureable non-specific effects on MUC4 and MUC 16 transcript.
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Figure 39: Effect of MUC 16 specific siRNA on MUCl and MUC4 mRNA expression 
in EEC cell lines. MUCl and MUC4 gene expression is not affected by MUC 16 
knockdown. Bar graphs show the effect of MUC 16 siRNA (purple) on MUCl and 
MUC4 transcript levels in Hec-l-A (blue), Hec-l-B (red), Ishikawa (green) and Hec50 
(orange) by qRTPCR. Endometrial epithelial cells were treated with scrambled 50nM 
siRNA and 50nM MUC 16 specific siRNA for 48hrs. Data shown are average from 
three independent experiments. Values given are mean mRNA starting quantity 
normalised to RPL-19 ± STDEV from triplicates. Data was analysed using a two-tailed 
Student’s T-test *p=<0.05, **p=<0.01 vs. scrambled siRNA control.
Figure 39A shows the effect of MUC 16 siRNA treatment on MUCl transcript in the 
model cell lines. There is no change to MUCl expression in any of the cell lines tested 
after 48hrs of MUC 16 siRNA.
Figure 39B shows the effect of specific MUC 16 gene silencing on MUC4 mRNA levels 
after 48hrs. Again, there is no significant change in MUC4 transcript in Hec-l-A,
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Ishikawa and Hec50 cells after MUC16 siRNA. Hec-l-B cells remained negative for 
MUC4 mRNA expression.
The data shown in figures 37, 38 and 39 suggests that MUC1 and MUC16 siRNAs are 
highly specific for MUC1 and MUC16 transcripts, and that silencing of any one mucin 
does not result in any compensatory up-regulation of other closely related mucin 
molecules.
3.26 Expression of MUC1 protein in endometrial EEC cell lines
3.261 Immunocytochemistry
Having determined mRNA expression levels of MUC1, MUC4 and MUC16, and 
demonstrated silencing of MUC1 expression while expression of other mucins was 
unaffected. MUC1 protein levels were investigated. Immunocytochemistry (ICC) was 
used to measure the intensity of MUC1 staining across all four cell lines.
Figure 40 shows ICC staining of Hec-l-A, Hec-l-B, Ishikawa and Hec-50 cells for 
MUC1 reactivity using the MUC1 VNTR antibody (Santa Cruz Biotechnology). 
Representative images show the characteristic MUC1 staining pattern in Hec-l-A, Hec- 
l-B and to a lesser extent Ishikawa and Hec50 cells. MUC1 reactivity was assigned an 
H-SCORE using a standardised ICC protocol. Mean expression of MUC1 in Hec-l-B 
(3.4) was 2.36 fold higher relative to Hec-l-A (1.44), Ishikawa (0.76) and Hec50 (1.56). 
Staining intensity variation between the model cell lines was assessed for significant 
differences using Kruskal-Wallis, and significant differences between groups were 
observed (H=82.5, p<0.0001). Subsequently, the Mann-Whitney-U test was used to 
compare groups and significant differences between Hec-l-A and Hec-l-B (p<0.05), 
Ishikawa and Hec-l-B (p<0.01) and Hec50 and Hec-l-B (p<0.05) were again observed 
demonstrating the differences in MUC1 protein expression between the cell lines.
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Figure 40: The expression of MUC1 protein in EEC cell lines: ICC 
(A-D) Immuno-cytological staining showing intensity of MUC1 ND protein (brown 
staining) on Hec-l-A, Hec-l-B, Ishikawa and Hec50 cell monolayers. (E) H-SCORE 
forMUCl protein staining.
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Cells were antibody stained for MUC1 and nuclei were counter stained with 
Hematoxylin. Representative ICC images were taken using the Axio CamHRc colour 
camera (Zeiss) at 20x magnification. Cumulative scores for each cell line are plotted. 
Values are median (®) and inter-quartile range (Quartile 1 and Quartile 3). Statistical 
analysis was performed using the Kruskal-Wallis test followed by the Mann-Whitney 
test. *p<0.05 and **p<0.01 are considered significant. Kruskal-Wallis showed a very 
strong significant difference between groups (p= 8.52'18)
3.262 High content screening
ICC (Figure 40) had demonstrated that MUC1 protein expression was variable across 
all four endometrial cell lines, and that Hec-l-B was a relatively high MUC1 expresser. 
Additionally, ICC revealed a heterogeneous, patterned, expression profile of MUC1 
protein across the monolayer. This non-uniform distribution of MUC1 has been 
previously observed (Meseguer et al. 2001; Quenby et al. 2007) but the functional 
implications are still poorly understood. High content screening (HC3) was used to 
assess MUC1 staining distribution across large numbers of adherent cells. HCS was an 
improvement over ICC as it has the capability to conduct multiple target analysis 
algorithms on large cell numbers compared to tens of cells assessed subjectively during 
previously reported ICC. Cells were stained for MUC1 and counter stained with DAPI, 
and HCS was used to take 30 low magnification images randomly distributed across the 
cell culture plate. Image data was obtained in 2 image channels; (Figure 41A-D insert) 
nuclear using DAPI (emission A,=461 nm) and (Figure 41A-D) cellular using Texas-red 
conjugated anti-mouse secondary IgG that recognised the MUC1 primary antibody 
(emission X,=615 nm). INCELL analyzer 2000 developer proprietary software was used 
to generate average fluorescent output values (au) for all images.
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Figure 41: The expression of MUC1 protein in EEC cell lines: HCSHec-l-B is a 
relative high expresser of MUC1 at the protein level. Bar graphs show basal MUC1 
protein expression in Hec-l-A (blue), Hec-l-B (red), Ishikawa (green) and Hec50 
(orange). Scatter plot shows the number of cells from each cell line included in the 
analysis (colours are corresponding). Representative images were taken with the
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INCELL analyzer 2000. Confluent cell monolayers were fixed and stained for MUC1 
protein using Texas-red conjugated secondary antibody (Main window: false colour 
green shown here). Nuclei were counterstained with DAPI (Insert: false colour black 
and white shown here). Image data was acquired through automated high throughput bi- 
channel imaging using HCS. Images were post-processed within INCELL analyzer 
2000 developer software. Individual cells were identified using a nuclear mask in the 
DAPI channel (nuclei). Subsequent analysis using a modified cytoplasmic mask 
assigned a relative value for cytoplasmic fluorescence to each cell (MUC1). 
Approximately 15000+ cells for each cell line.
Data shown are average from three independent experiments. Values given are mean 
fluorescent output from adherent cell populations, normalised to background ± STDEV 
from triplicates.
Figure 41 shows the expression of MUC1 protein as determined by INCELL total well 
fluorescence analysis and secondary axis shows the numbers of cells that were 
individual assessed. Following background correction, Hec-l-A, Hec-l-B, Ishikawa and 
Hec50 cell monolayers displayed fluorescence outputs of 46, 196, 24 and 5 AU 
calculated from 15052, 15472, 19739 and 14977 individual cells (Figure 4 IE). This data 
replicated the trend seen in previous ICC studies and confirmed Hec-l-B to be a high 
expresser of MUC1. Qualitative image analysis indicated presence o f certain cells 
within the Hec-l-A and Hec-l-B population that displayed much higher staining 
denoting extremely high levels of MUC1 protein. This has been previously been 
observed (Harris et al. 2009) but no attempt has been made to characterise the function 
of this distribution. HCS provided a novel opportunity to interrogate the distribution of 
these patterns across very large numbers of cells.
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3.27 MUC1 distribution patterns
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Figure 42: MUC1 protein distribution patterns in EEC cell lines. Hec-l-B cell 
populations display heterogeneous distributions of MUC1 protein. (A) Representative 
image of Hec-l-A cells showing the elevated MUC1 sub-population [MUC1 is stained 
green, nuclei are stained blue] (B) Bar graph shows the percentage of cells from the 
increased staining sub-population of each cell line. (C). Histogram shows spread of 
MUC1 staining intensity across model cell line populations
Cell monolayers were fixed and antibody stained for MUC1 protein. Nuclei were 
counterstained with DAPI. Images were acquired using automated high throughput bi­
channel imaging using HCS. INCELL analyzer 2000 developer software identified 
approximately 3000-5000 (dependent on cell line) individual cells using a nuclear mask 
of the DAPI channel. Subsequent analysis in the Texas-red channel (MUC1) using a 
modified cytoplasmic mask assigned fluorescence value to each cell. The minimum cell 
number from four data sets (3062 individual cells) was used as a cap for analysis and 
allowed direct comparison of the cell lines. Cells were sorted into groups based on their 
fluorescent signal; groups consisted of a range between 500au and 4500au at intervals
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of 10 allowing visualisation of the spread of data in histograms. The upper 10th 
percentile of Hec-l-A cells was used as a benchmark to characterise high expressing 
cells and allowed the percentage of elevated MUC1 cells to be calculated for all the cell 
lines.
Figure 42A shows a representative image of Hec-l-A cells stained for MUC1 protein, 
and clearly demonstrates increased protein expression in a small cellular sub population. 
This patterning was present in Hec-l-A and Hec-l-B cell monolayers but less so in 
Ishikawa and Hec50.
Figure 42B shows high resolution histograms mapping the distribution of fluorescence 
intensity across the monolayer. The relatively narrow spread of values across the 
Ishikawa and Hec50 monolayers denotes a homogeneous expression profile. Hec-l-A 
has a somewhat flatter curve shifted to the right representing a higher proportion of high 
expressing cells. In sharp contrast, Hec-l-B has a very flat curve indicating a 
heterogeneous pattern of MUC1 protein expression across the cell population. 
Additionally, the extended tail reveals a residual population of cells occurring at very 
low frequency but exhibiting abundant MUC1 expression.
Figure 42C shows the percentage of cells expressing high levels of MUC1 protein in the 
cell line models. Across the Hec-l-A cell population, 10% of cells show increased 
MUC1 reactivity. The Hec-l-B population contained 57% of highly expressing cells. In, 
contrast less than 1% of Ishikawa and Hec50 cells expressed elevated MUC1. The 
significance of cells expressing elevated MUC1 on implantation is still unclear.
The data shown in Figure 41 and Figure 42 suggests that total MUC1 protein in Hec-1- 
A expression was relatively low and homogenous across the monolayer, with the 
exception of a small number of high expressing cells that represented 1 0 % of the cell 
population. In contrast, Hec-l-B had higher total expression and a heterogeneous 
expression profile with a wide distribution of MUC1 intensities. These data aided 
understanding of the monolayer MUC1 distribution in the model cell lines, the 
functional implications of which are explored in chapter 5. HCS has the capability to 
identify subtle trends in expression that are not obvious using more traditional 
molecular biology techniques such as Western blot and QRTPCR that rely on pooled 
cell lysates for analysis.
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3.28 Ovarian hormones influence MUC1 distribution patterns
3.281 E2  and P4  in isolation
Although MUC1 expression had been induced by P4  and E2  (Figure 34), the effect had 
been subtle and masked by variation in control samples. Despite this and to further 
exploit the HCS platform, protein analysis was conducted on a smaller data set of 3000- 
5000 cells. Cell monolayers were stained for MUC1 protein and counterstained with 
DAPI, images were post-processed, counted on a cell by cell basis, assigned a 
fluorescence value and sorted on fluorescence output.
Figure 43 shows the effect of ovarian hormones on distribution of MUC1 protein across 
monolayers. Histograms revealed very subtle increases in MUC1 protein after 48hrs of 
lOOnM P4  stimulation across endometrial monolayers in Ishikawa and Hec50 cells 
(Figure 43C+D) which are represented by shifts to the right on the curves. The Hec-l-B 
curve shifted further to the right suggesting a higher proportion of cells were expressing 
elevated MUC1 protein following treatment (Figure 43B). Hec-l-A showed almost no 
change as control (green) and P4  treated (red) curves were almost superimposed.
The histograms show that lOnM E2  reduced the expression of MUC1 protein in Hec-1- 
A. This effect was more noticeable in Ishikawa cells as denoted by the shift of the blue 
curve to the left. This result supported previous data (Figure 33C) that demonstrated a
3.2 fold reduction of MUC1 mRNA following stimulation with lOnM E2  for 48hrs in 
Ishikawa cells. E2  appeared to induce MUC1 expression in Hec-l-B, while in Hec50 
there was no change as the two curves were superimposed. The application of HCS to 
the characterization of endometrial cell line models allowed the detection of subtle 
fluctuations in MUC1 distribution following hormone stimulation which were 
previously masked by variation at the mRNA level.
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Figure 43: The effect of progesterone and estradiol on MUC1 protein distribution in 
EEC cell lines. (A-D) Histograms show MUC1 distribution across the population in 
Hec-l-A, Hec-l-B, Ishikawa and Hec50 cell monolayers following stimulation with 
lOOnM P4 and lOnM E2 for 48hrs.
Cell monolayers were treated, fixed and antibody stained for MUC1 protein. Nuclei 
were counterstained with DAPI. Images were acquired using automated high throughput 
bi-channel imaging using HCS. INCELL analyzer 2000 developer software identified 
approximately 3000-5000 (dependent on cell line) individual cells using a nuclear mask 
of the DAPI channel. Subsequent analysis assigned fluorescence value to each cell. 
Cells were sorted into groups based on their fluorescent signal; groups consisted of a 
range between 500au and 4500au at intervals of 10 allowing visualisation of the spread 
of data in histograms. Individual cell data was grouped from 3 independent repeats.
3.282 E 2, P4 and MPA in combination
Hec-l-A cell monolayers were primed with lOnM E2 for 24hrs, and then treated with 
combinations of either lOOnM P4 or lOOnM MPA without E2 thus allowing the direct 
comparison of total mRNA, total protein and protein distribution analysis of cells
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subject to hormone stimulation. The proportion of cells expressing high MUC1 protein 
was investigated to see if this changed following stimulation. Hec-l-A was a candidate 
for this focused investigation because previous data in this chapter (Figure 42) and 
published studies (Hey & Aplin 1996) have shown it to express heterogeneous patterns 
of MUC1 across adherent monolayers, referred to in the literature as the “mosaic” 
pattern (Hey & Aplin 1996).
RNA
5 0 08
£  0 06
B 70 
60
S
-  503a
o 40
8 30£
I  20
2  10
Fluorescence
n
Surface distribution
f  >p»r r >mpa r >m pa«f fc »P fc k »Mf»A t  > lif'A k
15 U
QLO* QHigh expressing c e lt
Figure 44: The effect of E2 and P 4  on MUC1 mRNA expression, well fluorescence and 
cellular distribution in EEC cell lines. (A) MUC1 transcript levels, (B) MUC1 total well 
fluorescence output and (C) distribution of high and low expressing cells after 72hrs 
combined E2 and P4 stimulation in Hec-l-A cells.
Hec-l-A and Ishikawa cells were primed with lOnM E2 for 24hrs then treated with 
lOOnM P4 or lOOnM MPA for 48hrs (with and without E2). Data shown are average 
from three independent experiments. (A) Values given are mean mRNA starting 
quantity normalised to RPL-19 ± STDEV from triplicates. Data was analysed using a 
two-tailed Student’s T-test *p=<0.05, **p=<0.01 vs. control. (B) Values are total well 
fluorescence calculated from 3000 cells ± STDEV from triplicates (C) Individual cells 
were sorted into high and low. The 10th percentile of the Hec-l-A control cell 
population used to determine a fluorescence value for high expressing cells.
Figure 44A shows MUC1 transcript was induced 1.18 fold after treatment with E2 for 
24hrs and then P 4  for 48hrs (p<0.01) and 1.42 fold after treatment with E2 for 24hrs with 
a combination of E2 and P 4  for 48hrs (p<0.01), showing that E2 in combination with P 4  
produced a heightened response. E2 primed cells stimulated with MPA produced a 
significant 1.25 fold up-regulation in MUC1 (p<0.05). The exception was E2 primed 
cells followed by combined treatment of E2 and MPA which showed no significant 
change in MUC1 mRNA expression. The tight grouping between replicates meant that 
trends were significant. Again responses to hormones were very subtle (1.18-1.42 fold) 
and not consistent with previous data shown in Figure 34. Despite the subtle change in
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mRNA levels there were no measureable changes in total MIJC1 protein expression 
following any of the hormone treatments (Figure 44B).
Subtle changes in percentage of cells expressing elevated MUC1 protein were observed 
following combined ovarian hormone stimulation (Figure 44C). The upper 10th 
percentile of the control cells was used as the fluorescence threshold, and cells that 
exceeded this value were defined as high expressers. Monolayers were primed with E2 
for 24hrs, and subsequent stimulations of P4 , P4+E2 , MPA, MPA+E2 resulted in 29%, 
13%, 18% and 25% high expressing cells out of the total cell population. All treatments 
increased the number of high expressers compare to control (10%) showing that the 
ovarian hormones can regulate the heterogeneity of the endometrial monolayer.
3.29 The effect of siRNA on MUC1 protein expression and distribution
Previous experiments (Figure 36 and Figure 37) had shown effective down-regulation
of MUC 1 gene expression following siRNA treatment. The effects of this modulation 
on MUC1 protein expression were also investigated at the protein level using HCS.
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Figure 45: The effect of siRNA treatment on MUC1 protein expression in EEC cell 
lines.Bar graph shows cellular fluorescence output levels of MUC1 in (A) Hec-l-A 
(blue) + Hec-l-B (red) and (B) Ishikawa (green) + Hec50 (orange). Coloured dots 
represent numbers of attached cells at included in analysis.
Cells were treated with scrambled siRNA and MUC1 specific siRNA for 48hrs. They 
were then fixed, and antibody stained for MUC1 protein using Texas-red conjugated 
goat anti-Mouse secondary antibody. Cell nuclei were counter stained with DAPI. The 
INCELL analyzer 2000 platform imaged 30 fields at random in 2 channels. The 
INCELL analyzer developer software suite was used for subsequent image analysis. 
Bar graphs represent total well fluorescence output from all images. Each treatment had
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a dedicated well negative for primary and secondary antibody and this well intensity 
value was deducted to account for background. Data shown is one representative repeat 
from two independent experiments. Values given are mean fluorescent output from 
adherent cell populations, normalised to background ± STDEV from triplicate wells.
Hec-l-A, Hec-l-B, Ishikawa and Hec50 cells were seeded on 96 well plates and three 
wells were subjected scrambled control siRNA (50nM for 48hrs), three wells treated 
with MUC1 siRNA (50nM for 48hrs) and three wells were left untreated.
Analysis revealed that MUC1 protein expression in Hec-l-B cells was reduced by 
53.9% after 48hr MUC1 siRNA treatment compared to scrambled siRNA (p<0.001) 
(Figure 45A). Hec-l-A cells showed a trend towards reduced MUC1 protein expression 
of 22.6%, but this result was not significant.
The data in Figure 45B demonstrates that the treatment with both control and MUC1 
siRNA induced cell death in Ishikawa and Hec50 and their use was not continued for 
future experiments. This highlights the importance of cell viability assay during siRNA 
knockdown experiments. There was loss of cell viability in the scrambled siRNA 
control which suggests that the lipofectamine transfection reagent negatively affected 
cell viability in these two cell lines.
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Figure 46: The effect of siRNA treatment on the MUC1 protein distribution in Hec-l-A 
and Hec-l-B cells. MUC1 siRNA reduces the number of high expressing cells in (A) 
Hec-l-A and (B) Hec-l-B cell models. Individual cells were sorted into high and low. 
The 10th percentile of the Hec-l-A control cell population used to determine a 
fluorescence value for high expressing cells.
Figure 46 shows the percent of cells expressing high MUC1 protein decreases from 
10.15% to 6.52% after 48hrs MUC1 siRNA treatment. In the Hec-l-B cell line the
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percentage of high expressing cells was reduced from 56.04% to 16.58% demonstrating 
that the siRNA reduced the percentage of high expressing cells.
3.3 Discussion
The expression of MUC1, MUC4 and MUC 16 mRNA has been interrogated in the 
selected cell lines. Hec-l-B cells expressed relatively high levels of MUC1 mRNA, 
Hec-l-A expressed relatively high levels of MUC4 and Ishikawa expressed the highest 
levels of MUC 16. The varying expression patterns of mucins in these three EEC cell 
lines provides an opportunity to study the role of mucins in implantation biology. The 
cell lines were screened for MUC4 and MUC 16 because of the important roles they 
play in the endometrium (Gipson et al. 2008; Perez & Gipson 2008; Albrecht & 
Carraway 2011). However, MUC1 is of particular interest because clinical data has 
shown MUC1 to be up-regulated during the secretory phase (Song et al. 2012), able to 
present binding epitopes to the embryo (Margarit et al. 2009) and linked to infertility 
(Margarit et al. 2010; A. W. Home et al. 2001).
The response of endometrial mucins to P4  and E2  in EEC cell lines was shown be 
inconsistent at the mRNA level. Healthy endometrial tissue has been shown to express a 
range of nuclear receptors such as estrogen receptor (ER) (Critchley 2002), 
progesterone receptor (PR) (Niklaus et al. 2007), androgen receptor (AR) (Slayden et al. 
2001) and human chorionic gonadotrophin receptor (CG) (Zimmermann et al. 2012), 
that meditate the actions of their respective hormones, and elicit morphological changes 
across the endometrium during the menstrual cycle. P 4  serum concentration increases 
during the late secretory phase and promotes expression of molecules that facilitate 
embryo implantation. Indeed, expression of MUC1 in human endometrium is high 
during this period and experiments using the PR antagonist RU486 have resulted in 
MUC1 inhibition suggesting it is progesterone driven (Meng et al. 2009). The cell lines 
investigated were shown to express PR mRNA but treatment with P 4  had no effect and 
in combination with E2  only slightly increased MUC1 expression in the Hec-l-A cell 
line. Progesterone signalling is mediated through two receptor isoforms, PR-A and PR- 
B (Wen et al. 1994) which are encoded by the same gene but have different promoters. 
PR-B is the stronger transcriptional activator in most cell types, and PR-A acts as a 
dominant negative repressor for PRB (Vegeto et al. 1993). It has been shown using 
transfected PR isoforms in Hec-l-A cells that PR-B stimulates MUC1 expression and
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that PR-A acts as an antagonist for MUC1 expression (Brayman et al. 2006). 
Additionally, PR-B becomes the dominant receptor during the secretory phase (Amett- 
Mansfield 2004) suggesting that it is likely to mediate the effect of progesterone during 
the receptive period. The ratio of PR-A:PR-B in endometrial cell lines is the subject of 
conflicting reports, mRNA data has shown that Hec-l-A cells express a high ratio of 
PR-A:PR-B (Harduf et al. 2009), whilst others have reported no PR-B protein 
expression in Hec-l-A or Hec-l-B and very low levels in Ishikawa (Neubauer et al.
2011). It is possible that the cell lines are expressing a high PR-A:PR-B ratio resulting 
in minimal activation of MUC1 transcription. Moreover, P4  is able to suppress 
expression of PR, and the relatively high concentrations of P4  (lOOnM) administered 
may have contributed to PR reduction.
When Hec-l-A cells were primed with E2  and then treated with E2  and P4 /MPA in 
combination there was a modest but significant increase in MUC1 expression at the 
mRNA level. Total protein showed no significant increase, but HCS analysis showed 
that the percentage of high MUC1 expressing cells increased with the combination 
treatments. E2  signalling is mediated through two forms of estrogen receptor, ERa and 
ERp which are encoded by two separate genes, ESR1 and ESR2. It has been established 
for some years that E2  increases synthesis of PR while degradation remains constant 
(Nardulli et al. 1988) and whilst there are no ERE’s in the promoter regions of PR-A or 
PR-B, ER is able to exert transcriptional changes through interaction with other DNA 
binding proteins such as SP1 (Petz & Nardulli 2000). Treatment with 10-20nM E2  for 
24hrs has been shown to increase PR mRNA (Lee & Gorski 1996), so it is plausible to 
suggest that administration of lOnM E2  for 24hrs prior to 48hr incubation with P4 /MPA 
and E2  up-regulated PR and increased the potency of the P4  response in terms of 
increased MUC 1 expression.
Experiments performed using a transfected MUC1 promoter to study regulation of the 
protein have used Hec-l-A (Wang et al. 2010; Brayman et al. 2007), Hec-l-B (Home et 
al. 2006) to create null and constitutive models of MUC 1 expression. In contrast we 
used Hec-l-B as a natural constitutive high expressing model for MUC1, and employed 
siRNA to down-regulate expression. This technique provided a valuable molecular tool 
with which to control mucin gene expression in endometrial cell lines. Monolayers of 
Hec-l-B cells are also ideal for the study of the role of mucins and specifically because
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Hec-l-B does not express MUC4 or MUC 16. Moreover, siRNA treatment reduced 
MUC1 mRNA levels by 96.1% and protein expression by 53.9%.
Using HCS to investigate pattern of adhesion proteins in endometrial cells showed that 
the heterogeneity of MUC1 expression across an endometrial monolayer can be 
modified with ovarian hormones. MUC1 is thought to be a regulator of implantation, 
and may exert some quality control over the potential embryos through mechanical 
trapping of the embryo and affinity for trophoblast localised molecules such as L- 
selectin. Hec-l-A and Hec-l-B cell lines in combination with post-transcriptional gene 
silencing represent a suitable model required to further interrogate the non-specific and 
specific roles played by MUC1 during embryo implantation
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4.1 Introduction
The mechanical and molecular adhesion of the embryo to the uterine wall requires a 
plethora of adhesive markers that contribute to the endometrial glycocalyx. These 
molecules are regulated through the menstrual cycle by the actions of E2 and P4 (Young 
2013). The apposition phase of implantation is likely to involve initial mechanical 
impedance when the embryo first encounters the membrane bound mucus layer and 
becomes trapped in a “mucin cloud” (Figure 47).
This membrane bound mucus layer typically consists the adhesive mucus layer (AML) 
located next to the cell surface and the apical luminal mucus layer (LML). These layers 
function as a barrier to non-specific nano-particles such as viruses, and protect apical 
membranes of endometrial epithelia from enzymatic and bacterial assault (DeSouza et 
al. 1999). The AML principally consists of large glycosylated mucins such as MUC1, 
MUC4 and MUC 16 that are tethered to the cell membrane in a dynamic fashion. This 
system is dynamic because mucins are constantly secreted and when subjected to 
frictional forces large mucin proteins can detach from the apical surface and envelop an 
opposing body, a process mediated by the SEA and EGF domains. The LML is 
comprised of smaller mucins (Lai et al. 2009; Hattrup & Gendler 2008) such as 
MUC5A and MUC5B (Thornton et al. 2008) and is not thought to contribute 
significantly to the mucus layer because it is of much lower density (Gniewek & 
Kolinski 2012).
» Approaching embryo
Trapped embryo
S trom al
Layer
Figure 47: The composition of the epithelial mucus layers. The endometrial layer of the 
endometrium is protected by a membrane bound mucus layer. Comprised of two sub­
layers; the adhesive mucus layer and the luminal mucus layer may act to mechanically
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retard the embryo as it encounters the endometrial glycocalyx allowing specific 
adhesion to occur.
MUC1 is abundant in the AML protecting endometrial epithelia (Hattrup & Gendler
2008) but its precise adhesive contribution is not fully understood and elucidating the 
true function has been slow. Progress has been hampered by conflicting studies in the 
literature suggesting both adhesive (Geng et al. 2013; Costa et al. 2011) and anti­
adhesive (Wesseling et al. 1995) roles for the protein. Fluorescence imaging of Hec-l-A 
monolayers co-cultured with mouse embryos show a halo of MUC1 reduction 
surrounding the embryo suggesting local clearance of MUC1 to be a requisite for 
implantation (Meseguer et al. 2001). Moreover, MUC1 does not correlate with 
pinopods, small mushroom-like projections positively associated with embryo adhesion 
(Home et al. 2005). However, shorter structural MUC1 isoforms (resulting from a 
reduced number of tandem repeats in the extracellular domain) correlate positively with 
unexplained infertility (Home et al. 2001) and decreased expression with increased 
implantation failure (Home et al. 2005), which both suggest the expression of fully 
formed MUC1 protein is required for fertility. The carbohydrate moieties that decorate 
MUC1 are believed to be important in embryo recognition (Margarit et al. 2009) and 
this hypothesis is tested extensively in chapter 5.
In this chapter the mechanical properties of MUC 1 endometrial were investigated using 
new quantitative AFM mode. Two avenues of nano-scale investigation are pursued; an 
exploratory study of fixed endometrial cell monolayers, and a complete investigation on 
their live cell counterparts under near physiological conditions.
Peak force quantitative nano-mechanical mapping (PFQNM) enables imaging at speeds 
comparable with AC mode but allows extraction of quantitative information (e.g. 
adhesion data) at very high resolution. PFQNM has been used to quantify forces on 
various living systems such as yeast (Alsteens et al. 2012), human epidermal (Heu et al.
2012) and neuronal (Berquand et al. 2012) cell lines. At the time of writing PFQNM has 
never been attempted on endometrial monolayers so a preliminary examination was 
undertaken on fixed Hec-l-A and Hec-l-B monolayers to optimise the technique.
Evidence suggests MUC1 is an important a regulator of implantation (Carson et al. 
2006; Margarit et al. 2010). Nevertheless a paradox exists in which a protein described 
as anti-adhesive protein is required for successful implantation. My hypothesis is that
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the apposition phase of implantation is dependent on two sequential interactions; the 
first is a non-specific trapping of the embryo in the AML, which retards it sufficiently to 
allow a second specific tethering to the uterine epithelium via specific molecular 
recognition events. The first part of this hypothesis is tested in this chapter and it is 
believed that high levels of MUC 1 protein will increase adhesion across the monolayer. 
This notion is supported by insights into MUC1 structure and adhesive characteristics 
on non-endometrial epithelia in the literature (Kim & Lillehoj 2008; Albrecht & 
Carraway 2011). Moreover, the WOI is a defined period of high endometrial adhesion 
that coincides with a progesterone induced increase of MUC 1 protein. The aim of this 
chapter is to assess the nano-mechanical properties of the endometrial cell surface and 
correlate these with MUC1 expression using the endometrial epithelial surface model 
developed in chapter 3.
4.2 Results
In order to understand the role of MUC 1 and MUC 16, cell monolayers were scanned 
using quantitative AFM. PFQNM scans consisted of large areas (up to 150pm2) of 
monolayer encompassing multiple cells and allowed nano-mechanical quantification of 
the monolayer as a single entity. Fixing cells provides mechanical stability to the cells, 
which in turn enables them to withstand the perturbations of the scanning probe 
revealing ultra-fine structural cell surface detail (Francis et al. 2009). The fixed cell 
study revealed the cell surface topology and optimised examination of live cell nano­
mechanical properties. Fixed endometrial epithelial cells are laid out in the form of 3 
dimensional maps with accompanying bar graphs showing quantitative data extracted 
using bearing analysis.
4.21 High resolution quantitative mapping of the endometrial monolayer
Cell monolayers were fixed and imaged using PFQNM. These images contained a
reduced number of cells compared to fluorescence microscopy techniques used in 
chapter 3 (Figure 48A) but benefited from increased resolution revealing details of the 
membrane ultra-structure from which nano-mechanical data could be obtained (Figure 
48B+C).
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Figure 48: The transition from low magnification qualitative imaging to high 
magnification quantitative imaging using the atomic force microscope. Hec-l-A cells 
were grown until 90% confluence and fixed using paraformaldehyde. (A) Medium 
magnification immunofluorescence images of endometrial cells stained with anti- 
MUC1 mAb and counterstained with DAPI. (B) The AFM was used to image regions of 
the endometrial monolayer. (C) Higher magnification captured single cells.
4.22 Mapping the fixed cell monolayer
Studies from our group have identified variations in MUC1 expression between fertile 
(high) and infertile (low) pathology (Margarit et al. 2010). Previous studies from this 
group had correlated MUC1 expression with increased surface roughness and cell 
height in Hec-l-A and Ishikawa endometrial cell lines (Francis et al. 2009). This 
highlighted that MUC1 could influence nanoscale surface properties. In order to assess 
nano-scale differences between Hec-l-A and Hec-l-B, cells were grown in glass dishes 
until 90-100% confluent and fixed using paraformaldehyde. The fixed cells were 
quantitatively imaged using PFQNM in three separate areas across the monolayer. The 
cantilever deflection sensitivity was calculated buy ramping into hard surface (glass) in 
force spectroscopy mode, while the spring constant was calibrated using the thermal 
tune method, thus ensuring PFQNM was fully quantitative. Data was analysed using
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Nanoscope analysis software using the “bearing analysis” function. Each region of cell 
monolayer was assessed for topography, adhesion, deformation and dissipation and 
stiffness. Nano-mechanical properties are visualised in 3-dimensional maps generated 
using Nanoscope analysis.
4.221 Topography and surface roughness
Hec-l-A and Hec-l-B were analysed for cell height and surface roughness using the 
AFM. Three regions of Hec-l-A were chosen at random across a monolayer and imaged 
using PFQNM. These consisted of area Al (40pm2), area A2 (50pm2) and area A3 
(70pm2) having average heights of 3.8pm, 4.3pm and 5.1pm respectively. Combined 
average height of Hec-l-A monolayers was 4.4 +/- 0.65pm. Three areas of Hec-l-B 
were imaged: area B1 (30pm2), area B2 (30pm2) and area B3 (50pm2) having average 
heights of 3.7pm, 4.3pm and 4.6pm respectively. Combined average height of Hec-l-B 
monolayers was 4.2+/-0.46pm.
Topographical maps of Hec-l-A and Hec-l-B and bar graphs reveal no significant 
differences in height between the two fixed cell monolayers (Figure 49). Roughness had 
been previously linked with MUC1 expression in these cell lines (Francis et al. 2009) 
and initial visual observations of topographical images suggested that Hec-IB cells had 
a rougher surface when compared to Hec-IA. In order to assess if MUC 1 expression 
influenced the surface roughness of the endometrium thirty 3 pm2 areas were measured 
for Ra from each cell line, ten areas were sampled from each area (A1-A3, B1-B3). 
Average roughness measurements from Hec-l-A and Hec-l-B had a mean Ra of 
41.04nm and 45.68nm respectively (Figure 49D). Although Hec-l-B was slightly 
rougher than Hec-l-A the Kruskal-Wallis statistical test did not show this to be 
significant.
120
Chapter 4 Nano-mechanical mapping o f a model endometrial cell surface
A
1 2  3 1 2
H e c - l -A  Hec- l -B
Hec- l -A Hec- l - B
7.4(11))
17 
X (nm)
17 
X (pm)
Hec- l-A Hec- l -B
B
Figure 49: Topographical and surface roughness measurements of Hec-l-A and Hec-IB 
cells. Adherent Hec-IA and Hec-IB endometrial epithelial cells were grown to 80- 
100% confluence, fixed and imaged. Two representative topographical maps are shown. 
Each map shows- 30 pm2 the cell surface of (A) Hec-l-A and (B) Hec-l-B cell 
monolayers. Each map is generated from 262144 sample points (C) topographical data 
for three distant and distinct regions across the monolayer for both Hec-l-A and Hec-1- 
B Data was analysed using a two-tailed Student’s t-test *p<0.05, **p<0.01, 
***p<0.001. (D) Surface roughness readings were taken at random from 30x 3pm2 
areas randomly selected from the whole cell surface of Hec-l-A and Hec-l-B cells. Ra 
readings (nm) are presented here summarized as boxplots (mean ®). The Kruskal- 
Wallis test was used to test for statistical significance at the 95% confidence level with a 
p value <0.05. Differences were not shown to be significant (P=0.145)
Height and surface roughness measurements show no significant differences between 
Hec-l-A and Hec-l-B. This suggests that MUC1 (strongly expressed by Hec-l-B) and 
MUC 16 (expressed in Hec-l-A, not expressed in Hec-l-B) may contribute equally to 
the endometrial glycocalyx height.
4.222 Stiffness
When imaging soft surfaces such as cells the probe is able to indent far into the 
substrate. As this is past the tip apex, a spherical model for modulus is no longer 
suitable, so conical model (Sneddon) was used to calculate the elastic modulus of the
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endometrial cell. By default, Peak Force QNM generates data in the elastic modulus 
channel using the DMT model for modulus (a spherical model suited to hard surfaces) 
and at the time of experiment did not allow for other models of elasticity. To account 
for this a high speed data capture (HSDC) file was generated for areas A1-A3 and B I­
BS, totalling 6 HSDC files. Generating a HSDC file involved increasing the resolution 
from 128 samples/ line to 5000 samples/line, and then scanning a single high resolution 
line across the centre of the image (Figure 50).
Surface track at high resolution
0 5  1 1 5  2 2 5  3 3 5  4 < 5
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Figure 50: HSDC transect line across the monolayer. A HSDC file is generated for 
every monolayer image. (A) After imaging a very high resolution line is scanned across 
the body of the imaging frame. (B) High resolution scan profile showing track across 
cell monolayer against time. Force curves contained within this file can be exported for 
analysis using proprietary software.
Stiffness was calculated from HSDC file force curves, peripheral regions that did not 
traverse the cell were excluded from analysis. After excluding these force curves,
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number of data points used to calculate stiffness was typically 4500-5000. Hec-l-A 
displayed an average stiffness of 53KPa, 74 KPa and 128 KPa for each HSDC (Figure 
51C). Across all areas stiffness of Hec-l-A monolayers was 85 +/- 39KPa.
Hec-l-B areas displayed combined stiffness of 99KPa, 86KPa, and 123KPa 
respectively. Across all areas, stiffness of Hec-l-B monolayers was 103 +/- 18KPa. The 
stiffness profile of Hec-IB was higher than Hec-IA, although this trend was not shown 
to be significant (p=0.516), possibly due to the high degree of variation over the Hec-1- 
A areas. The stiffness of both cell lines displayed a high degree of inter-cellular 
variation. This ranged from 53 KPa to 128 KPa in Hec-IA and 99 KPa to 123 KPa in 
Hec-IB.
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Figure 51: Stiffness measurements of Hec-l-A and Hec-IB cells. Hec-IA and Hec-IB 
cells were grown to 80-100% confluence, fixed and imaged. (A+B) Two representative 
topographical maps with elasticity overlay are shown (DMT). Each map shows 35 pm2 
the cell surface of (A) Hec-l-A and (B) Hec-l-B cell monolayers. Each map is 
generated from 262144 sample points. The HSDC feature was used to generate one very 
high resolution (5000 data point) scan line transecting the image for Hec-IA (A) and 
Hec-IB (B). (C) Force curves that occurred over the cell body were analysed. Stiffness 
data was generated from three HSDC scan lines from three different cells across the 
monolayer for both Hec-l-A and Hec-l-B.
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4.223 Deformation
7  11The AFM tip exerts a force on the sample surface which can range from 10’ to 10' N, 
depending on imaging conditions. This force causes nano-indentation which is
. . .  7described as ‘nN force causing nm indentation on nm contact area’ (Weisenhom 1993), 
which induces sample deformation. Areas A1-A3 were assessed for surface 
deformation, having average deformation of 191nm, 156nm and 223nm respectively 
(Figure 52C). Across all areas, deformation of Hec-l-A monolayers was 190 +/- 34nm. 
Areas B1-B3 displayed average deformation of 145nm, 208nm and 182nm respectively 
(Figure 52C). Across all areas, deformation of Hec-l-B monolayers was 178 +/- 32nm. 
There were no significant differences between the two data sets (p=0.684). Membrane 
deformation is inversely proportional to membrane stiffness meaning a stiffer surface is 
less likely to deform under the applied force generated dining tapping.
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Figure 52: Deformation measurements of Hec-l-A and Hec-IB cells. Hec-IA and Hec- 
IB endometrial epithelial cells were grown to 80-100% confluence, fixed and imaged. 
(A+B) Examples of two representative topographical maps with deformation overlay 
encompassing approximately 30pm2 of Hec-IA and Hec-IB cell monolayers. Each map 
is generated from 262144 sample points. (C) Deformation data was generated for three 
distant regions across the monolayer for both Hec-l-A and Hec-l-B.
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4.224 Dissipation
Changes in cell deformation can be related to the cytoskeletal changes (Muller et al.
2009), loss of microtubules or actin filaments and can lead to lower cell stiffness and 
higher deformation (Suresh 2007). AFM is often used to determine cell stiffness and 
relate this to altered cell physiology. However, the cell membrane is not a homogenous 
surface and during force spectroscopy experiments there exists a hysteresis between the 
approach and retraction curve indicating a dissipation of energy. It is possible to 
calculate the energy dissipated at the tip-sample junction by taking advantage of the 
observed steady-state motion of the cantilever during tapping, and calculating the 
energy inputs and outputs of the system. The phase of the oscillating cantilever can be 
directly related to the energy loss in the tip-sample junction, and a numerical value for 
the power being lost can be extracted (Cleveland et al. 1998). This has been recently 
shown using human skin fibroblast cells (Klymenko et al. 2009).
Hec-l-A areas (A1-A3) displayed average dissipation of 3.1 KeV, 2.5 KeV and 1.8 
KeV (Figure 53C). Across all areas, energy dissipation of Hec-l-A monolayers was 2.7 
+/- 0.65 KeV. Energy dissipation across the Hec-l-B areas (B1-B3) was shown to be 
2.5 KeV, 4.2 KeV and 4.9 KeV respectively (Figure 53C). Across all areas, energy 
dissipation of Hec-l-B monolayers was 3.8 +/- 1.2nm. Average energy dissipation 
between the AFM tip and the surface of Hec-IA was 2.5 KeV while Hec-IB 3.9 KeV, 
however this trend was not shown to be a significant difference between the two data 
sets (p=0.157). Although there was no significant difference in energy dissipation 
between both cell types a strong trend existed between dissipation and cell height. 
Energy dissipation 3D maps show indicate a correlation with dissipation and cell 
boundaries, this could be related to topographical features or localised expression of 
adhesive molecules in this region.
4.225 Adhesion
MUC1 is an adhesion protein with relevance in implantation and is believed to 
contribute significantly to the AML. The adhesive characteristics of the endometrial 
glycocalyx may provide the mechanical environment required to trap the embryo and 
are likely to be heavily influenced by mucins
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Figure 53: Energy dissipation measurements of Hec-l-A and Hec-IB cells. Hec-IA and 
Hec-IB were grown to 80-100% confluence, fixed and imaged (A+B) Two 
representative topographical maps with dissipation overlay encompassing 
approximately 30pm2 of Hec-IA (A) and Hec-IB (B) cell monolayers. Each map is 
generated from 262144 sample points. (C) Deformation data was generated for three 
distant regions across the monolayer for Hec-l-A and Hec-l-B.
Hec-l-A and Hec-l-B cell lines were used as models for high and low MUC1 
expression and positive and negative MUC16 expression. The three Hec-l-A areas (Al- 
A3) displayed adhesion of 181 pN, 142 pN and 98 pN respectively (Figure 54C). 
Across all areas, adhesion of Hec-l-A monolayers was 140 +/- 42 pN. Hec-l-B areas 
(B1-B3) showed average adhesion measurements of 207 pN, 215 pN and 243 pN 
respectively (Figure 54C). Across all areas, adhesion of Hec-l-B monolayers was 221 
+/- 19 pN. The average adhesion for Hec-IB cell monolayers was 221pN while Hec-IA 
was 140pN which indicated a significant difference (p=0.036). In contrast to other 
nano-mechanical properties measured using PFQNM the differences in adhesion were 
marked. There was a high degree of variation across the Hec-IA monolayer, (98 to 181 
pN). In contrast, Hec-l-B areas were similar, 207, 215 and 243 pN (Figure 54C). 3D 
topographical maps with adhesion overlay revealed that depressions surrounded by high
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sides were more adhesive in both cell types. In the context of the monolayer this refers 
to the boundary between cells. (Figure 54A+B). There appears to be a spatial 
association between adhesion and energy dissipation across the monolayer. This could 
be due to a localised elevation of adhesive molecule expression at certain regions such 
as E-cadherin expression at intercellular junctions. The differences between the cell 
types could be related to expression differences of adhesion proteins on the apical 
membrane such as MUC1 protein.
2 5 0  
Z  2 0 0
|  150
*55
4 100
50
1 2  3 1 2  3
H e c - l - A  H e c - l - B
Figure 54: Adhesion measurements of Hec-l-A and Hec-IB cells. Hec-IA and Hec-IB 
endometrial epithelial cells were grown to 80-100% confluence, fixed and imaged. 
(A+B) Two representative topographical maps with adhesion overlay encompassing 
approximately 30pm2 of Hec-IA (A) and Hec-IB (B) cell monolayers. Each map is 
generated from 262144 sample points. (C) Adhesion data was generated for three 
distant regions across the monolayer for both Hec-l-A and Hec-l-B.
The adhesion data implicates MUC1 as a dominant contributor to the adhesive 
characteristics of the cell glycocalyx because the Hec-l-B, a high MUC1 expresser is 
the most adhesive and does not express MUC4 or MUC16. However, Hec-l-A is not
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without adhesion suggesting that MUC4 or MUC16 could be contributing as well as the 
residual MUC1 expressed on Hec-l-A cell monolayers.
4.226 Combined fixed  cell properties
The nano-mechanical properties of fixed Hec-l-A and Hec-l-B cells revealed that 
topography, stiffness, dissipation and deformation were not significantly different 
between the two cell types (Figure 55). Adhesion, the notable exception, was 
significantly higher in Hec-l-B measuring around 220pN compared to 140pN of Hec-1- 
A (p=0.036). It is plausible to suggest that adhesion of the monolayer strongly 
influences endometrial receptivity during the implantation window. The data shows that 
adhesion is 1.57 fold higher in Hec-l-B cells relative to Hec-l-A which corresponds 
well with the elevated MUC1 protein levels in Hec-l-B relative to Hec-l-A (chapter 
3:Figure 41).
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Figure 55: Combined nano-mechanical measurements of fixed Hec-l-A and Hec-IB 
cell monolayers. When compiled, the surface properties of the Hec-1 cell lines 
highlighted a divergence in the adhesive profile of the two cell lines. Data was analysed 
using a two-tailed Student’s T-test *p<0.05, **p<0.01, ***p<0.001 vs. control.
The data obtained in this initial study of a small number of fixed cells revealed a 
significant difference in adhesion between Hec-l-A and Hec-l-B and demonstrated the 
utility of PFQNM. Experiments were therefore extended to live cell monolayers to 
enable a better insight into the adhesive function of MUC1.
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4.23 Mapping the live cell monolayer
AFM imaging of living cells is challenging, and mammalian cells are sometimes very 
sensitive to the environment and physical contact. In order to avoid the deformation of 
cells by contact with an AFM tip during scanning, a non-contact mode of operation 
should be used. Nonetheless, the soft membrane means lateral resolution is reduced and 
the cells have to be maintained at physiological conditions for the duration of the 
experiment. Most AFM systems have the ability to image living cells in liquid, the 
living samples are covered in growth medium and the probe lowered into the liquid to 
scan the cell surface. The laser beam is still able to penetrate the liquid to detect changes 
in the probe position due to surface features. Horizontal resolution for living cells in 
aqueous medium is tens of nanometers compared to l-5nm for imaging in air. Near- 
physiological conditions are achieved by maintaining the liquid growth medium at 37°C 
at carbon dioxide at 5% using specially design incubation chambers.
Initial images recorded with PFQNM illustrated that quantitative imaging of 
endometrial epithelial cells was possible. The Hec-l-B cell line was much more difficult 
to image than Hec-l-A and resulted in increased scanning artifacts. A combination of 
extreme cell heights, combined with steep relief features exceeded the capability of the 
tip to accurately map some areas of the monolayer surface (Figure 56).
Using the Hamamatsu ORCA camera it was not always possible to identify areas with 
topographical limitation prior to AFM mapping. This problem was circumvented by 
careful selection of scan areas across the monolayer; cells with high contrast or of round 
appearance were avoided. Due to imaging artifacts average scan size was reduced in 
Hec-l-B, Hec-l-A average scan size was 105 pm while Hec-l-B average scan size was 
48 pm. Steep sided cells were bypassed using offset feature where appropriate. Lastly 
the peak force oscillating amplitude was increased to 1 pm from the standard 300 nm 
through manipulation to Nanoscope software. This final adaption improved scanning 
reliability significantly.
The experiments above using fixed cell monolayers suggested a correlation between 
MUC1 expression and adhesion. Application of the AFM to live cells allowed 
examination of the effect of altered MUC1 expression. Removal of any cross-linking 
artifacts due to fixation could reveal further insight into the biophysical state, and 
functionality of the cells. Endometrial epithelial cells were grown until 80-100%
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confluent and imaged using PFQNM. Live Hec-l-A and Hec-l-B cell monolayers were 
quantitatively mapped for stiffness, deformation and adhesion at near physiological 
conditions.
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Figure 56: Overcoming scanning artifacts resulting from steep relief features. A 
proportion of Hec-l-B cells induced scanning artifacts due to their extreme height and 
steep relief features. (A) Height image of a Hecl-B cell measuring over 12 pm, the tip 
is unable to contact the cell periphery and results in a shadow. (B) Phase imaging shows 
a grouping of Hec-l-B cells induce “parachuting” and creates a false map of relief (the 
tip is scanning from top to bottom). (C) Substrate level view shows the steep relief of 
certain Hec-l-B cells. (D) The relationship between tip height and cell height is thought 
to be important here.
Excitingly, PFQNM-AFM was able to image live endometrial epithelial cell monolayers 
under physiological conditions at a range of scan areas and resolutions from 128 
samples per line to 512 samples/ line (Figure 57).
Live Hec-l-A and Hec-l-B monolayers were imaged in nine separate areas that were 
chosen at random. Areas were scanned at 128 samples/line resolution in order to allow 
the maximum number of areas to be imaged and to reduce the chance of sample 
degradation.
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Figure 57: PFQNM is able to map endometrial cell monolayers. Hec-1 cell monolayers 
were grown until 80-100% confluence and imaged using Peak Force QNM. (A) Light 
microscope image showing monolayers of epithelial cells with the AFM cantilever 
above. The live monolayer was imaged at varying resolutions at randomly chosen 
locations. (A) 128, (B) 256 and (B) 512 samples/line. Scan sizes up to 150x150pm were 
possible but size depended on localised topographical features. Large scan sizes 
captured up to 20 adherent cells
Where possible a scan size of 100pm was used, however in some cases topographical 
features limited the scan area. Three areas were scanned from each of the three 
biological repeats, resulting in nine total areas (3x3). Scans of Hec-l-A monolayer 
(Figure 58) consisted of scan areas Al (100pm2), A2 (100pm2), A3 (100pm2), A4 
(100pm2), A5 (100pm2), A6 (100pm2), A7 (100pm2), A8 (65pm2) and A9 (65pm2).
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Figure 58: Panel of Hec-l-A monolayer images A1-A9. Hec-l-A cell monolayers were 
grown until 90-100% confluent and imaged live in media. (A1-A9) Bank of images 
used for extraction of nano-mechanical data.
Hec-l-B was also imaged resulting in areas B1 (50pm2), B2 (50pm2), B3 (50pm2), B4 
(50pm2), B5 (20pm2), B6 (50pm2), B7 (50pm2), B8 (100pm2) and B9 (50pm2) (Figure 
59). Hec-l-B areas were smaller on average owing to the increased frequency of 
scanning artefacts as described earlier (Figure 56).
4.231 Stiffness
Hec-l-A and Hec-l-B had not shown differences in surface stiffness; however the 
process of fixation could be a contributory factor in the results. In order to maintain 
continuity with prior experiments on fixed monolayers, force curves were extracted 
from HSDC files that were generated for each of the nine areas scanned for Hec-l-A 
and Hec-l-B and stiffness analysed from approximately 5000 force curves. Hec-l-A
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stiffness readings for repeats 1-3 were 79.6, 84.0 and 72.6KPa while Hec-l-B showed 
stiffness of 91.8, 78.8 and 69.8KPa (Figure 60).
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Figure 59: Panel of Hec-l-B monolayer images Bl-B9.Hec-l-B cell monolayers were 
grown until 90-100% confluent and imaged live in media. (B1-B9) Bank of images used 
for extraction of nano-mechanical data.
Across all three repeats Hec-l-A areas displayed average stiffness 78.7 +/- 18.6 KPa. 
Hec-l-B areas produced average stiffness of 80 +/- 15KPa. The average stiffness of 
Hec-l-A and Hec-l-B membranes was very similar at 79 and 80 KPa respectively. 
Stiffness readings across the Hec-l-A areas were closely clustered ranging from 53.3 to
101.2 KPa while Hec-l-B areas were also clustered ranging from 64.2 to 107.8 KPa, 
and reflected fixed cell measurements. The cell stiffness, similar across both cell types, 
was similar to live cell stiffness measurements (13KPa-150KPa) reported by others 
(Weisenhom 1993). As expected stiffness measurements on live cells were lower than 
previous experiments on the fixed cell monolayers, this is likely due to the cross-linking
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effect of the paraformaldehyde fixative used. Similarly to the fixed cell approach the 
effect of the substrate was to increase stiffness in the cell periphery, while nuclear 
regions were softer. Stiffness is likely to be related to cell organelles and components of 
the cytoskeleton and not the expression of proteins such as MUC1 or MUC16 on the 
apical membrane.
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Figure 60: Stiffness measurements of Hec-l-A and Hec-IB cells. Adherent Hec-l-A 
and Hec-l-B endometrial epithelial cells were grown in glass dishes to 80-100% 
confluence and imaged at intermediate resolution using PFQNM-AFM. The High Speed 
Data Capture (HSDC) feature was used to generate one very high resolution (5000 data 
point) scan line transecting the image for Hec-IA (A) and Hec-IB (B). Force curves 
that occurred over the cell body were subjected to offline analysis using the sneddon 
variation. Stiffness data was generated from nine areas across the monolayer, three areas 
from each independent repeat. All three independent repeats are shown for both Hec-1- 
A (blue) and Hec-l-B (red). Error bars are ± STDEV from triplicate HSDC files. Data 
was analysed using a two-tailed Student’s T-test *p<0.05, **p<0.01, ***p<0.001 vs. 
control.
4.232 Deformation
Hec-l-A deformation for repeats 1-3 was 143.6, 151.8 and 169.3nm, similar to Hec-l-B 
which displayed deformation of 157.1, 154.5 andl78.6nm for the three repeats (Figure 
61). The average deformation of Hec-l-A areas (A1-A9) of cell monolayers was 155 +/- 
27 nm while the average deformation of Hec-l-B monolayers measured 163 +/- 25 nm. 
This small difference was not shown to be significant (p=0.498). There was moderate 
variation across both Hec-l-A and Hec-l-B monolayers with readings from all areas 
ranging from 125 to 201 nm.
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Figure 61: PFQNM deformation analysis of the endometrial cell line membranes. Hec-1 
cell monolayers underwent quantitative mapping for nano-mechanical properties. 
PFQNM was used to image 9x 50-150pm2 regions of the live cell monolayer from 3 
biological repeats. Deformation data was generated from nine areas across the 
monolayer, three areas from each independent repeat. All three independent repeats are 
shown for both Hec-l-A (blue) and Hec-l-B (red). Error bars are ± STDEV from 
triplicate scans. Data was analysed using a two-tailed Student’s T-test *p<0.05, 
**p<0.01, ***p<0.001 vs. control.
4.233 Adhesion
Hec-l-A adhesion for repeats 1-3 was 136.7, 147.0 and 160.7pN, while Hec-l-B was 
much more adhesive showing 265.3, 277.7 and 271.3 for the three repeats (Figure 62). 
Across all Hec-l-A areas adhesion was 148 +/- 19 pN. In contrast, average adhesion 
across areas B1-B9 of the Hec-l-B monolayer was 271 +/- 35 pN which was shown to 
be a significant difference (p=8.96xl0~8). This represented a 1.83 fold difference. The 
difference in adhesion was more pronounced compared to fixed cells (1.57 fold) 
suggesting the fixative was dampening adhesion between the tip and the cell surface. 
There was some variation across the Hec-l-B monolayer with readings from all ranging 
from 205 to 318 pN while Hec-l-A areas were more closely clustered ranging from 117 
to 172 pN. This reflects the increased heterogeneity of adhesion molecule expression in 
Hec-l-B shown in Chapter 3. Adhesion maps revealed that in Hec-l-A adhesion 
appeared to be unrelated to cell height, with similar adhesion in nuclear and cell 
periphery regions, while Hec-l-B did exhibit higher adhesion in nuclear regions. The 
adhesive characteristics of the endometrial monolayer are likely dependant on 
expression of adhesive proteins while deformation and elasticity are likely influenced 
by underlying substrate, such as the nucleus or the glass on the cell periphery.
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Figure 62: PFQNM adhesion analysis of the endometrial cells. PFQNM was used to 
image 9x 50-150pm regions of the live cell monolayer from 3 biological repeats. 
Adhesion data was generated from nine areas across the monolayer, three areas from 
each independent repeat. All three independent repeats are shown for both Hec-l-A 
(blue) and Hec-l-B (red). Error bars are ± STDEV from triplicate scans. Data was 
analysed using a two-tailed Student’s T-test *p<0.05, **p<0.01, ***p<0.001 vs. control.
4.234 Combined live cell properties
When combined, the nano-mechanical properties of live Hec-1 cells revealed that 
stiffness and deformation were consistent between Hec-l-A and Hec-l-B monolayers 
(Figure 63). Adhesion, was significantly higher in Hec-l-B measuring 271 pN relative 
to 148 pN across Hec-l-A. These results are comparable to the data obtained from fixed 
cell monolayers, and show Hec-l-B exhibits a 1.8 fold increase in adhesion relative to 
Hec-l-A in a live cell system (Figure 63).
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Figure 63: Combined nano-mechanical measurements of live Hec-l-A and Hec-IB cell 
monolayers. When compiled, the surface properties of the Hec-1 cell lines highlighted a 
divergence in the adhesive profile of the two cell lines while the monolayer stiffness and 
deformation remained consistent. Hec-l-A (blue) and Hec-l-B (red) are shown) All
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three independent repeats are combined for both Hec-l-A (blue) and Hec-l-B (red). 
Error bars are ± STDEV from triplicate repeats. Data was analysed using a two-tailed 
Student’s T-test *p<0.05, **p<0.01, ***p<0.001 vs. control.
4.235 The effect o f  fixation
The nano-mechanical properties of the Hec-l-A and Hec-l-B cell monolayers followed 
the same trends whether within the fixed cell system or using the live cell approach. 
Fixation increased the membrane stiffness by 9% and 21% and increased the membrane 
deformation by 18% and 9% in Hec-l-A and Hec-IB respectively. In contrast adhesion 
decreased by -6% and -22% in Hec-l-A and Hec-IB respectively (Figure 64).
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Figure 64: Stiffness, adhesion and deformation are all affected by fixation. Hec-l-A 
(blue) and Hec-l-B (red) cells exhibit similar trends in percentage change following 
addition of paraformaldehyde fixative.
This data suggests that far from being inferior fixed cell monolayers are good models 
for investigating nano-mechanical properties at the endometrial surfaces as they are 
representative of live cells. AFM imaging of live cells can be problematic but use of 
fixed cell monolayers provides an opportunity to study “real” nano-mechanical effects 
without the time constraints demanded by live cell imaging.
4.24 MUC1 and endometrial nano-mechanics
Hec-l-A and Hec-l-B have been used as a system for high and low expression of 
MUC1 protein, however this was an indirect assessment of MUC1 because expression 
of unknown adhesive mediators could be contributing towards the adhesive phenotype 
of Hec-l-B. In order to address this MUC1 gene expression was specifically targeted
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using siRNA to determine whether any biophysical changes to the monolayer 
glycocalyx subsequently observed by AFM could be directly attributed to MUC1.
Knockdown of MUC1 resulted in a 96.1% reduction in gene expression and a 20% 
reduction in protein expression (detected by fluorescence) across the Hec-l-A 
monolayer. In Hec-l-B siRNA knockdown of MUC1 showed a greater effect with a 
96.6% reduction in gene expression and corresponding 56% reduction in protein 
expression across the monolayer. This was likely due to the higher Hec-l-B basal 
expression levels. The Hec-l-B cell line was shown to express 4.5 fold greater MUC1 
protein than Hec-l-A. However, following treatment with siRNA expression in Hec-1 - 
B expression was shown to be similar to that of Hec-l-A basal levels. This provided a 
useful tool with which to compare the functional consequences of MUC1 on the surface 
properties of Hec-l-A and treated Hec-l-B.
The Hec-l-A and Hec-l-B monolayers treated with MUC1 siRNA were imaged using 
PFQNM. The experiment was repeated three times and each time three areas across the 
monolayer were imaged. Hec-l-A areas comprised; A1T (100pm2), A2T (120pm2), A3T 
(100pm2), A4T (100pm2), A5T (100pm2), A6T (100pm2), A7T (100pm2), A8T (100pm2) 
and A9t (150pm2). Nine areas of Hec-l-B from three independent repeats were mapped 
resulting in; B1T (50pm2), B2T (50pm2), B3T (50pm2), B4T (50pm2), B5T (50pm2), B6T 
(50pm2), B7t (50pm2), B8T (50pm2) and B9t (73pm2). Hec-l-B areas were generally 
smaller owing to the difficulties experienced when imaging these cells.
Figure 65 and Figure 66 show the regions of Hec-l-A and Hec-l-B cell monolayers 
captured using PFQNM. Data was extracted from these images using “bearing 
analysis”, or HSDC methods in the case of membrane stiffness. Quantitative data 
showing membrane stiffness, deformation and adhesion from MUC1 siRNA treated 
Hec-l-A and Hec-l-B live cell monolayers was compared to control monolayers 
(Figure 67).
The range of stiffness readings from Hec-l-A cells was measured (Figure 67A), 
resulting in average stiffness of 78.7 +/- 18.6 KPa in control cells, and following MUC1 
gene silencing 73.2 +/- 15.1 KPa (Figure 68). Hec-l-A monolayers displayed a small 5% 
reduction in stiffness after treatment but this was not significant (p=0.6507). Hec-l-B 
cells displayed stiffness measurements of 80 +/- 15KPa KPa and, following MUC1 
silencing, the average stiffness was found to be 76.9 +/- 17.6KPa (Figure 68). Hec-l-B
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monolayers displayed a small 4% reduction in stiffness following MUC1 siRNA 
treatment but this was not significant (p=0.6849). The small, non-significant reduction 
in stiffness was likely a product of monolayer variation across areas rather than a 
biophysical consequence of MUC1 knockdown.
Image: A1T Image: A2T Image: A3T
Imaae: A4T Image: A5T Image: A6T
Image: A7T
Figure 65: Panel of Hec-l-A monolayer images following treatment with MUC1 
siRNA: A1T-A9T. Hec-l-A cell monolayers were grown until 60% confluent, treated 
with MUC1 siRNA for 48hrs and imaged live in media. (A1T-A9T) Bank of images 
used for extraction of nano-mechanical data.
Deformation readings across 18 areas of Hec-l-A monolayer are shown (Figure 67C) 
and average deformation was found to be 155 +/- 27 nm (Figure 68) and, following 
MUC1 gene silencing the average deformation measurement was calculated to be 175.0 
+/- 28.9nm (Figure 68). While this represented a 13% increase inter-region variation 
resulted in no significant change (p=0.1449). Figure 67D shows the spread of 
deformation across the 18 Hec-l-B areas, and average deformation was calculated to be
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163 +/- 25 nm (Figure 68). MUC1 gene silencing increased the average deformation 
measurement to 164.7 +/- 25.4nm. This resulted in no significant change in deformation 
as a result of MUC1 gene silencing (p=0.9145).
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Figure 66: Panel of Hec-l-B monolayer images following treatment with MUC1 
siRNA: B1T-B9T. Hec-l-B cell monolayers were grown until 60% confluent, treated 
with MUC1 siRNA for 48hrs and imaged live in media. (B1T-B9T) Bank of images used 
for extraction of nano-mechanical data.
Adhesion measurements were recorded from all nine untreated Hec-l-A areas (Figure 
67E) and average adhesion was 148 +/- 19 pN (Figure 68). MUC1 knockdown reduced 
the average adhesion measurement to 116.9 +/- 23.9 pN (Figure 68). This represented a 
significant 21% reduction in adhesion (p=0.0071). Adhesion readings were taken from 
18 Hec-l-B areas (Figure 67F) and average adhesion of control areas was 271 +/- 35 pN 
(Figure 68). MUC1 gene silencing reduced average adhesion measurement in all areas 
and the combined average was calculated to be 118 +/- 19.3pN (Figure 68). This 
represented a 56% reduction in adhesion and was highly significant (P= 0.0000).
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Figure 67: MUC1 gene silencing is able to affect surface nano-mechanical properties of 
EEC cell lines. Quantitative mapping of Hec-l-A (blue) and Hec-l-B (red) cell 
monolayers was undertaken to determine nano-mechanical properties following MUC1 
siRNA treatment. Moreover, each region was subjected to HSDC for offline calculation 
of membrane stiffness using the sneddon variation. For each cell line nine areas were 
subjected to specific MUC1 siRNA treatment (purple bars) and nine areas with 
scrambled siRNA control (blue/red bars depending on cell line). Each treatment group 
comprised approximately nine areas from three biological repeats. Subsequent post 
processing made use of bearing analysis within Nanoscope software to compute 
adhesion and deformation. Stiffness was derived from HSDC files using RAINBOW 
software (Bruker-nano). Graphs show the stiffness (A+B), adhesion (C+D) and 
deformation (E+F) of Hec-l-A (blue bars) and Hec-l-B (red bars) respectively. 
Treatment refers to specific MUC1 siRNA and control is untreated cells.
MUC1 reduction from the monolayer resulted in no statistical change to deformation or 
membrane stiffness but a statistically significant decrease in adhesion in the two cell 
lines. Following treatment the Hec-l-B cells showed a greater reduction in adhesion 
when compared to Hec-l-A. This corresponded to a greater loss of MUC1 protein
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across the Hec-l-B monolayer compared to Hec-IA, thus providing further support for 
a link between MUC1 protein and adhesion. This result shows for the first time the 
significant contribution MUC1 protein makes to the adhesive status of apical cell 
surfaces in two endometrial cell models.
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Figure 68: MUC1 gene silencing reduces adhesion in Hec-l-A and Hec-l-B cell 
monolayer. Hec-1 cells were treated with MUC1 specific siRNA and quantitatively 
mapped with PFQNM. Hec-l-A and Hec-l-B MUC1 siRNA treated monolayers (purple 
bars) were compared to scrambled siRNA control monolayers (blue and red bars 
respectively). Stiffness, adhesion and deformation mapped from nine regions of the 
monolayer and compiled here. ± STDEV from triplicate nine areas. Data was analysed 
using a two-tailed Student’s T-test *p<0.05, **p<0.01, ***p<0.001.
4.4 Discussion
In this chapter a thorough interrogation of the nano-mechanical status of two EEC cell 
lines was undertaken. Excitingly, it was revealed that MUC1 protein has a significant 
role regarding the functional adhesive status of the apical epithelium. The adhesive 
contribution was shown to be independent of two other biophysical properties; stiffness 
and deformation. The functional approach taken facilitated novel assessment of 
endometrial biomechanics and the role played by MUC1. The expression of MUC1 can 
be directly correlated with the biophysical state of these cell monolayers. The adhesive 
effect of MUC1 protein has been quantified, and a direct correlation between MUC1 
and adhesion established.
Comparison of fixed and live monolayers provided a unique opportunity to assess the 
effect of fixation on endometrial epithelial cell bio-mechanics. Previous examination of 
endometrial cells within our group had made use of highly optimized glutaraldehyde
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fixation procedures (Francis et al. 2010) to investigate correlations between MUC1 
expression on the apical membrane and surface roughness (Francis et al. 2009).
Figure 69: Hec-l-A endometrial epithelial cells phase imaged using PFT AFM. (A) 
Following fixation membrane appears stable and nano-scale structures are readily 
observed (B) When imaged live in media the membrane appears to undulate as a 
response to tip indentation (Resolution: 512 samples/line).
The direct comparison between live and fixed cell monolayers demonstrates that, as 
would be expected, artificial fixation alters the monolayer biophysical properties. 
However, despite this, the trends observed in the biophysical properties of these cells 
were unaffected using our fixation process. Following fixation, membrane stiffness 
increased by up to 21% and membrane deformation increased by up to 18%. Adhesion, 
central to our investigation, was reduced 21%. In the fixed cell system Hec-l-B was 
1.57x more adhesive than Hec-l-A compared to 1.84x more at near physiological 
conditions. It is plausible that adhesion is dampened due to a loss of adhesion protein 
function as other components of the apical membrane (carbohydrates, lipids, nucleic 
acids) are thought to be trapped in a matrix of cross-linked proteins, thus also providing 
rationale for the increases in stiffness that was observed.
PFQNM was used to explore adhesion, deformation, energy dissipation and stiffness of 
EEC cell monolayers and to correlate any changes in these properties to epithelial 
mucins. Surface deformation results from tip sample interaction and has been shown to 
be related to energy dissipation (Zhang et al. 2013). The experiments in this chapter 
revealed that deformation did not differ significantly between Hec-l-A (190nm) and 
Hec-l-B (178nm) independent of MUC1 levels at the cell surface. This suggests that
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surface protein expression does not influence the membrane deformation. It is likely 
that sub-membranous structures such as the cytoskeleton, actin filaments, organelles 
and microtubules could account for changes to membrane deformation caused by the 
tip, and this is reported in the literature (Berquand et al. 2010). Moreover, the images 
revealed a strong association between cell height and deformation and the nuclear 
regions of cells in the monolayer consistently show higher deformation compared to the 
cell periphery. This was expected as the underlying influence of the stiffer substrate 
does not permit high deformation while the nucleus is subject to increased deformation 
(Yokokawa et al. 2008).
Cell stifthess is often selected as the property with which to investigate mechanical 
function in pathologies such as cancer (Weder et al. 2013) and osteoarthritis (Khan et al. 
2013) as cell stiffness directly impacts processes related to events such as cancer 
metastasis. In the endometrium monolayer stiffness may affect the interactions of the 
epithelial layer and the embryo. Stiffness was calculated using Sneddon model for 
elasticity which was selected because it accounts for the indentation of a tip featuring 
cone-shaped geometry, as opposed to hertz which considers a spherical model. 
Additionally, Sneddon considers short range forces acting within the contact area 
whereas hertz only considers long range surface forces acting outside the contact area. 
Membrane stiffness was very similar between live Hec-l-A (78.7KPa) and Hec-l-B 
(80.0KPa) and within the 13KPa-150KPa range reported by others (Weisenhom 1993). 
There is a difference of MUC1 and MUC16 expression between Hec-l-A and Hec-l-B 
but this does not appear to affect the stiffness of the membrane. This property is more 
likely to dependent on alterations to sub-membranous structures such as the 
cytoskeleton and not apical expression of membrane proteins (Wang et al. 2013). Being 
closely related to deformation, stiffness was also shown to correlate with cell height. 
Again the influence of the underlying substrate is clearly shown. Nuclear regions appear 
soft, while the cell periphery and especially cell junctions are very stiff. This effect is 
due to the underlying substrate and a consequence of the in vitro approach taken here. It 
would be revealing to measure the stiffness of epithelial layer in co-culture with stromal 
cells. In the context of implantation and invasion the stiffness of the epithelial 
monolayer is likely to be affected by embryo derived signaling as it seeks to invade 
through the epithelia into the stroma, although as yet there are no studies in this area.
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Evidence suggests that energy dissipation on cell surfacess is a primarily a result of 
frictional and viscous damping within the cell caused by cytoskeleton internal friction 
and actin de-polymerization (Smith et al. 2005). However, experiments here showed 
energy dissipation to be greater in Hec-l-B (3.8KeV) compared to Hec-l-A (2.7KeV). 
No differences in the deformation or stiffness of Hec-l-A and Hec-l-B were shown 
suggesting that the underlying cytoskeleton is not responsible for this trend, and the 
interaction of the tip with surface proteins could cause this mechanical dampening 
effect. In both cell types areas of high energy dissipation correlated with areas of high 
adhesion. Rupture of the adhesive bonds formed between the surface and the tip 
requires energy, which may explain why areas of high adhesion also exhibit high energy 
dissipation. Interestingly, energy dissipation was elevated at cell-cell junctions. When 
probing the cell boundary, the tip may be coming into contact with the lateral surface of 
the cell where other adhesive proteins are located, thus contributing towards increased 
energy dissipation. Additionally, it may be that area of contact with the cone-shaped tip 
increased due to surface relief in these regions. This may allow lateral forces to occur 
between the sides of the tip and the surface thus removing energy from the system, 
resulting in increased dissipation.
The MUC1 high expressing cell line, Hec-l-B had an average adhesion between the 
surface and the tip of 271pN compared to 148pN of the relatively low MUC1 expresser 
Hec-l-A. This represents an almost 2 fold difference in adhesion. Interestingly, this is a 
similar order of magnitude to the difference in MUC1 protein expression quantified 
across the same Hec-l-A and Hec-l-B monolayers. Protein expression across Hec-l-B 
and Hec-l-A monolayers was quantified by fluorescence as 196AU to 46AU 
respectively. The similarity in MUC1 expression and adhesion between Hec-l-A and 
Hec-l-B suggest there may be a close link between MUC1 expression and adhesion in 
the endometrial cell lines. When MUC1 siRNA was introduced to the Hec-l-A 
monolayer MUC1 protein expression was shown to decrease 22% and adhesion 
decreased by 21%. Following the same treatment in Hec-l-B cell monolayers MUC1 
protein expression was shown to decrease 53% while adhesion decreased by 56%. The 
specificity afforded by siRNA dictates that only MUC1 mRNA was targeted, thus 
translation of MUC1 transcript is blocked while expression of other surface proteins is 
unaffected. These findings further support the suggestion that MUC1 ectodomain is a 
major component of adhesion in Hec-l-A and Hec-l-B endometrial epithelial cells.
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There was a degree of intra-monolayer variation in the adhesion across individual areas 
imaged with the AFM and this again corresponds to fluorescence observation of 
heterogeneous MUC1 patterning. However, even considering normalization of the 
observed trends by intra-monolayer variation the differences in adhesion were still 
significant.
Whilst some reports have suggested that MUC1 has an anti-adhesive function the data 
presented here suggests, that in the context of indentation with an AFM tip, MUC1 is 
highly adhesive. Our data also demonstrates that endometrial mucins, and in particular 
MUC1, contribute significantly to an AML covering endometrial cells that could 
potentially trap the embryo allowing specific molecular recognition to occur. A 
suggested mechanism for this process is the L-selectin/sLex interaction which the 
following chapter explores in detail.
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5.1 Introduction
The focus of this chapter was to adapt AFM to investigate the distinct molecular 
interactions that are believed to occur during the initial stages of embryo implantation, 
the hypothesis being that an intimate biochemical and biophysical understanding, and 
quantification of such interactions can be significantly enhanced using single molecule 
force spectroscopy alongside well characterised endometrial epithelial live cell models. 
The specific adhesion which occurs between MUC1 and L-selectin is assessed at the 
nanoscale in this chapter.
Single molecule force spectroscopy (SMFS) has emerged as a technique able to 
quantify the interactions and mechanisms of molecular interactions contributing to the 
correct functioning of cellular systems (Hinterdorfer & Dufrene 2006; Muller 2008). 
Some SMFS bio-applications characterize the interaction of proteins localised to 
artificial bio-molecular systems such as membrane rafts or purified proteins (Xu et al. 
2013). Such in vitro experiments are limited in their scope because they characterise 
biomolecules that are removed from the cellular context. Deciphering how cells control 
bio-molecular interactions in such a highly complex and dynamic environment requires 
transferring SMFS to the living cell. During live cell experiments a ligand 
functionalised AFM tip is brought into contact with the cell surface allowing molecular 
bond formation. The tip is then retracted and as the tip separates from the cell 
membrane the bio-molecules first enter a stretched configuration and, if further 
mechanical stress is then applied, elongate (proteins may unfold during this stage) and 
then separate. If the tip is functionalised with a receptor and its ligand localised to the 
substrate, then ligand binding can be investigated (Muller 2009) (Figure 70A).
The sensitivity of the AFM allows quantification of nanonewton (10_9N, nN) or even 
piconewton (10'12N, pN) forces resulting from bio-molecular bond separation. These 
forces range from pN for example DNA binding proteins (Lee et al. 2012) to several nN 
as in the case of streptavidin-biotin bonds (Lee et al. 1994). In order to probe such bio- 
molecular interactions a cantilever with a spring constant O.OlN/m-O.IN/m must be 
used as this is sufficiently stiff to resist the inter-molecular and intra-molecular forces 
resulting from these bio-molecular interactions.
The cantilever and linker molecule pairing may be considered as an elastic element and 
thus obey Hooke’s Law. Hooke’s law states that force (F) needed to extend or compress
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a spring by some distance (x) is proportional to that distance where (&) is a constant 
factor characteristic of the spring, its stiffness.
Hooke’s Law: F = kx
The ligand-receptor bond can also be modelled as an elastic element which is generally 
stiffer than the AFM cantilever. This bound arrangement results in two elastic elements 
arranged in series. Hooke’s law dictates that as the cantilever is withdrawn, distance x 
increases and thus force (F) also increases. Force may be considered as the change in 
potential energy (U) over a change in position (x).
Force and potential energy: F =  6U/Sx
When the potential energy in the system exceeds the local maximum the bond will 
break (Figure 7OB).
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Figure 70: The separation of Ligand Receptor pairs. Single molecule force 
spectroscopy of L-selectin and ligands on endometrial cells. (A) Graphical 
representation of an AFM tip functionalised with L-selectin protein. A laser dot 
reflected off the back of the cantilever records deflection. The tip is driven into the 
endometrial cell where it remains stationary for 100ms. If intermolecular bonding 
occurs between the tip and the surface then potential energy is required to separate 
molecular bonds when the tip is withdrawn. (B) Diagrammatical representation of the 
AFM cantilever and linker molecule which act as an elastic element obeying Hooke’s 
law as force is applied to the system (C) This force is recorded as a change in laser 
deflection and is visualised as a curve of force against distance. The large change of 
deflection is the separation of an intermolecular bond.
The bond rupture event may be characterised by the distance that it occurs from the 
contact point, or by the force required for separation, and a field of research analysing 
retraction force curves and modelling bond ruptures has developed (Noy 2011). 
Specialised software packages to analyse rupture events on force curves such as 
PUNAIS, OpenFovea, and JPK data processing have been developed, with varying 
success. After consideration of the above software packages, JPK data processing was 
chosen to analyse force curves for bond rupture events. The “step-fitting” feature native 
to this platform detects and characterises bond rupture events as “steps”. The software is 
able to distinguish between curves with one or more steps (Figure 71 A) and curves that 
are negative for steps (Figure 7IB). The algorithm highlights the step with a vertical 
line and records the position (pm) and step height (pN-nN) for every step detected on 
the force curve. After analysis has finished the data on all recorded steps can be 
exported for post-processing using spread-sheet software (Excel).
The force required for separation of ligand-receptor bonds pairs is dependent firstly on 
the method by which the ligand is attached onto the AFM tip, and secondly the velocity 
that the tip is withdrawn, referred to as bond loading (Evans 2001; Evans et al. 1995). 
This has been demonstrated in the case of the sLex-L-selectin bond using polyethylene 
glycol (PEG) linkers (Evans et al. 2001).
The approach taken here was to utilise a rigid linker strategy using glutaraldehyde (Li et 
al. 2011). Silicon nitride [Si2N3] probes are washed and silanization with (3- 
Aminopropyl)triethoxysilane [H2N(CH2 )3 Si(OC2Hs)3 ] (Silberzan 1991) (Figure 72A).
150
Chapter 5 Force Spectroscopy analysis o f MUC1 and L-selectin
B
!
I
I
Step identified
•oj oo i K h i l  -yn\
No step identified
|  Stp*£JftC« * 1 '
o  * ow, ^ a* ct
* -  O M iF lto ^ e flln n v *
r*m1 If* W
O " O’*. 9»C»
* - Cm.
x  wv.iin-.fl
5 MSx#i«*o*s»u 
-  u.< i n w j r
Figure 71: JPK data processing can identify steps on the retraction part of the force 
curve. User controlled parameters can set a maximum and minimum height within 
which the software will search for steps. The curves are smoothed before step analysis 
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151
Chapter 5 Force Spectroscopy analysis of MUC1 and L-selectin
The silanization approach offers the advantage that the probe can be functionalized 
directly without other prior surface preparation. This results in Si-O-Si covalent bonds 
between the tip and silane molecules, and hydrogen bonding interactions between the 
aliphatic chains of the silane molecules. The reactive NH2  group is used for the next 
step of the functionalization. The probes are now treated with giutaraidehyde 
[CH2 (CH2 CHO)2 ] which reacts with the free NH2  group and releases one molecule of 
water (Migneault et al. 2004) (Figure 72B).
The tips are then exposed to the desired ligand which binds to the remaining free end of 
the giutaraidehyde molecule releasing H2 O. This completes the cross linking reaction.
In this study DNP-10 tips were functionalised with monoclonal antibody and a 
recombinant peptide. The MUC1 VU4H5 antibody (Santa Cruz Biotechnology #sc- 
7313) is a mouse monoclonal raised against the naked peptide VNTR region located in 
the extracellular (ND) domain of MUC1.
In order to probe the surface for L-selectin ligands, tips were coated with recombinant 
L-selectin (Randox Life Sciences # RCP9253) consisting of a 294 amino acid fragment 
(aa39-332) corresponding to the mature and fully functional L-selectin extracellular 
domain. This extracellular region contains the lectin domain required for binding to 
sialyl lewis x (sLex) epitopes present on endometrial epithelium. AFM tips were coated 
in anti-MUCl and L-selectin at 200pg/ml to ensure the tip density was comparative 
between to two functionalization molecules.
The molecular interactions at the embryo-maternal interface during the period of 
blastocyst adhesion are not yet fully understood continuing biochemical studies (Koot et 
al. 2012; Salilew-Wondim et al. 2012; Garrido-Gomez et al. 2013; Dharmaraj et al. 
2013; Cheong et al. 2013). AFM probes were functionalised with recombinant L- 
selectin protein to allow probing of a cell monolayer for potential L-selectin ligands, 
such as sLex which has been shown to associate with MUC1 in Hec-l-A and Hec-l-B 
cells (Hey & Aplin 1996). The approach taken was to complement trophoblast spheroid 
attachment assays by assessing, at the molecular level, the involvement of embryo 
adhesion molecules, and characterising the number and strength of interactions with 
their representative ligands located on endometrial epithelial cell monolayers.
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L-selectin and sLex interactions have parallels in other systems (Dominguez et al. 
2005), and L-selectin and sLex antigen are up-regulated during the window of 
implantation. Additionally, it has been shown that disruption of the MUC1 and sLex 
correlates with PCOS and endometriosis (Margarit et al. 2010; Margarit et al. 2009). It 
is very likely that glycosylation is a requisite for MUC1 function at the endometrial 
surface in embryo recognition. Decoration of MUC1 with sLex is dependent on the 
VNTR region, and requires a host of glycosyltransferase enzymes (Tjew et al. 2005) 
that generate the sLex ligands that have been associated with MUC1 in these cell lines. 
These factors add additional regulatory control to the process through which MUC1 
may present ligands to the embryo (Figure 73).
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Figure 73: MUC1 may act as a scaffold for L-selectin ligands and present them to the 
approaching embryo. (A) MUC1 has a large extracellular domain (ND) that extends 
around 250-500nm into the lumen. The VNTR region of MUC1 consists of 20-125 
repeats of the amino acid sequence GVTSAPDTRPAPGS. MUC1 also has an 
intracellular domain (CD) and sites for enzymatic cleavage (SEA). (B) MUC1 presents 
sLex epitopes to the calcium dependent lectin domain of L-selectin, the affinity between 
these regions may assist in tethering the embryo to the uterine surface.
The main objective of this chapter was to evaluate the distribution, localisation and 
force properties of the MUC1 protein and L-selectin ligands presenting on the 
endometrial epithelial cell surface. The secondary objective was to investigate whether 
L-selectin binding was related to MUC1 surface expression. AFM tips were 
functionalised with MUC1 antibody in order to investigate surface binding in Hec-l-A 
and Hec-l-B cells. MUC1 knock down allowed examination of the functional effect on 
L-selectin binding in the model cell lines thus testing the hypothesis that MUC1 
presents ligands to the embryo.
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5.2 Results
5.21 AFM operation
The JPK Nanowizard II AFM was operated in force spectroscopy mode and a 2x2pm 
region of the cell was probed. The cantilever was ramped 5mm from the cell surface, to 
ensure clearance between the tip and the cell glycocalyx upon retraction, and ensure any 
molecular binding between endometrial ligands and antibody (or L-selectin) on the tip 
occurred on the approach (Tsapikouni & Missirlis 2011). Resolution was initially 32x32 
resulting in 1024 force curves per area but this was reduced to 16x16 resulting in 256 
force curves per area. A retraction delay of 100ms (Sulchek et al. 2005) allowed the tip 
to rest on the surface and facilitating bond formation. In this chapter ‘area’ refers to a 
2 pm2 region of cell surface selected at random for force mapping.
5.22 Rupture analysis
Force volume files were analysed using the JPK Data Processing software package. 
This involved a semi-automated curve by curve analysis of each force volume file. 
Steps were detected and characterised using a pre-programmed algorithm. Force curves 
were subjected to visual quality control by an operator and excluded if they did not meet 
certain criteria of a flat baseline, low noise and a return to baseline (i.e complete 
separation of tip and sample) to prevent false positives resulting from electrical noise. 
The location and number of steps were visualised using 2D maps generated in JPK data 
processing. The spread of rupture forces (step size) was recorded and the distribution 
plotted in histogram format. The bond strength between L-selectin and any potential 
ligands on the endometrial surface is interesting in the context of embryo adhesion 
because a smaller number of high affinity bonds might be required for embryo adhesion 
to the uterine wall. These experiments sought to investigate the potential role of L- 
selectin and MUC1 in embryo adhesion.
5.23 Functional characterisation of MUC1 at the endometrial surface
MUC1 is up-regulated by progesterone in secretory phase endometrium but human in
vitro models suggest localised MUC1 removal by embryo derived factors is a requisite 
for implantation (Meseguer et al. 2001). However, the interaction between endometrial 
MUC1 and the trophoblast expressed adhesion mediator L-selectin has yet to be 
determined.
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5.231 Rupture event identification
Before functionally characterising MUC1 expression, the Hec-l-A and Hec-l-B cells 
were force mapped using DNP-10 tips functionalised with GAPDH antibody. As the 
cell surface is devoid of GAPDH this experiment served as a negative control for 
surface binding. Three areas across the monolayer were selected at random from both 
cell types (A-F). Out of a total of 768 force curves from 3 areas just 4 step featuring 
curves were detected representing a 0.65% of all curves. When probing Hec-l-B there 
were just 16 out of 786 curves with steps, representing a 2.6% positive ratio. These 
experiments characterised the null-binding model and established confidence that the 
functionalization strategy and “step-fitting” parameters would not induce false 
positives.
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Figure 74: Detection, localization and rupture analysis of single GAPDH molecules on 
endometrial Hec-l-A and Hec-l-B cells using SMFS. (A-F) Maps showing number of 
steps on each force curve (2pm x 2pm) recorded with a GAPDH probe on living Hec-1- 
A (maps A-C) and Hec-l-B (maps D-F) cells. Steps (coloured pixels) were detected 
using JPK data processing software and colour scaled according to occurrence 1-10+. 
(G) Percentage of force curves considered positive [>1 steps] or negative [<1 steps], 
data from all measured areas (n=3). (H-I) Distribution of step sizes measured on Hec-1- 
A and Hec-l-B respectively for all measured areas (n=3). (J) Example force curves with 
no steps. 3 areas (A-C,D-F) are shown from each experiment. Extracted data (G-I) from 
3 areas (786 force curves).
156
Chapter 5 Force Spectroscopy analysis of MUC1 and L-selectin
5.232 MUC1 at the endometrial surface
Five areas of Hec-l-A and five areas of Hec-l-B were mapped resulting in 1280 force 
curves per cell line (5 x 256FC) (A-F). Hec-l-A was force mapped and 324/1280 force 
curves were positive for one or more steps, representing 25% of the total curves for this 
data set. Hec-l-B displayed increased MUC1 binding resulting in 538/1280 curves 
displaying steps (42% of total curves). This was consistent with data from chapter 3 
showing MUC1 expression is higher in Hec-l-B than Hec-l-A. Hec-l-B is likely to 
present higher levels of MUC1 molecules at the surface explaining the increased 
binding.
The step size required for tip sample separation on Hec-l-A cell lines was between 100- 
200pN, whereas most steps occurring on Hec-l-B derived force curves were in the 200- 
300pN range (H+I).
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Figure 75: Detection, localization and rupture analysis of single MUC1-Antibody bonds 
on Hec-l-A and Hec-l-B cell monolayers using SMFS. (A-F) Maps showing number of 
steps on each force curve (2pm x 2pm) recorded with a MUC1 antibody probe on living 
Hec-l-A (maps A-C) and Hec-l-B (maps D-F) cells. Steps (coloured pixels) were 
detected using JPK data processing software and colour scaled according to occurrence 
(1-10+). (G) Percentage of force curves considered positive [>1 event] or negative [<1 
event], data from all measured areas n=10. (H-I) Distribution of step size measured on 
all Hec-l-A (n=5) and Hec-l-B (n=5) areas respectively. (J) Example force curves with 
no steps. (K) Example force curves with detectable steps. 3 representative areas (A-
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C,D-F) are shown from each cell type. Extracted data (G-I) from 5 areas (1280 force 
curves). Blue and red bars represent Hec-l-A and Hec-l-B respectively
Taken together these results demonstrate that the AFM probe is able to quantify and 
spatially map the distribution of MUC1 protein across the endometrial cell monolayer. 
When probing the surface with anti-MUCl the percentage of total force curves with 
steps was 25% and 42% in Hec-l-A and Hec-l-B respectively, compared to the 0.65% 
and 2.6% in the negative control.
In order to directly correlate any change in surface binding due to MUC1 surface 
expression, Hec-l-B cells were treated with siRNA treatments to knockdown MUC1. 
Force mapping was conducted on five 2 pm areas from each treatment group using anti- 
MUCl mAb tips, and step frequency was found to be decreased following reduction of 
MUC1 protein. The number of curves positive for one or more steps fell from 361/1280 
to 81/1280, a change from 28% to 6% of the total curves (G). There was similarity 
between numbers of positive curves recorded on untreated basal Hec-l-B 0  (324/1280) 
and Hec-l-B treated with control siRNA () (361/1280) demonstrating there was no 
negative effect on surface binding as a result of the lipofectamine transfection vehicle or 
control siRNA and therefore that the observed measurements could be attributed to the 
loss of MUC1. In the control samples step size was mainly between 200-300pN, while a 
small number of steps were shown to be between 200-600pN in size (H). Large bond 
rupture forces may result from the breaking of multiple MUC1-antibody bonds, given 
that multiple binding is less likely the occurrence of such events would be infrequent. 
The data clearly shows a decrease in steps occurring at higher forces; 200-300pN (305 
steps) 300-400pN (61 steps) 400-500pN (13 steps) and 500-600pN (4 steps). With each 
lOOpN increment, the number of detected steps decreased. Reduction of MUC1 
expression resulted in a loss of surface associations greater than 200pN in strength, but 
binding did remain in the 100-200pN range (I).
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Figure 76: Detection, localization and rupture analysis of single MUC1 molecules on 
endometrial Hec-l-B cells following siRNA treatment using SMFS. Force Imaging 
living Hec-l-B cells using single-molecule AFM. (A-F) Maps showing number of steps 
on each force curve (2pm x 2pm) recorded with a MUC1 antibody probe. (A-C) 
Scrambled siRNA treatment. (D-F) Specific MUC1 siRNA treatment. Steps (bright 
pixels) were detected using JPK data processing software are colour scaled according to 
occurrence. (G) Percentage of force curves considered positive [>1 step] or negative [<1 
step], data from all measured areas n=10. (H-I) Distribution of step size measured on 
scrambled siRNA and MUC1 siRNA respectively. 3 representative areas (A-C,D-F) are 
shown from each treatment. Extracted data (G-I) from 5 areas (1280 force curves)
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5.24 Functional characterisation of L-selectin ligands at the endometrial surface
Steps were fitted to retraction curves using the JPK “step fitting” program. Within the 
parameters of the software the significance value of lx l O'4 dictates that that there is less 
than 1/1000 chance the identified steps are the results of noise. As the bond strength of 
the L-selectin binding that may characterises the initial tethering between the embryo 
and the uterine epithelium is not known, it cannot be used to identify the bond here, 
rather these experiments rely on the step fitting algorithm to clearly differentiate steps 
from background noise to a high degree of probability. If the probe is calibrated by 
ramping into a hard surface and calculating Dsens then the size of the steps is fully 
quantitative and may identify a characteristic L-selectin binding event. Here we use 
SMFS to quantify the interaction between L-selectin and the endometrial epithelium and 
investigate the effect on this interaction following loss of MUC1. Nine 2pm2 areas of 
Hec-l-A monolayer were selected at random for force mapping, three areas from each 
of the three biological repeats (Figure 77A-I). Out of 2304 force curves only 219 were 
positive for step(s), representing a 9% of the total curves (Figure 77J). Step size was in 
the 300-400pN range, although significant numbers of steps did occur between 100- 
600pN (Figure 77K). Percentages of curves positive for step(s) and step size were 
plotted for each area in order to examine variation between areas (Figure 77L-M). 
Average step size across areas 1-9 were between 97-301pN (Figure 77L). With the 
exception of area 1 (which had only 1 bond rupture) the average step size across all 
remaining areas was between 200pN and 301pN (Figure 77L).
The rupture force required for separation of L-selectin and its ligands on the 
endometrial surface of Hec-l-A did not show great variation between cells and suggests 
a characteristic interaction (Figure 77). These data suggest that the representative bond 
strength between L-selectin and a ligand expressed on Hec-l-A is between 200-300pN.
The number of steps in 2 areas (Figure 77H+I), was elevated relative to the other 7 areas 
(Figure 77A-G). Analysis of area H resulted in 25% curves with steps and area I, 17% 
of curves with steps, these figures represented 4.87 fold and 2.86 fold increases in step 
frequency compared to the remaining 7 areas which averaged 6%. This suggests that 
certain cells across the Hec-l-A monolayer have increased affinity for L-selectin, 
possibly through expression of L-selectin ligands leading to the notion of an 
endometrial monolayer with regions of high L-selectin affinity. This corresponds to the 
observation that MUC1 is expressed in a heterogeneous pattern of across the
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endometrial monolayer (Chapter 3), and with the HCS data that showed approximately 
7.5% of Hec-l-A cells expressed high MUC1 protein relative to the rest of the 
monolayer. As MUC1 is able to host sLex moieties required for L-selectin binding it is 
plausible to suggest that increased MUC1 in certain cells accounts for the increased 
frequency of L-selectin binding. These experiments show for the first time a functional 
difference between areas of the live endometrial monolayer in terms of frequency of L- 
selectin binding, which could be related to MUC1 expression patterning on this tissue.
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Figure 77: Detection, localization and rupture analysis of L-selectin ligands on 
endometrial Flee-1-A cells using SMFS. (A-I) Maps showing number of steps on each 
force curve (2pm x 2pm) of Hec-l-A cell surface recorded with a L-selectin 
functionalised probe. Steps (coloured pixels) were detected using JPK data processing
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software are colour scaled according to occurrence (0-10+). (J) Percentage of force 
curves considered positive [>1 step] or negative [<1 step], data from all measured areas 
(n=9). (K) Distribution of step size, compiled data from all measured areas (n=9). (L) 
Average step size from steps on areas 1-9. (M) Percentage of total curves featuring 1 or 
more steps on areas 1-9. (N) Example of no step force curves. (O) Examples of force 
curves showing a step. Extracted data (J-M) from nine areas (2304 force curves). Blue 
bars indicate Hec-l-A cell line.
The Hec-l-B cell line is a high expressing model for MUC1 protein. In order to 
investigate whether elevated MUC1 expression in Hec-l-B resulted in increased or 
decreased L-selectin binding efficiency, it was also probed with L-selectin 
functionalised tips. Step fitting analysis detected steps on 239/2304 force curves, 
representing 10% of the total (Figure 79: Detection, localization and rupture analysis of 
L-selectin ligands on endometrial Hec-l-A cells treated with MUC1 siRNA using 
SMFS. (A-F) Maps showing number of steps on each force curve (2pm x 2pm) of Hec- 
l-A cell surface recorded with a L-selectin functionalised probe. Steps (coloured pixels) 
were detected using JPK data processing software are colour scaled according to 
occurrence (0-10+). (G) Percentage of force curves considered positive [>1 step] or 
negative [<1 step], data from all measured areas (n=9). Purple bars indicated MUC1 
siRNA treatment.
J). Step sizes were mainly in the 300-400pN range, although steps did occur across the 
whole 100-600pN spectrum (Figure 79: Detection, localization and rupture analysis of 
L-selectin ligands on endometrial Hec-l-A cells treated with MUC1 siRNA using 
SMFS. (A-F) Maps showing number of steps on each force curve (2pm x 2pm) of Hec- 
l-A cell surface recorded with a L-selectin functionalised probe. Steps (coloured pixels) 
were detected using JPK data processing software are colour scaled according to 
occurrence (0-10+). (G) Percentage of force curves considered positive [>1 step] or 
negative [<1 step], data from all measured areas (n=9). Purple bars indicated MUC1 
siRNA treatment.
K). When compared, the number of force curves displaying L-selectin surface binding 
on Hec-l-A (219/2304, 9% of total) and Hec-l-B (239/2304, 10% of total) monolayers 
are both similar. This suggests that affinity for L-selectin is not totally dependent on 
absolute MUC1 expression levels (as Hec-l-B is a much higher expresser), it may be 
that variations in MUC1 structure such as the VNTR length or glycosylation status 
could influence L-selectin binding. Additionally, step size analysis showed a very
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similar distribution of L-selectin rupture forces between both cell types (Figure 77K and 
Figure 79: Detection, localization and rupture analysis of L-selectin ligands on 
endometrial Hec-l-A cells treated with MUC1 siRNA using SMFS. (A-F) Maps 
showing number of steps on each force curve (2pm x 2pm) of Hec-l-A cell surface 
recorded with a L-selectin functionalised probe. Steps (coloured pixels) were detected 
using JPK data processing software are colour scaled according to occurrence (0-10+). 
(G) Percentage of force curves considered positive [>1 step] or negative [<1 step], data 
from all measured areas (n=9). Purple bars indicated MUC1 siRNA treatment.
K) with the most commonly occurring step size being 300-400pN. This result further 
supported the idea that total MUC1 expression does not regulate the binding of L- 
selectin to the uterine epithelium. Whilst there were fewer steps detected when probing 
with L-selectin relative to MUC1 mAb, there were more than detected with the GAPDH 
mAb negative control (), which suggests a ligand for L-selectin was present at the 
surface of Hec-l-A and Hec-l-B.
Hec-l-B cells were then analysed across nine areas to assess for variation across the 
monolayer. Two areas (Figure 79: Detection, localization and rupture analysis of L- 
selectin ligands on endometrial Hec-l-A cells treated with MUC1 siRNA using SMFS. 
(A-F) Maps showing number of steps on each force curve (2pm x 2pm) of Hec-l-A cell 
surface recorded with a L-selectin functionalised probe. Steps (coloured pixels) were 
detected using JPK data processing software are colour scaled according to occurrence 
(0-10+). (G) Percentage of force curves considered positive [>1 step] or negative [<1 
step], data from all measured areas (n=9). Purple bars indicated MUC1 siRNA 
treatment.
H+I) displayed elevated average step size when compared to the other 7 areas (Figure 
79: Detection, localization and rupture analysis of L-selectin ligands on endometrial 
Hec-l-A cells treated with MUC1 siRNA using SMFS. (A-F) Maps showing number of 
steps on each force curve (2pm x 2pm) of Hec-l-A cell surface recorded with a L- 
selectin functionalised probe. Steps (coloured pixels) were detected using JPK data 
processing software are colour scaled according to occurrence (0-10+). (G) Percentage 
of force curves considered positive [>1 step] or negative [<1 step], data from all 
measured areas (n=9). Purple bars indicated MUC1 siRNA treatment.
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L). The combined average step size from L-selectin-ligand separation occurring over the 
first 7 areas was 154pN, while area H averaged 410pN, a 2.65 fold increase when 
compared to the first 7 areas. The second anomalous area, I, displayed average step size 
of 873pN, a 5.63 fold increase compared to the first 7 areas. These areas with large step 
sizes also displayed increased numbers of steps occurring across the 2 pm2 region. When 
combined, the first 7 areas had low numbers of curves featuring steps (5% of the total) 
while areas H+I showed increased frequency of these curves (15% and 39% of all 
curves from these areas) representing a 2.82 fold and 7.01 fold increases in numbers of
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with one or more steps respectively.
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Figure 78: Detection, localization and rupture analysis of L-selectin ligands on 
endometrial Hec-l-B cells using SMFS. (A-I) Maps showing number of steps on each 
force curve (2pm x 2pm) of Hec-l-B cell surface recorded with a L-selectin 
functionalised probe. Steps (coloured pixels) were detected using JPK data processing 
software are colour scaled according to occurrence (0-10+). (J) Percentage of force 
curves considered positive [>1 step] or negative [<1 step], data from all measured areas
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(n=9). (K) Distribution of step sizes, compiled data from all measured areas (n=9). (L) 
Average step size from events on areas 1-9. (M) Percentage of total curves featuring 1 
or more steps on areas 1-9. (N) Examples of force curves featuring steps from area (H). 
(O) Subset of force curves from area (I). Extracted data (J-M) from nine areas (2304 
force curves). Red bars indicate Hec-l-B cell line.
Certain Hec-l-B cells had an increased number of surface binding events (steps) and the 
force require for bond separation of these bonds (step size) was elevated in these cells 
(Figure 79: Detection, localization and rupture analysis of L-selectin ligands on 
endometrial Hec-l-A cells treated with MUC1 siRNA using SMFS. (A-F) Maps 
showing number of steps on each force curve (2pm x 2pm) of Hec-l-A cell surface 
recorded with a L-selectin functionalised probe. Steps (coloured pixels) were detected 
using JPK data processing software are colour scaled according to occurrence (0-10+). 
(G) Percentage of force curves considered positive [>1 step] or negative [<1 step], data 
from all measured areas (n=9). Purple bars indicated MUC1 siRNA treatment.
L+M). In contrast the variation of steps across Hec-l-A cell monolayers was limited to 
number only and the force required to break these bonds was more consistent across 
each area (Figure 77L+M).
These results document a second example of inter-monolayer heterogeneity of L- 
selectin binding to the cell surface in an endometrial in vitro model. Some regions of 
monolayer displayed high-strength bonds requiring large rupture forces for separation 
(Figure 79: Detection, localization and rupture analysis of L-selectin ligands on 
endometrial Hec-l-A cells treated with MUC1 siRNA using SMFS. (A-F) Maps 
showing number of steps on each force curve (2pm x 2pm) of Hec-l-A cell surface 
recorded with a L-selectin functionalised probe. Steps (coloured pixels) were detected 
using JPK data processing software are colour scaled according to occurrence (0-10+). 
(G) Percentage of force curves considered positive [>1 step] or negative [<1 step], data 
from all measured areas (n=9). Purple bars indicated MUC1 siRNA treatment.
N+O), which were up to 4nN in extreme cases (Figure 79: Detection, localization and 
rupture analysis of L-selectin ligands on endometrial Hec-l-A cells treated with MUC1 
siRNA using SMFS. (A-F) Maps showing number of steps on each force curve (2pm x 
2pm) of Hec-l-A cell surface recorded with a L-selectin functionalised probe. Steps 
(coloured pixels) were detected using JPK data processing software are colour scaled 
according to occurrence (0-10+). (G) Percentage of force curves considered positive [>1
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step] or negative [<1 step], data from all measured areas (n=9). Purple bars indicated 
MUC1 siRNA treatment.
O). Within the context of the endometrial cell line model, the cells that exhibit increased 
frequency of high-strength interactions could have significantly increased affinity for L- 
selectin (and therefore the embryo). It is possible that these cells express significantly 
increased MUC1 but that MUC1 must be appropriately decorated with the correct 
carbohydrate moieties to allow L-selectin to bind.
Force curves from this data set suggest the extracellular domain of L-selectin is able to 
bind to the surface of endometrial epithelial cells. However the variation in step 
frequency between Hec-l-A and Hec-l-B suggested that L-selectin recognition was not 
entirely dependent on levels of MUC1 expressed by cells. Hec-l-A and Hec-l-B cells 
were treated with MUC1 siRNA to reduce apical expression of the protein and the effect 
on L-selectin binding is further investigated.
Following MUC1 siRNA treatment six areas across the Hec-l-A monolayer (total 
curves: 3072) and eight areas across the Hec-l-B monolayer (total curves: 2816) were 
selected at random for force mapping with L-selectin functionalised tips ( and ). The 
curves were analysed using the “step-fitting” algorithm and steps were detected in only 
2% of total force curves following MUC1 knockdown, compared to 9% in untreated 
Hec-l-A areas. In Hec-l-B, steps were identified in 14% of the total curves, a slight 
increase when compared to 10% in the control. However, this increase may be the result 
of area (B) which displayed uncharacteristically high binding and could have affected 
the average (B), and could be a consequence of the heterogeneous monolayer. If area B 
is excluded from the analysis then the number of L-selectin curves is reduced to 3.5%.
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Figure 79: Detection, localization and rupture analysis of L-selectin ligands on 
endometrial Hec-l-A cells treated with MUC1 siRNA using SMFS. (A-F) Maps 
showing number of steps on each force curve (2pm x 2pm) of Hec-l-A cell surface 
recorded with a L-selectin functionalised probe. Steps (coloured pixels) were detected 
using JPK data processing software are colour scaled according to occurrence (0-10+). 
(G) Percentage of force curves considered positive [>1 step] or negative [<1 step], data 
from all measured areas (n=9). Purple bars indicated MUC1 siRNA treatment.
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Figure 80: Detection, localization and rupture analysis of L-selectin ligands on 
endometrial Hec-l-B cells treated with MUC1 siRNA using SMFS. (A-F) Maps 
showing number of steps on each force curve (2pm x 2pm) of Hec-l-B cell surface 
recorded with an L-selectin functionalised probe. Steps (coloured pixels) were detected 
using JPK data processing software are colour scaled according to occurrence (0-10+). 
(G) Percentage of force curves considered positive [>1 step] or negative [<1 step], data 
from all measured areas (n=9). Purple bars indicated MUC1 siRNA treatment.
The average step size for Hec-l-A and Hec-l-B monolayers was reduced following 
MUC1 knockdown (H and J), with most steps measuring 100-200pN, whereas step size
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was typically 300-400pN on untreated monolayers (Figure 77K and Figure 79: 
Detection, localization and rupture analysis of L-selectin ligands on endometrial Hec-1- 
A cells treated with MUC1 siRNA using SMFS. (A-F) Maps showing number of steps 
on each force curve (2pm x 2pm) of Hec-l-A cell surface recorded with a L-selectin 
functionalised probe. Steps (coloured pixels) were detected using JPK data processing 
software are colour scaled according to occurrence (0-10+). (G) Percentage of force 
curves considered positive [>1 step] or negative [<1 step], data from all measured areas 
(n=9). Purple bars indicated MUC1 siRNA treatment.
K). The reduction of MUC1 expression at the cell surface resulted in a corresponding 
reduction of L-selectin average rupture force (step size) and in a reduction of the 
number of ruptures (steps) detected in Hec-l-A and Hec-l-B cells. As L-selectin 
binding is mediated through sLex epitopes and MUC1 reduction decreases this binding 
in terms of strength and frequency it is plausible to suggest that these epitopes are 
hosted by MUC1, and it is the MUCl:L-selectin interaction that is being detected. 
However, it is likely that variation in glycosylation for example through alterations in 
glycosyl-transferase enzyme expression, further regulates this adhesive interaction.
5.25 Sialyl Lewis x distribution patterns
MUC1 knockdown using siRNA reduces the binding of L-selectin to the surface of 
Hec-l-A and Hec-l-B cells. While this does suggest that MUC1 is able to mediate L- 
selectin binding, the surface recognition events occurring between AFM tips and cell 
surface were more frequent when tips were functionalised with a MUC1 antibody 
(raised against the naked VNTR peptide) than when compared to L-selectin (which 
requires glycosylated epitopes for recognition). This suggests that not all MUC1 present 
at the apical cell surface is presenting the epitopes required for L-selectin recognition. 
The carbohydrate decoration of MUC1 is important to the functionality of the molecule, 
and the initial glycosylation step involves synthesis of GalNAc through a-O-glycosidic 
linkage to Serine/Threonine residues in the MUC1 VNTR naked peptide. This process 
is dependent on the glycosyltransferase enzyme GlcNAc6ST-2 (Okayama et al. 2011). 
The presence of sLex on Hec-l-A and Hec-l-B monolayers was investigated using two 
approaches; immunofluorescence against the carbohydrate epitope sLex (recognised by 
MECA-79 mAb) and mRNA quantification of a GlcNA2-6ST. Protein expression of 
sulphated sLex was quantified using the INCELL analyzer HCS system and mRNA 
expression of GlcNA2-6ST was assessed using qRTPCR.
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Analysis of immunofluorescence images of Hec-l-A and Hec-l-B monolayers (Figure 
82A and B) stained for sulphated sLex and counterstained with DAPI showed that, 6% 
of Hec-l-A and 15% of Hec-l-B cells were positive for sLex (Figure 82C). GlcNA2- 
6ST mRNA was found to be expressed at low levels in both cell types (Figure 82D). As 
GlcNA2-6ST is required for generation of L-selectin ligands, low expression could 
result in limited L-selectin binding as the MUC1 presenting at the apical surface may 
not be functionally receptive to L-selectin. Moreover, the images reveal certain cells 
across the monolayers that express very high sLex relative to the main population.
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Figure 81: Combined effect on percentage of force curves that showed molecular bond 
ruptures
Heterogeneous expression of the L-selectin ligand seen in these cell lines is consistent 
with recent in vivo data (Nejatbakhsh et al. 2012) and could explain the frequent and 
strong force required to separate the L-selectin-ligand interactions observed on a small 
number of cells across the Hec-l-B monolayer (Figure 79: Detection, localization and 
rupture analysis of L-selectin ligands on endometrial Hec-l-A cells treated with MUC1 
siRNA using SMFS. (A-F) Maps showing number of steps on each force curve (2pm x 
2pm) of Hec-l-A cell surface recorded with a L-selectin functionalised probe. Steps 
(coloured pixels) were detected using JPK data processing software are colour scaled 
according to occurrence (0-10+). (G) Percentage of force curves considered positive [>1
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step] or negative [<1 step], data from all measured areas (n=9). Purple bars indicated 
MUC1 siRNA treatment.
O). The majority of cells across the endometrial monolayer of Hec-l-A and Hec-l-B 
cell lines are not decorated (to the same extent) with the epitope recognised by L- 
selectin and therefore would not present an adhesive surface to the embryo through this 
mechanism (Figure 82). Hec-l-A and Hec-l-B cell lines are described as poorly 
adhesive in implantation assays using JAR cells (human trophoblast) or mouse 
blastocysts (Harduf et al. 2009; Martin et al. 2000; Dominguez et al. 2010) when 
compared to other endometrial cell lines such as RL95. The low frequency expression 
of L-selectin ligands in these cells may contribute to this poor adhesiveness.
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Figure 82: The level of glycosylation in Hec-l-A and Hec-l-B cell monolayers. (A+B) 
Hec-l-A and Hec-l-B cells were grown until 80% confluence and fixed and stained for 
MECA-79. (C) The INCELL analyzer 2000 protein analysis platform was used to 
determine the number of cells that were positive for MECA-79 expression. (D) mRNA 
expression of GlcNA2-6ST glycosyltransferase and MUC1.
5.3 Discussion
In this chapter, specific interactions between AFM tips fimctionalised with MUC1 mAb 
or L-selectin and the endometrial epithelium were investigated using direct and 
quantifiable approaches. For the first time in isolation, L-selectin protein has been 
shown to bind to the surface of endometrial epithelial cells. The strength (step size) and 
frequency (step count) of L-selectin binding can vary between cells across a population, 
and increased L-selectin affinity in a small number of cells correlates with increased 
expression of the L-selectin ligand sLex in a small cellular sub population. Down 
regulating the expression of MUC1 protein reduced the number of L-selectin binding 
events, suggesting that MUC1 hosts L-selectin ligands under the conditions tested.
The approach taken here was to functionalise the AFM tip using a rigid linker system 
and specialised software to detect ‘steps’ in the retraction force curves resulting from 
force induced bond ruptures. This allowed for the characterisation of the L-selectin 
interaction on live endometrial monolayers. As previously mentioned the bond rupture 
force can be affected by the rate of bond loading and functionalisation strategy. 
Alexandre Noy describes 'A force-induced bond rupture in the atomic force microscope 
is simply a thermally driven transition from the bound state into an unbound state over 
a potential energy surface that is constantly modified by the time- dependent potential 
o f the loading spring ’ (Noy 2011). However, the potential energy requirement for bond 
separation may be modified by the linker strategy used. Rigid linker systems preserve 
the Hookean spring model during bond separation whereas more flexible tethers (such 
as PEG) make the probe behave in a semi-harmonic fashion (Noy 2011). The 
implication of flexible linker molecules is that once an unbound state is reached the 
entropic elasticity of the tether pulls the molecules apart and prevents bond reformation. 
This means the first passage dissociation is characteristic of the bond rupture because 
the bond never returns to the equilibrium state (before energy maxima is reached). 
However, when a rigid linker is used the bond has a chance to reform and return to a 
state of equilibrium or existing in a near equilibrium state thus requiring a secondary 
dissociation event. In this situation the bond dissociation is determined by the rate of
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bond loading, and so if the cantilever is withdrawn quickly the transition from the 
bound to unbound state will mimic the first passage dissociation that occurs with 
flexible tethers. However, if the cantilever is withdrawn slowly the system will be 
permitted to sample both bound and unbound states and exist at near equilibrium.
This first passage analysis of SMFS measurements is known as dynamic force 
spectroscopy where the rupture strengths for weak biochemical bonds are not constants 
but instead depend on the rate of force application and duration of (Evans & Ritchie 
1997; Merkel et al. 1999; Evans 1998). The loading rate acting on the bond is not 
equivalent to the loading force applied by cantilever, due to the fact that the molecule 
being probed is akin to a non-linear spring and conforms to a freely jointed chain (FJC) 
model of elastic extension rather than the hookean spring. Analysing bond dissociation 
is a major challenge in AFM because the strength of bond rupture can easily be affected 
by experimental conditions. This highlights importance of maintaining a constant 
loading force, and thus it is important to keep the AFM cantilever and functionalization 
strategy consistent during dynamic SMFS experiments.
The direct functionalization of Si2N 3 tips used in this chapter ensures is there is no loss 
of tip accuracy. In contrast, when tips are coated with successive metal layers such as 
gold (Takano et al. 1999), tungsten (Albrecht et al. 1990) or chromium (Oesterschulze 
et al. 1997) to improve surface properties prior to functionalization, the metallic layer(s) 
may add some 40-100nm to surface thickness (Barattin & Voyer 2008) and can 
negatively affect tip geometry. The direct silanization of Si2N3 results in the grafting of 
aliphatic chains onto the silica surface, via trichlorosilane groups, to form organosilane 
layers. Using 3-aminopropyl triethoxysilane (APTES) as the silanization reagent results 
in a monolayer with a terminal amino group (Riener et al. 2003), a distinct advantage 
when tethering proteins such as antigen (Ros et al. 1998) or antibody (Li et al. 2005). 
The terminal amino group can be reacted with glutaraldehyde creating an imine bond 
and resulting in a free aldehyde group to accept the protein of interest through an 
addition imine bond (Vinckier et al. 1995). This approach has been applied and 
reproduced in other biological systems such as probing synaptic vesicle fusion proteins 
(Yersin et al. 2003), glutamate receptor (Steiner et al. 2005) and 
glycosylphosphatidylinositol (GPI) membrane proteins (Roduit et al. 2008). The 
functionalization of silicon-based tips by the formation of organosilane layers is
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therefore a convenient way to change the surface chemistry of a tip and a valuable 
complement to the metallization strategy.
5.31 MUC1 surface presentation
The Hec-l-A and Hec-l-B cell lines were used as high and low models of MUC1 
expression but surface affinity for L-selectin was consistent across both cell 
monolayers. This suggested one of two possibilities; either MUC1 did not host sLex in 
Hec-l-A and Hec-l-B or not all MUC1 was not decorated with sLex in these cell lines. 
MUC1 gene knockdown reduced L-selectin binding demonstrating that MUC1 does 
host sLex. Moreover, HCS revealed that a small sub-population of cells strongly 
expressed the MECA-79 epitope corresponding to sLex. It is possible that these cells are 
targeted in the small subset of curves which show high L-selectin binding and therefore 
have an increased adhesiveness to L-selectin due to this increased glycosylation status.
SMFS was used to characterise the interaction between MUC1 and a mAb recognising 
MUC1 VNTR naked peptide across the live cell surface of the Hec-l-A and Hec-l-B 
EEC cell lines. The surface interactions observed between tips functionalised with 
MUC1 mAb and the cell surface were higher in Hec-l-B than Hec-l-A which supported 
data showing Hec-l-B to be a relative high expresser of MUC1. Moreover, down- 
regulation of MUC1 reduced surface binding clearly demonstrating that the AFM can 
be used to detect specific changes in surface expression of MUC1 protein. Rupture 
forces differed between the two cell lines, across Hec-l-A monolayers most ruptures 
occurred between 100-200pN. In contrast, Hec-l-B showed a clustering of rupture 
forces in the 200-300pN range.
Interactions between MUC1 and antibody have been previously studied, Sulchek and 
colleagues quantified the force required for MUC1-antibody bond separation and 
showed this to be directly proportional to the number of bonds (Sulchek et al. 2006) 
(Figure 83). The rupture force for a single bond between a single-chain variable 
fragment (scFv) fusion MUC1 antibody and a MUC1 peptide immobilised on a gold 
substrate was shown to be approximately 150pN (Sulchek et al. 2006). Each additional 
MUCl-scFv bond was shown to increase the required rupture force by ~150pN (Figure
83). In the present study the most frequent rupture force measured on Hec-l-A was 
between 100-200pN, which equates to a single MUCl-mAb interaction. Whilst Hec-1- 
B ruptures generally occurred in the 200-3OOpN range, suggesting the possibility that
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this rupture resulted from multiple bond separations possibly due to the increased 
density of MUC1 on the Hec-l-B ceil surface.
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Figure 83: The measured rupture forces as a function of the number of MUC1-Antibody 
fragment bonds between the AFM tip and sample Graph adapted from (Sulchek et al. 
2006)
In the context of implantation biology, the use of live cells to investigate MUC1 biology 
has many advantages including the carbohydrate decoration that is a requisite for L- 
selectin recognition and potential embryo implantation.
5.32 MUC1 and L-selectin ligand
AFM tips functionalised with recombinant L-selectin used to probe Hec-l-A and Hec-1- 
B allowed the detection of L-selectin binding events on 10% of all curves taken from 
both Hec-l-A and Hec-l-B cells and there was no difference in step frequency between 
the two cell lines. Hec-l-B expresses MUC1 at a much higher level than Hec-l-A, 
however this did not result in increased L-selectin binding through sLex. The bulk of 
MUC1 glycosylation consists of O-linked glycans with minimal presence of N-linked 
glycans on the VNTR protein core. The decoration of serine and threonine residues 
present in the VNTR that are targets of O-linked glycosylation and each VNTR motif is 
able to host five glycans (Figure 13) (Albrecht & Carraway 2011). It is unclear whether 
the primary amino acid sequence of MUC1 or the expression of fucosyltransferases 
determines sLex the content of the protein (Lopez-Ferrer et al. 2000).
The VNTR region of MUC1 can vary from 20-125 repeats of the sequence N' 
GSTAPPAHGVTSAPDTRPAP c , influencing the length (and thus glycosylation) of 
the a sub-unit (extracellular ND domain) of the protein. The VUH45 antibody used in 
these experiments is raised against the VNTR naked peptide so variation in VNTR 
length between Hec-l-A and Hec-l-B could result in multiple binding to a single 
MUC1 molecule, thus increasing the rupture force required for bond separation.
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The cell Hec-l-A and Hec-l-B cell lines are derived from endometrial adenocarcinoma 
and express under-glycosylated MUC1. This could be a consequence of the structural 
isoform (VNTR region), and also the pattern of glycosyltransferases expressed in these 
cells. Analysis of Hec-l-A and Hec-l-B for carbohydrate epitope sLex using MECA-79 
mAb in a HCS for every cell across a population (10,000+ cells) revealed a small subset 
of cells that expressed the moiety. This was approximately 6% of Hec-l-A cells and 
15% of Hec-l-B cells. The majority of both Hec-l-A and Hec-l-B cells exhibited very 
low expression (close to background).
These results support qualitative observations of functional patterning in primary tissue 
(Home et al. 2002). Electron microscopy has provided compelling visual evidence for 
variation of MUC1 sialylation across epithelial monolayers of primary explants of 
healthy secretory phase endometrium (Campbell et al. 2000). Expression of the 
glycosyltransferase enzyme GlcNAc2-6ST has been shown to be low in both cell lines 
which support the protein data showing limited sLex expression as GlcNAc2-6ST is 
required for sLex generation.
5.33 Selectin ligands
Several AFM studies have reported P-selectin-sLex bonds. Rupture forces have been 
shown to range between 50pN (Askarova et al. 2013), 250pN (Zhang, Chen, et al. 2004) 
and 312pN on live capillary endothelial cells (Tsapikouni & Missirlis 2011), but vary 
depending on the functionalization strategy employed (Tsapikouni & Missirlis 2011). 
These forces are a similar order of magnitude to the forces required for L-selectin-sLex 
bond separation observed on live endometrial epithelial cell surfacess in this chapter; 
typically between 100-400pN. However, the very high, nano-newton scale L-selectin 
bond separation forces observed here on a small sub-population of cells appears to be an 
endometrial specific phenomena. Previous studies mounting a single (trophoblast 
derived) JAR cell onto an AFM cantilever, and bringing it into contact with monolayers 
of Hec-l-A cells for durations ranging from ms - 40mins have been attempted. A 1 
minute interaction time between the JAR cell and the Hec-l-A cell layer resulted in 
significant adhesion (7.1 +/- 2 nN) while after 40mins adhesion increased further (16.0 
+/- 4 nN) (Thie et al. 1998). This suggests that the time required for stable adhesion to 
occur between the embryo and the maternal surface meaning the initial embryo capture 
(possibly through selectins) is important.
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Previous functional adhesion studies focusing on attachment rates of embryos or 
trophoblast derived cell lines (Lalitkumar et al. 2007; Mardon et al. 2007; Teklenburg & 
Macklon 2009b; Wang et al. 2012b) to endometrial monolayer or co-culture models and 
show the effect of certain implantation molecules and the effect of hormones on 
implantation success. Here we show that MUC1 can serve as a scaffold for the 
glycosylated epitope sLex and have characterised the binding between L-selectin and the 
endometrial epithelial cell surfacee showing it to be highly variable. While experiments 
detected both MUC1 expression and limited expression sLex on both cell types a co­
localisation antibody study is necessary to demonstrate that the observed correlation 
represents functional activity on specific cells
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6.01 Summary of results
In this thesis the INCELL cell analyzer has been used for HCS to quantify the 
distribution of MUC1 protein across endometrial epithelial monolayers and revealed 
that ovarian hormones E2  and P4  can exert their influence in the endometrium by 
affecting the patterning of adhesion proteins such as MUC1. Additionally, for the first 
time integrated high resolution FD curve based AFM and live endometrial monolayers 
showing that the high MUC1 expressing cell line Hec-l-B was almost 2 fold more 
adhesive than Hec-l-A, and that this highly adhesive state was reduced following 
MUC1 gene silencing signifying that MUC1 contributes significantly to the non­
specific mechanical adhesion in the endometrium. Finally single molecule force 
spectroscopy revealed insights into the surface distribution of MUC1 at molecular 
resolution on live cells which was again specifically targeted using gene silencing. 
Single molecule force spectroscopy showed that the Hec-l-A and Hec-l-B present 
ligands for L-selectin, while immunofluorescence imaging confirmed the presence of 
the endometrial L-selectin ligand, sLex on these cell surfaces. MUC1 gene silencing 
reduced L-selectin binding suggesting that it can act as a scaffold for sLex L-selectin 
ligands in the endometrium making the MUC1/L-selectin adhesion mechanism an 
important contributor to endometrial receptivity.
6.02 Adhesion molecule patterning
MUC1 is expressed in heterogeneous patterns across endometrial epithelial cell 
monolayers. The literature describes “small numbers of cells with increased MUC1 
reactivity” (Quenby et al. 2007) and this heterogeneous patterning of MUC1 has been 
referred to as “characteristic MUC1 staining” (Singh et al. 2010). INCELL analyzer 
based HCS has for the first time quantified the proportion of cells in the population 
expressing high levels of an endometrial adhesion protein. Characteristic MUC1 
staining patterns have been observed in Ishikawa cells (Singh et al. 2010) and secretory 
phase biopsies, and may relate to local sites of implantation. Primary tissue samples 
clearly illustrate differential expression patterns of MUC1 (Home et al. 2005) (Figure
84) and demonstrate that the endometrial cell lines used for this project are good models 
for MUC1 presentation. The importance of MUC1 patterning is further highlighted by a 
correlation between increased numbers of high expressing cells and the infertile 
phenotype (Home et al. 2005). The application of HCS to this in vitro cell line model
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permits quantitative analysis of the heterogeneous patterning of MUC1 and can be 
applied to other adhesion proteins (Figure 84).
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Figure 84: Integrating HCS with endometrial biopsies. Images show the comparison 
of MUC1 staining between EEC cell lines imaged and analysed using HCS and 
endometrial biopsies imaged using confocal microscopy (Home et al. 2005). The 
histogram shows a comparison between MUC1 expression patterns in 4 EEC cell lines.
Despite a variety of emerging approaches such as genomics (Garrido-Gomez et al. 
2013), secretomics (Cheong et al. 2013), and lipidomics (Vilella et al. 2013) there are 
no reliable endometrial markers of receptivity (Edgell et al. 2013). The application of 
HCS is complementary to these approaches, and could be used to screen endometrial 
biopsy tissue for patterns of biomarker expression and possibly, for example provide 
some insight into the suitability of individuals for IVF. Whilst obtaining uterine fluid 
required for secretomics, proteomics and lipidomics approaches is less invasive than 
endometrial biopsy required for HCS, uterine fluid contains abundant serum proteins 
(Hannan et al. 2009) which may mask low abundance secreted proteins in uterine fluid.
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In contrast, HCS provides a direct quantifiable analysis adhesion molecule patterning of 
the epithelial cell layer that presents to the embryo.
HCS was able quantify very subtle changes in MUC1 distribution patterns resulting 
from ovarian hormone stimulation. In contrast to the subtle effects of hormones, 
specific gene silencing reduced MUC1 protein levels by 56% while the proportion of 
high expressing cells decreased 72%, demonstrating that the gene silencing using RNAi 
was more pronounced in the high expressing cells because of the higher basal transcript 
levels. Such detailed analysis highlights the power of HCS and informs and strengthens 
the biophysical observations in by providing rationale for the reduction in L-selectin 
binding affinity following MUC1 gene silencing.
6.03 MUC1 is adhesive
Several studies have suggested a role for MUC1 in human implantation, yet it has been 
implicated in both adhesive and anti-adhesive roles, and its expression is retained 
throughout the late secretory phase (Meseguer et al. 2001). If MUC1 is correctly 
categorised as an anti-adhesion molecule this presents a somewhat confusing paradox. 
The intrinsic heterogeneity of expression demonstrated by the molecule in the 
endometrium may define a receptive site for implantation or act as a quality control for 
embryos by blocking adhesion for defective embryos that lack paracrine signalling. 
Quantitative mapping of live Hec-l-A and Hec-l-B endometrial monolayers suggested 
MUC1 to be an adhesive component of the endometrial glycocalyx. MUC1 specific 
gene silencing clearly reduced the ability of the AFM tip to adhere to the cell surface 
and further supported this notion. Previous publications from our group reported 
increases in fixed cell surface roughness following hormone treatments and correlated 
roughness with MUC1 expression (Francis et al. 2009). The approach taken here was 
complementary to the surface roughness data but returns a wide range of nano­
mechanical properties at high resolution, and takes into consideration live cells in a 
monolayer configuration. Gene silencing targeted MUC1, therefore the observed 
changes to the adhesion between the tip and cell surface can be directly attributed to 
loss of MUC1. Moreover, the reduction in adhesion following gene silencing proved to 
be significant despite the observed heterogeneity of the monolayer, directly linking 
MUC1 with adhesion and independent of other nano-mechanical properties. MUC1 has 
been described in the literature as an anti-adhesive molecule (Makiguchi et al. 1996), 
that is anti-adhesive to the embryo (Meseguer et al. 1998). Whilst MUC1 may regulate
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embryo adhesion by masking the effect of other adhesion molecules, and the embryo 
has been shown to locally clear MUC1 after initial implantation (Meseguer et al. 2001), 
our observations suggest it likely that MUC1 is directly adhesive. Furthermore, the 
adhesive characteristics presented here, and the characteristic spontaneous shedding and 
cleavage of mucin proteins (Thathiah et al. 2003) provide a modus operandi for 
mechanical retardation of the embryo during the apposition stage of implantation. Once 
ensnared in a mucin cloud ‘juxtacrine’ signalling between the embryo and epithelium 
may reveal further adhesive contacts through targeted MUC1 clearance.
Peak force mode imaging of live cells is not routine (Pittenger et al. 2013) and there is 
only one other study of live mammalian cells using PFQNM mode (Heu et al. 2012), 
therefore a preliminary study was conducted using endometrial monolayers following 
fixation. When compared to subsequent live cell monolayers, fixed cells are shown to 
be representative of the live cell model. When combined with the distribution patterns 
these results suggest an endometrium with a distinctly heterogeneous adhesion profile 
which could result in regions of elevated and impaired receptivity.
It appears that MUC1 contributes significantly to the AML in these cell lines. As MUC1 
is an adhesive component of the AML it is potentially able to to retard the embryo to 
allow for initial apposition against the endometrial epithelium, allowing specific 
interactions to occur.
6.04 MUC1 presents ligands for L-selectin
MUC1 has been shown to co-localised with the L-selectin ligand sLex (Hey & Aplin 
1996) in endometrial epithelial cells. Carson showed that MUC1 functions as a scaffold 
for selectin ligands through the secretory phase of the menstrual cycle (Carson et al. 
2000). Moreover, the HECA-452 and MECA-79 epitope selectin ligands have been 
shown to increase from proliferative to the secretory phase in fertile individuals (Lai et 
al. 2005; Home et al. 2002). More recent studies from our group demonstrated not only 
an association of L-selectin ligand with menstrual cycle phase but also with fertility 
status (Margarit et al. 2009). Supported by the weight of clinical data surrounding L- 
selectin ligands, a further step has been taken here to interrogate the functional 
mechanism by which L-selectin ligand can mediate embryo attachment. SMFS AFM 
was used to detect the presence of MUC1 on the surface of two endometrial cells lines 
at molecular resolution. Again, gene silencing reduced specific surface interactions
185
Chapter 6 Thesis summary and conclusions
detected with MUC1 mAb and provided a model with which to test the hypothesis that 
MUC1 hosts ligands for L-selectin. MUC1 gene silencing reduced L-selectin binding 
demonstrating for the first time that the affinity of L-selectin for the surface of 
endometrial cells was influenced by MUC1. While L-selectin binding was detected, 
surface binding was less than that of the MUC1 antibody suggesting that not all MUC1 
expressed in these cells is functionally receptive to L-selectin. The application of SMFS 
is a unique approach in the endometrium and has been able to quantify the strength and 
frequency of L-selectin binding at nano-meter resolution, and complements adhesion 
assays using trophoblast spheroids (Harduf et al. 2009; Wang et al. 2012; Xiong et al. 
2012; Tinel et al. 2000). The disparity of L-selectin binding affinity to cells across the 
monolayers is highlighted by a small proportion of Hec-l-B (and to a lesser extent Hec- 
l-A) cells that displayed altered L-selectin binding characteristics. These included 
increased binding frequency and greatly increased bond strength, suggesting that areas 
of the monolayer vary with respect to embryo affinity. Moreover, there is a strong 
correlation between the heterogeneous expression patterns of L-selectin ligands sLex in 
Hec-l-A and Hec-l-B cells and the heterogeneity in L-selectin binding across 
monolayers of these cells. MUC1 gene silencing treatment disproportionately reduced 
the size of the sub-population of high expressing cells, and resulted in the loss of strong 
L-selectin binding in Hec-l-B suggesting that the MUC1 high expressing cells associate 
with L-selectin binding. Moreover, ovarian hormones can subtly alter the proportions of 
high expressing cells, which was most notable in E2  treated Ishikawa cells where 
numbers of MUC1 high expressing cells were reduced. The effect of ovarian hormones 
on cells expressing elevated adhesion molecules provides rationale for the impaired 
receptivity in hyperstimulated endometria because the sub-population of high 
expressing cells affected by hormones (excess E2 ) could be important in embryo 
implantation.
In order to fully delineate the role of MUC1 and sLex with respect to L-selectin binding 
at the endometrial surface, a direct correlation needs to be made between sLex 
expression and L-selectin binding affinity. This objective could be met with a 
combination of fluorescence staining and targeted single molecule force spectroscopy, 
using an integrated AFM-confocal microscope. Studies of this nature are starting to 
emerge, for example lymphoma cells populations were stained for CD20 (cancer 
marker) and +ve cells were force mapped with a tip functionalised with rituximab, an
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anti-CD20 monoclonal antibody targeted drug (Li et al. 2013), the resulting force curves 
were used to estimate the drug binding affinity to cancer cells. A similar strategy 
employed in the endometrial setting could compare a cohort of cells from each sub- 
population (high and low) for binding of embryo adhesion markers such as L-selectin. 
Once functional adhesion markers have been identified, HCS can be used to assess their 
expression and distribution in infertile pathologies.
A recurring theme throughout this thesis is the heterogeneity of the adhesion molecule 
expression in the endometrium, this has been shown independently using molecular 
biology and biophysical analysis. During the final stage of IVF a fertilised embryo is 
inserted into the endometrium in fluid using a slender catheter device, the fluid and 
embryo are expelled and any implantation site is random. A greater understanding of the 
molecular patterning that defines the adhesive characterises of the endometrium may 
help improve the current low success rates associated with IVF by identifying adhesion 
molecule patterns associated with infertility or regions within the endometrium that are 
more likely to be receptive to the embryo.
6.05 Final conclusions
Infertile pathologies such as ovulatory PCOS and unexplained infertility have been 
linked with high MUC1 expression and altered MUC1 patterning across the endometrial 
epithelium. The heterogeneous expression of MUC1 is likely to result in variation of 
receptivity across the endometrium.
AFM is a very valuable tool in determining the functional availability of MUC1 at the 
endometrial epithelial cell surface and has shown that levels of L-selectin binding are 
independent of total MUC1 expression and more likely to be dependent on 
glycosylation of MUC1. Sialyl lewis x is down regulated in PCOS, unexplained 
infertility and endometriosis. A small sub-population of endometrial cells expressed 
sialyl lewis x moieties and this corresponds with areas of elevated L-selectin affinity 
highlighting the importance of this mechanism in embryo implantation.
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